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Measureable concentrations of antibiotics are released into the environment 
from anthropogenic sources. Environmental risk assessment investigates the 
risks these concentrations pose to aquatic life but does not determine whether 
selection for resistance is occurring. Recent studies suggest environmental 
concentrations of tetracycline, ciprofloxacin and cefotaxime may be able to 
select for resistance in complex microbial communities.  
The aims of research presented in this thesis were to determine whether 
selection for resistance occurs at environmentally relevant concentrations of 
macrolide antibiotics; to understand how mixtures of antibiotics affect selective 
endpoints; to understand the effect of temperature on selective endpoints, and, 
finally, to compare the methods used with previously published methods. 
Selective endpoints of macrolide antibiotics were found to be 1,000 µg/L of 
azithromycin and erythromycin and 750 µg/L of clarithromycin which is 
significantly higher than current environmental concentrations. 
Mixing of antibiotics produces at least an additive, if not a synergistic, effect. 
The selective endpoints of sulfamethoxazole and trimethoprim decrease over 
11 times and by a half, respectively, when used in combination. The selective 
endpoint of macrolides is reduced by a third when they are found in 
combination. 
Selective endpoints of individual genes are affected by temperature but, as only 
preliminary data has been produced, overall effect concentrations have not 
been determined across the entire experimental resistome. Alternative gene 
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targets associated with taxa favoured at low temperatures may be under 
selection. 
Finally, the phenomenon of increased persistence has been described and the 
minimal increased persistence concentration has been defined for the first time.  
Data presented here can be used by policy makers in environmental risk 
assessments, in conjunction with other ecotoxicological endpoints to determine 
safe release levels of antibiotic residues in wastewater. This will help minimise 
selection for antibiotic resistance in the environment and, therefore, exposure of 
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Figure 60A: mphA as a function of AZ at 37 °C. B: mphA as a function of 
AZ at 28 °C. C: mphA as a function of AZ at 20 °C. x = significant increase in 
comparison to the control to 90% confidence.  xx = significant increase in 
comparison to the control to 95% confidence.  ** = significant positive selection 
to 95% confidence. Standard error is represented by the error bars. 
Figure 61A: Selection for intI1 in the presence of AZ at 37 °C. B: Selection 
for intI1 in the presence of AZ at 28 °C. C: Selection for intI1 in the 
presence of AZ at 20 °C. ** = significant positive selection to 95% confidence. 
Standard error is represented by the error bars. 
Figure 62: TetG as a function of TET concentrations. A: Graph shows only 
the day 7 prevalence data. B: Graph shows the prevalence data from both 
days, although prevalence of tetG at the end of the experiment is so low 
that this cannot be observed on the graph. Please note that these graphs 
are on different axes as the day 7 data cannot be visualised otherwise. 
Standard error is represented by the error bars. x = a significant increase in 
prevalence relative to the no antibiotic control to 90% confidence. 
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Figure 63: TetG as a function of TET concentrations in a biofilm flow 
through system. Reproduced from Lundström et al. 2016. * = p <0.05, *** = p 
< 0.001. A one – tailed Student’s t-test was used on log2 transformed data to 
determine significance. 
Figure 64: Selection coefficient of tetG by TET.  The square root of 
tetracycline concentration was plotted. Absolute concentrations represented by 
this graph are 0, 0.1, 1, 10 and 100 µg/L of TET. The blue line is the polynomial 
line of best fit (order 2), the grey shading represents the confidence intervals 
and the purple points represent the selection coefficients for each replicate. 
Figure 65: TetG as a function of a large range of TET concentrations. The 
low range of concentrations are represented in 65A and the high in 65B. Two 
high outlier replicates have been removed from the 3.90625 µg/L sample and 
one from the 7.8125 µg/L sample. Standard error is represented by the error 
bars.  
Figure 66: TetG as a function of low TET concentrations – day 7 only. 
Standard error is represented by the error bars. xx = significant persistence to 
95% confidence. 
Figure 67: TetG as a function of high TET concentrations – day 7 only. 
Standard error is represented by the error bars. xx = significant persistence to 
95% confidence. 
Figure 68: TetM as a function of low TET concentrations. Standard error is 
represented by the error bars.  
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Figure 69: TetM as a function of high TET concentrations. Standard error is 
represented by the error bars. ** = significant positive selection to 95% 
confidence. 
Figure 70: IntI1 as a function of low TET concentrations. Standard error is 
represented by the error bars.  
Figure 71: IntI1 as a function of high TET concentrations. Standard error is 
represented by the error bars. * = significant positive selection to 90% 
confidence, ** = significant positive selection to 95% confidence. 
Figure 72: Selection coefficient of intI1 by TET. A reduced range of 
concentrations ranging from 62.5 to 2,000 µg/L of TET is plotted here to make 
the line of best fit more accurate and the most protective. The blue line is the 
polynomial line of best fit (order 2), the grey shading represents the confidence 
intervals and the purple points represent the selection coefficients for each 
replicate. 
Figure 73: Tetracycline resistance gene prevalence from metagenome 
analysis as a function of TET concentration. Standard error is represented 
by the error bars. ** = significance to 95% confidence. 
Figure 74: TetW as a function of TET concentration. Standard error is 
represented by the error bars. * = significance to 90% confidence. ** = 
significance to 95% confidence. 
Figure 75: TetA as a function of TET concentration. Standard error is 
represented by the error bars. * = significance to 90% confidence. ** = 
significance to 95% confidence. 
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Figure 76: Tet32 as a function of TET concentration. Standard error is 
represented by the error bars. * = significance to 90% confidence. ** = 
significance to 95% confidence. 
Figure 77: Bacterial growth rate as a function of antibiotic concentration. 
Graph adapted from Gullberg et al. 2011 to include the sub-MSC persistence 
window (blue area) and the MIPC. The blue line indicates the change of growth 
rate of susceptible bacteria with increasing concentrations of antibiotic. The red 
line shows the change in growth rate of resistant bacteria with increasing 













 List of Accompanying Material 
Figure 78: Map showing the two wastewater treatment plant sampling sites in 
Cornwall. Red indicates the Camborne and Redruth plant which serves a 
population of approximately 34,000 people. Blue indicates the Falmouth and 
Penryn plant that serves a population of approximately 43,000 people. Map was 
made using ArcGIS 10.5.1. 
Table 11: Measured environmental concentrations of macrolide antibiotics. 
Table shows the measured environmental concentrations of azithromycin, 
clarithromycin, erythromycin and erythromycin – H2O. The matrix, location and 
reference for each study can also be seen. All concentrations are in µg/L. 
Figure 79: mef family as a function of low azithromycin concentrations (1 high 
outlier replicate removed). Standard error is represented by the error bars. 
Figure 80: Scatter plot showing the variation in mphA prevalence at day 7 in 
samples selected for by increasing concentrations of AZ. 
Figure 81: Graph showing the selection coefficient of ermF by AZ. The line of 
best fit (polynomial order 3, y= 0.05846 + 0.0006282x – 2.2e-06x2 + 1.752e-09x3, 
R2 = 0.07934) never crosses the x axis and no MSC can, therefore, be 
determined for this dataset. 
Figure 82: Graph showing the selection coefficient of ermF by CLA. The line of 
best fit (polynomial order 3, y = 0.2305 + 0.001955x – 4.514e-06x2 + 2.9e-09x3, R2 
= 0.3268) lies above and never crosses the x axis. A MSC can never, therefore, 
be determined. 
Figure 83: Bar chart showing the change in ermB with increasing concentrations 
of ERY from the metagenome dataset. A biological effect is observed at every 
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concentration of ERY but this is not reflected by the statistical analyses. 
Standard error is represented by the error bars. 
Table 12: Table showing the macrolide resistance genes prevalence data as a 
function of AZ concentration. This corresponds to the heat map in Figure 24.  
Table 13: Table showing the macrolide resistance genes prevalence data as a 
function of CLA concentration. This corresponds to the heat map in Figure 25.  
Table 14: Table showing the macrolide resistance genes prevalence data as a 
function of ERY concentration. This corresponds to the heat map in Figure 26.  
Table 15: Table showing the prevalence data of antibiotic resistance gene 
classes as a function of AZ concentration. This corresponds to the heat map in 
Figure 29.  
Table 16: Table showing the prevalence data of antibiotic resistance gene 
classes as a function of CLA concentration. This corresponds to the heat map in 
Figure 30.  
Table 17: Table showing the prevalence data of antibiotic resistance gene 
classes as a function of ERY concentration. This corresponds to the heat map 
in Figure 31.  
Figure 84: Heatmap showing the total community structure of samples 
passaged in the presence of azithromycin. 
Table 18: Table showing the data that corresponds to the heatmap shown in 
Figure 34. Data is the output from MetaPhlAn2 is relative abundance of species 
found in the day 7 sample of the AZ evolution experiment. Relative abundance 
is calculated by normalising the total reads per clade to the nucleotide length of 
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the clade’s key markers (Segata et al. 2012). E. unclassified = Escherichia 
unclassified. 
Figure 85: Heatmap showing the total community structure of samples 
passaged in the presence of clarithromycin. 
Table 19: Table showing the data that corresponds to the heatmap shown in 
Figure 35. Data is the output from MetaPhlAn2 is relative abundance of species 
found in the day 7 sample of the CLA evolution experiment. Relative abundance 
is calculated by normalising the total reads per clade to the nucleotide length of 
the clade’s key markers (Segata et al. 2012). E. unclassified = Escherichia 
unclassified. K. unclassified = Klebsiella unclassified. 
Figure 86: Heatmap showing the total community structure of samples 
passaged in the presence of erythromycin. 
Table 20: Table showing the data that corresponds to the heatmap shown in 
Figure 36. Data is the output from MetaPhlAn2 is relative abundance of species 
found in the day 7 sample of the ERY evolution experiment. Relative 
abundance is calculated by normalising the total reads per clade to the 
nucleotide length of the clade’s key markers (Segata et al. 2012). E. 
unclassified = Escherichia unclassified. K. unclassified = Klebsiella unclassified. 
Figure 87: Selection of intI1 by ciprofloxacin. Significant positive selection was 
observed to 90% confidence at 15.625 (p = 0.0634, GLM Gamma (identity)) and 
31.25 (p = 0.0553, GLM Gamma(identity)) and to 95% confidence at 62.5 µg/L 
(p = 0.0491, GML, Gamma (identity)) and at every subsequent higher 
concentration. Standard error is represented by the error bars. * = significant 
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positive selection to 90% confidence. ** = significant positive selection to 95% 
confidence. 
Figure 88: Selection coefficient of intI1 in the presence of ciprofloxacin. The line 
of best fit (polynomial, order 4 – y = 0.1093 + 0.293x – 0.5274x2 + 0.1921x3 – 
0.0188x4, R2 = 0.4397, Standard error = 0.2645, x intercept = 10.77) determines 
a MSC of approximately 11 µg/L of ciprofloxacin. The square root of 
ciprofloxacin concentration used to better visualise the data. 
Figure 89: Graph showing full 24 hour growth rate for SMX experiment 1 
Figure 90: Graph showing full 24 hour growth rate for TRMP experiment 2 
Figure 91: Graph showing full 24 hour growth rate for SMX experiment 2 
Figure 92: Graph showing full 24 hour growth rate for TRMP-SMX in 
combination 
Figure 93: Selection coefficient graph for intI1 in the presence of TRMP in 
isolation. The MSC is determined to be approximately 38 µg/L.  
Figure 94: Selection coefficient graph for intI1 in the presence of TRMP in when 
mixed with SMX. The MSC is determined to be approximately 19 µg/L.  
Figure 95: Selection coefficient graph for intI1 in the presence of SMX in 
isolation. The MSC is determined to be approximately 841 µg/L. The square 
root of SMX concentration has been plotted. The data values plotted equate to 
the absolute concentration values of 0, 62.5, 125, 250, 500, 1000 and 2000 
µg/L. 
Figure 96: Selection coefficient graph for intI1 in the presence of SMX in when 
mixed with TRMP. The MSC is determined to be approximately 69 µg/L. The 
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square root of SMX concentration has been plotted. The data values plotted 
equate to the absolute concentration values of 0, 62.5, 125 and 250 µg/L of 
SMX in the experiment. 
Figure 97: Graph showing the growth rate of a mixed community at 37 °C during 
a 24 hour period.  
Figure 98: Graph showing the growth rate of a mixed community at 28 °C during 
a 24 hour period.  
Figure 99: Graph showing the growth rate of a mixed community at 20 °C. A 
starting and final OD was quantified. Hour readings were taken between hour 
14 and 23 (exponential phase) so a growth rate could be calculated. 
Figure 100: mphA as a function of AZ at 37 °C at day 7. B: mphA as a function 
of AZ at 28 °C at day 7. C: mphA as a function of AZ at 20 °C at day 14. x = 
significant increase in comparison to the control to 90% confidence.  xx = 
significant increase in comparison to the control to 95% confidence.  ** = 
significant positive selection to 95% confidence. Standard error is represented 
by the error bars. 
Figure 101: Selection coefficient of tetG by TET. A MSC is not determined as 
the line of best fit (polynomial order 4, y = -1.357 – 0.01895x + 0.0003157x2 – 
1.439e-06x3 + 1.994e-09x4, R2 = 0.239) never crosses the x axis. The square 
root of all tetracycline concentrations from both the low and high experiments 
were plotted.  
Figure 102: Selection coefficient of tetM by TET. A MSC is not determined here 
as the line of best fit (polynomial order 2, y = 0.41 – 0.0024x + 7.5e-6x2, R2 = 
0.119) never crosses the x axis. The square root of tetracycline concentration 
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was plotted. All of the concentrations from both the low and high concentration 
experiment are represented here. 
Figure 103: Heatmap showing all detectable tetracycline resistance genes as a 
function of TET concentration. If the prevalence is displayed the genes with high 
prevalences skew the data and it appears that genes at lower prevalences are 
undetectable. The log(prevalence) is, therefore, represented in this graph. 
Genes that were undetected in all samples were excluded; these were tcr3, 
tet31, tet36, tet39, tet41, tet43, tetG, tetT, tetV, tetY and tetZ. White areas 
represent where the gene was below the limit of detection. * = significance to 
90% confidence, ** = significance to 95% confidence.  
Figure 104: Co-selection of antibiotic resistance gene classes by tetracycline. 
Co-selection is observed at the lowest concentration of TET sequenced for the 
classes aminoglycoside, bleomycin and trimethoprim. Other classes displayed 
here see an increase in their resistance genes at higher concentrations. White 
represents where the prevalence of a class is below the limit of detection. 
Classes that were below the limit of detection in every sample sequenced are 
not represented here. These were carbomycin, fusidic-acid, puromycin, 
spectinomycin and tetracenomycin-C. * = significance to 90% confidence, ** = 
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The component (or components) of a 
pharmaceutical that produces the effect 
Anthropogenic pollution Pollution that originates from human activity 
Antibiotic An antimicrobial that inhibits or kills bacteria 




A gene that encodes a protein which is able to 
prevent the activity of an antibiotic 
Antimicrobial A drug used to inhibit or kill a microorganisms such 
as bacteria, fungi, viruses or protozoa (used 
interchangeably throughout this thesis with 
“Antibiotic”) 
Antimicrobial resistance The ability of a microorganism to grow in the 
presence of an antimicrobial (used interchangeably 
throughout this thesis with “Antibiotic Resistance”) 
Assessment factor A value applied to results from ecotoxicology 
experiments to account for a degree of uncertainly 
Bacteria A diverse group of unicellular, microscopic 
microorganisms which lack organelles  
Bactericidal An antibiotic that kills bacteria 
Bacteriostatic  An antibiotic that inhibits the growth of bacteria 
Biofilm A thin layer of a bacterial community (and other 
microorganisms) that has adhered to a solid surface 
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Commensal bacteria Bacteria that live within another organism 
Co-selection The selection by an antibiotic of multiple resistance 
genes from different antibiotic classes 
Ecotoxicology The study of the potential harmful effects of 
chemicals on the biological organisms found in the 
environment 
Emerging contaminant Contaminants that enter water environments from 
anthropogenic pollution (such as wastewater 
treatment plants or agricultural runoff) 
Fitness advantage The advantage to an organism’s ability to survive by 
harbouring a particular gene or trait 
Fitness cost The disadvantage to an organism’s ability to survive 
by harbouring a particular gene or trait 
Horizontal Gene 
Transfer (HGT) 
The transfer of genetic material between bacterial 
cells and species that is not parent to offspring 
transmission 
Integron A mobile genetic element that are found in bacteria 
and are defined by an intI gene, a recombination site 
and a promotor 
In vitro Experimental work that is undertaken outside of a 
natural organism.  
Lowest Observed Effect 
Concentration (LOEC) 
The lowest concentration of a pharmaceutical tested 
at which a response is observed 
Minimal Increased 
Persistence 
The lowest concentration of an antibiotic required to 
see an increase of persistence (or differential rates 
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Concentration (MIPC) of negative selection) of resistance genes  
Minimal Selective 
Concentration (MSC) 
The lowest concentration of an antibiotic required to 
see an increase in positive selection  
Minimum Inhibitory 
Concentration (MIC) 
The lowest concentration of an antibiotic that is 
required to produce a visible reduction in growth of 
bacteria 
Mobile Genetic Element 
(MGE) 
Genetic material that is able to move around within 
the genome and can be passed between different 
cells and species 
No Observed Effect 
Concentration (NOEC) 
The highest concentration of a pharmaceutical 
where no effect is seen or the concentration tested 
below the LOEC 
Pathogenic Disease causing 
Plasmid A genetic element that is capable of replicating 
independent of the chromosome. It is typically 
circular and small and is often found in bacteria 
Polymerase Chain 
Reaction (PCR) 
An experimental technique that allows the 
amplification of a DNA target in which multiple 
rounds of heating and cooling are used to denature 
the DNA, to anneal DNA primers to the DNA strands 
and to extend and copy the DNA template using 
nucleotide bases and a polymerase enzyme.  
Predicted Environmental 
Concentration (PEC) 
The expected environmental concentration of a 
substance. Predictions take into account the 
concentration present and the concentration being 
inputted in the environment, the spread of the 
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substance through the environment and removal 
and/or degradation rate of the substance. 
Predicted No Effect 
Concentration (PNEC) 
The concentration of antibiotic at which no adverse 
effect is expected to be seen. In this case, where an 
assessment factor is applied to the No Observed 
Effect Concentration. 
Quantitative Polymerase 
Chain Reaction (qPCR) 
An experimental technique based on the PCR 
technique that is able to monitor the amplification of 
DNA in real time 
Resistome All antibiotic genes found in a given area in both 
pathogenic and non-pathogenic bacteria 
Risk Quotient (RQ) An estimation of risk that is calculated from the ratio 
of predicted environmental concentration to the 
predicted no effect concentration 
Selective endpoint The concentration at which selection is first 
observed. This can be a LOEC when using 
statistical means or an MSC when defining using a 











AMR Antimicrobial resistant 
ANOVA Analysis of variance 
API(s) Active pharmaceutical ingredient(s) 
ARB Antibiotic resistant bacteria 
ARG(s) Antibiotic resistance gene(s) 
ASRIT Activated sludge respiration inhibition 
test 
AZ Azithromycin 
bp Base pairs 
CDC Centers for Disease Control and 
Prevention 
CLA Clarithromycin 
EMEA European Medicines Agency 
epicPCR Emulsion, Paired, Isolation and 
Concatenation polymerase chain 
reaction 
ERY Erythromycin 
GLM Generalised Linear Model 
HGT Horizontal Gene Transfer 
IPCC Intergovernmental Panel on Climate 
Change 




MEC(s) Measured Environmental 
Concentration(s) 
MECmax Maximum measured environmental 
concentration 
MECmean Mean measured environmental 
concentration 
MECmedian Median measured environmental 
concentration 
MGE(s) Mobile Genetic Element(s) 
MIC(s) Minimum Inhibitory Concentration(s) 
MLS gene(s) Macrolide, lincosamide and 
streptogramin resistance genes 
MIPC(s) Minimal Increased Persistence 
Concentration(s) 
MSC(s) Minimal Selective Concentration(s) 
NOEC(s) No Observed Effect Concentration(s) 
NOEC/LOEC/MSCi NOEC/LOEC/MSC of the individual 
compound 
NOEC/LOEC/MSCm NOEC/LOEC/MSC of compound in 
mixture 
OD Optical Density 
OECD Organisation for Economic Co-
operation and Development 
OIE World Organisation for Animal Health 





PNEC(s) Predicted No Effect Concentration(s) 
PNECR(s) Predicted No Effect Concentration(s) 
for the selection of resistance 
PNECSW Predicted No Effect Concentration of 
surface water 
qPCR Quantitative/Real-time polymerase 
chain reaction 
Rpm Rotations per minute 




TRMP-SMX Combination of trimethoprim and 
sulfamethoxazole 
UBA Umwelt Bundesamt (German 
Environment Agency) 
UN United Nations 
WHO World Health Organisation 







Genes and encoded products 
Gene Encodes 
16s rRNA 30S subunit of bacterial ribosome 
intI1 Class 1 integron 
Confers beta-lactam resistance 
bla-CEP-04, bla-CTX-M ß – lactamase enzyme 
Confers ciprofloxacin resistance 
ΔacrR Deletion of HTH-type regulator gene acrR 
gyrA1 DNA gyrase subunit A 
gyrA2 DNA gyrase subunit A 
Confers macrolide resistance 
ereA, ereB Esterase enzyme 
erm(33), erm(35), erm(TR), 
ermA, ermB, ermC, ermF, 
ermG, ermT, ermX 
rRNA methylase enzyme 
macA, macB Subunit of an efflux pump (ABC transporter) 
mef family (mefA, mefE, 
mefI, mefO) 
Efflux pump (major facilitator) 
mphA, mphC Phosphortransferase enzyme 
msrA, msrC, msrD Efflux pump (ABC transporter) 
Confers sulfamethoxazole resistance 
sul1, sul2, sul3 Dihydropteroate synthase enzyme 
Confers tetracycline resistance 
tet32, tetM, tetO, tetQ, tetW Ribosomal protection protein 
tetA, tetG Efflux pump (major facilitator) 
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tetJ Efflux pump 
tetL Efflux pump 
Confers trimethoprim resistance 























Chapter 1: Introduction 
1.1 Background  
The discovery of antibiotics during the 20th century has transformed modern 
medicine (Aminov 2010). None of the classes of antibiotics that have been 
introduced, however, have escaped the emergence of resistance genes to 
combat them (Levy & Marshall 2004), (Figure 1). This is not a recent problem: 
even before penicillin was introduced in the clinic in 1945 (Gould 2016) 
observations in the laboratory suggested that certain bacterial species had the 











This image has been removed by the author of this thesis for copyright 
reasons. 
Figure 1: Timeline showing the introduction of an antibiotic class in the 
clinic and when subsequent resistance arose to that antibiotic class. 




There has been a rapid increase of the rate of emergence of resistance 
accompanied by a resulting increase in morbidity and mortality caused by 
resistant infections (Livermore 2009; Finley et al. 2013; Wellington et al. 2013). 
Currently, most bacterial infections are still treatable, but resistance has now 
developed even to “last resort” antibiotics, such as colistin (Thi Khanh Nhu et al. 
2016). It is feared that infections that are currently easily treated may become 
life threatening in the future as the range of effective antibiotics reduces further 
(Finley et al. 2013; Livermore 2009; Wellington et al. 2013). In 2014, the World 
Health Organisation (WHO) claimed that antimicrobial resistance (AMR) had 
become a public health crisis and stated that “a post-antibiotic era – in which 
common infections and minor injuries can kill – far from being an apocalyptic 
fantasy, is instead a very real possibility for the 21st Century” (WHO 2014). In 
addition, in work commissioned by the UK Government in 2014 (The Review on 
Antimicrobial Resistance), it was predicted that AMR will become the leading 
cause of death by 2050, totalling 10 million deaths per year and a total GDP 
loss of $100 trillion between 2014 and 2050 (O’Neill 2014). 
Antibiotics are important in a wide range of medical and non-medical 
applications. For example, in addition to the treatment of bacterial infections, 
there is heavy reliance on these pharmaceuticals for the prevention of infections 
arising from medical procedures such as organ transplants or when using 
immunosuppressive drugs in cancer management. In addition, food security will 
be impacted as global agricultural and aquacultural practices rely heavily on 
effective antibiotics for disease prevention and treatment in livestock and for 
growth promotion (Livermore 2009). 
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1.1.1 The overuse and misuse of antibiotics 
Although the relationship between antibiotic usage and the development of 
antibiotic resistance is complex, extensive and inappropriate use of antibiotics is 
one of the main drivers for the development of resistance (Friedman & Whitney 
2008).  
Inappropriate use of antibiotics includes over-prescription, for example 
prescribing antibiotics when a patient has a respiratory illness caused by a viral 
infection (Friedman & Whitney 2008). The Longitude Prize charity has 
conducted surveys within the United Kingdom and found that 55% of GPs feel 
pressure from patients to prescribe antibiotics, 44% of total GPs surveyed 
prescribing them to make a patient leave the appointment and 45% prescribing 
for viral infections when they were aware that the antibiotics will have no effect 
(Cole 2014). Furthermore, some countries such as China and India are reported 
to have high and inappropriate use of antimicrobials (Cui et al. 2017; Van 
Boeckel et al. 2014). In 2006, approximately 210,000 tons of antibiotics were 
produced in China and only 30,000 tons of this was exported; the remainder 
was consumed, with approximately 70% of hospital inpatients treated with 
antibiotics (Cui et al. 2017).  
In addition to inappropriate prescribing by doctors, over the counter availability 
of antibiotics in some countries inevitably leads to overuse and misuse by a 
public lacking diagnostic and other specialist knowledge (Aminov 2010). Even in 
countries with regulation, problems persist: for example, although it is illegal to 
sell antibiotics without prescription in Spain, they are available over the counter 
in some pharmacies (Llor & Cots 2009) and there has been a trend in the 
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United States for consumers to purchase antibiotics from other countries online 
(Mainous et al. 2009).  
1.1.2 Current trends in clinical resistance 
The effect of use and overuse of antibiotics is already visible. The extensive use 
of these drugs clinically and in agriculture in the last 75 years has increased the 
selective pressure on both disease-causing and non-pathogenic bacteria 
(Laxminarayan et al. 2013). There are many different surveillance programmes 
currently being undertaken such as “ResistanceMap” (The Center for Disease 
Dynamics Economics & Policy 2018) and the Global Antimicrobial Resistance 
Surveillance System (or GLASS) (WHO 2018) to fully understand the global 
scale of this problem. Programmes such as these are, however, highly 
dependent on the number of countries participating and reporting: GLASS, for 
example, had only 71 countries enrolled in its scheme in December 2018 (WHO 
2018) and, therefore, outputs from these programmes may be an 
underestimation of the true extent of the crisis. 
The report commissioned by the UK government (see Section 1.1 above) 
predicted that, globally, 10 million deaths will occur each year from AMR by 
2050, rising from 700,000 in 2014 (O’Neill 2014). One study investigated the 
effects of resistant infections in the European Union and the European 
Economic Area. Results showed that, in 2015, there were 671,689 cases of 
resistant infections reported which caused 33,110 deaths and 874,541 disability 
adjusted life years. The main groups of people affected were those younger 
than 1 and older than 65 (Cassini et al. 2019). Another study investigated the 
change in incidence of resistant blood stream infections in children in Malawi 
from 1998 to 2017. Over that period, they observed an increase in resistant 
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infections to all first line antibiotics from 3.4 to 30.2% and for Klebsiella spp. 
from 5.9 to 93.7% (Iroh Tam et al. 2019). In India, where the death rate from 
infectious diseases is double that of the United States, resistance to antibiotics 
is high. E. coli isolated in the community between 2004 and 2007, was found to 
have high levels of resistance to ampicillin (75%), naladixic acid (73%) and to 
trimethoprim and sulfamethoxazole used in combination (59%). An increase in 
high levels of resistance was also observed in E. coli to third-generation 
cefalosporins (70 to 83%) and fluoroquinolones (78 to 85%) between 2008 and 
2013 (Laxminarayan & Chaudhury 2016).  
Pandrug resistant infections, which are defined as infections with “non-
susceptibility to all agents in all antimicrobial categories” (Magiorakos et al. 
2012), have also emerged. In August 2015, a female in Nevada, United States, 
who had recently been hospitalised a number of times during an extended stay 
in India, was diagnosed with a Klebsiella pneumoniae infection. This particular 
bacterium was resistant to 26 antibiotics tested and resistant intermediately to 
tigecycline. The only antibiotic that the infection was susceptible to was 
fosfomycin. As this was only approved for uncomplicated cystitis in the United 
States, however, it could not be administered and the patient died of septic 
shock approximately one month after being admitted to hospital (Chen et al. 
2017). 
All these studies show that there is a trend of increasing resistance in clinical 
settings which will, ultimately, lead to an increased death rate as more 
resistance elements emerge and it becomes more difficult to treat multidrug and 
pandrug resistant infections. Although only a small number are presented here, 
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there are many other similar studies that have observed an increase in antibiotic 
resistant infections. 
1.1.3 Current strategies to mitigate resistance 
An obvious way to overcome the problem of resistant bacteria is to develop new 
antibiotics (O’Neill 2015b). However, in the past 30 years only 2 new classes of 
antibiotics (oxazolidinones and cyclic lipopeptides) have been developed 
(Gupta & Nayak 2014). The investment of time and money needed to bring an 
antibiotic to market is high (O’Neill 2015b). For pharmaceutical companies, it is, 
therefore, difficult to produce an economic return given that antibiotics are 
generally taken for short periods of time, unlike drugs used to treat chronic 
diseases and treatments for cancer (Braine 2011). This makes the development 
of new antibiotics an unattractive proposition for pharmaceutical companies 
(O’Neill 2015b). As a result, focusing on mitigating the development of 
resistance is an important strategy as it is imperative to protect the current 
available antibiotics. Governments and non-government organisations have and 
are still setting out strategies for the control of AMR. The WHO, for example, 
has proposed a range of strategies which, if implemented, should slow the 
development of resistance. Policies include reduction of the use of antibiotics in 
agriculture and antibiotic stewardship initiatives for both community and hospital 
environments (Finley et al. 2013; Leung et al. 2011). In 2019, the UK 
government produced its 5 year plan to tackle resistance. Their policies came 
under three headings “Reducing need for and unintentional exposure to 
antimicrobials,” “Optimising use of antimicrobials” and “Investing in innovation, 
supply and access to tackle AMR” (UK Government 2019).  
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Recently, the environment has been implicated in the dissemination of 
antibiotics, antibiotic resistant bacteria and resistance genes. Mitigation 
strategies to limit dissemination of antibiotics into these compartments, and in 
turn limiting their ability to select for antibiotic resistant bacteria, have been 
identified in two key documents: the O’Neill report on “Antimicrobials in 
Agriculture and the Environment: reducing unnecessary use and waste” and a 
report published by the United Nations (UN) in 2017 entitled “Antimicrobial 
Resistance: Investigating the Environmental Dimension.” Both documents 
discuss the impact of antibiotics in the environment, the selection for resistance 
in these areas and potential ways to mitigate this. Whilst the first document 
focuses on the use of antibiotics in agriculture and aquaculture, the latter goes 
further than this and also focuses on the release of pharmaceutical residues 
into the environment (O’Neill, 2015a; Gaze and Depledge, 2017). The UK 
government’s 5 year action plan also discusses ways of reducing the spread of 
resistance through the environment; the need to support additional research in 
this area and the need to increase public awareness of the risk to the 
environmental resistome (UK Government 2019). The role of the environment in 
the spread of antibiotics, the selection and spread of antibiotic resistant bacteria 
and genes and the potential for these bacteria to become clinical problems are 
discussed in more detail below. 
1.2 The role of the environment in antibiotic resistance 
Antibiotics and antibiotic resistance genes (ARGs) are found throughout 
environmental settings (Kümmerer 2003; Kümmerer 2004). Antibiotics occur 
naturally in the environment as they are produced by bacteria, such as the soil 
dwelling Actinomycetes, in order to gain a competitive advantage, for example, 
in relation to nutrients or space (D’Costa et al. 2006). Bacteria are also able to 
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utilise antibiotics as a sole carbon source (Dantas et al. 2008) and as signalling 
molecules (Romero et al. 2011). As antibiotics target a variety of bacterial 
processes, however, species with the ability to produce them must carry some 
form of resistance element (intrinsic resistance) as a “self-protection” method to 
avoid self-destruction by the compounds they are secreting (D’Costa et al. 
2006).  
As well as natural production of antibiotics and resistance, pollution from 
anthropogenic sources can lead to the dissemination of resistance genes, 
alongside detectable concentrations of antibiotics, throughout the natural 
environment. 
1.2.1 The Environmental Resistome 
The environmental resistome is defined as “all ARGs including those circulating 
in pathogenic bacteria, antibiotic producers, and benign non-pathogenic 
organisms found either free living in the environment or as commensals of other 
organisms” by Wright, 2010.  
Resistance genes can be mobilised from the chromosome and are able to move 
through a diverse range of species by a process called horizontal gene transfer 
(HGT) (Barlow 2009). HGT of ARGs does not only occur in clinical bacteria 
(Lerminiaux & Cameron 2019), but also has a role in the spread of ARGs in the 
environment (X. X. Zhang et al. 2009). HGT occurs by one of three key 
mechanisms that transfer genes. These are conjugation, transformation and 
transduction (Thomas & Nielsen 2005). Conjugation is usually considered the 
key method of HGT in the transfer of ARGs, although more recent evidence 
suggests that transformation and transduction may play a more important role 
than originally thought (von Wintersdorff et al. 2016).  
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Conjugative transfer is a process whereby plasmids are passed directly 
between two bacterial cells by cell-to-cell junctions and a bacterial cell pore 
(Thomas & Nielsen 2005). This type of HGT has been known to transfer ARGs 
since the 1950s (Berglund 2015). After the introduction of antibiotics in the 
clinic, plasmids bearing ARGs are found to be widespread (Wright 2010). 
Genes that reside within the chromosome can be mobilised to plasmids, and 
vice versa, by the help of mobile genetic elements (MGEs) and can, therefore, 
be transferred vertically as bacterial cells divide (Gaze et al. 2013). 
MGEs are defined as elements that are able to incorporate DNA from a plasmid 
into the chromosome, and vice versa, or from one genome or plasmid to 
another. There are four main types of MGEs: integrons; transposons; insertion 
sequences and integrative and conjugative elements (Partridge et al. 2018). 
Integrons are defined by the intI gene (encoding a recombinase), a 
recombination site and a promotor. The cassette array found in combination 
with these genes often includes multiple resistance genes. Integrons can 
integrate themselves and the associated cassette array via recombination into 
DNA that contains a recombination site (Partridge et al. 2009). Transposons 
and insertions sequences are fragments of DNA which are able to insert 
themselves and resistance genes that are associated with them into new 
sections of DNA within the host cell (Partridge et al. 2018). Integrative and 
conjugative elements (ICEs) are also able to excise themselves from a host 
chromosome and integrate into a new one. These elements have also been 
found to be associated with the transfer of ARGs (Sultan et al. 2018).  
Transformation involves the uptake of DNA from the extracellular environment. 
This includes uptake into bacterial cells, integration of extracellular DNA into the 
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host chromosome and the functional expression of that gene within the host 
bacterial cell. Many human pathogenic bacteria, including Streptococcus and 
Neisseria, are able to take up extracellular DNA naturally from the environment 
(Thomas & Nielsen 2005). Environmentally, the transfer of free DNA may seem 
unlikely, as DNA is sensitive and can easily degrade. However, stabilisation can 
occur within the environment by the adhesion to soil and sediment particles 
(Berglund 2015). 
Transduction is the movement of DNA between cells using bacteriophages 
(phages) as vectors. Phages are viruses that infect bacteria by inserting their 
own DNA into host bacterial cells and then replicating inside them. Specialised 
phages are able, when replicating, to produce particles that contain both their 
own replication machinery and everything they need to survive as well as 
portions of the bacterial cell chromosome, therefore playing an important role in 
the evolution of the bacterial species they are infecting. The role of phages in 
the spread of antibiotic resistance has previously been a relatively neglected 
area of study. However, recently, metagenome analysis has found virome 
genes linked to resistance genes for, amongst others, tetracycline and ampicillin 
(Balcázar 2014).  
There are two key types of environmental resistance genes: natural resistance 
and resistance from anthropogenic pollution. Together, these comprise the 
environmental resistome. 
1.2.1.1 Natural resistance 
As stated, environmental microorganisms produce antibiotics for a variety of 
purposes. This has led to the development of ARGs to provide self-protection 
for producers and protection for competitors (D’Costa et al. 2006). Antibiotics 
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were first thought to have been produced naturally by bacteria between 40 
million and 2 billion years ago. It would seem to follow, therefore, that ARGs 
were present and widespread prior to the introduction of antibiotics for the 
treatment of clinical infections and are able to be found in pristine environments 
where there is minimal human contact and anthropogenic pollution (D’Costa et 
al. 2011).  
A number of studies have investigated the presence of ARGs in pristine 
environments. For example, Zeng et al., 2019 used metagenome analysis to 
investigate presence and diversity of ARGs in animal guts in comparison to two 
pristine environmental sampling sites (Antarctica soil and Alaskan permafrost). 
The number of ARGs detected in the pristine environment was significantly 
lower than in the animal gut microbiomes, although they were always detected 
(Zeng et al. 2019). Van Goethem et al., 2018 also used a metagenomic 
approach to investigate ARG presence and diversity in Antarctic soil. Over 17 
sites they identified 177 ARGs which typically encoded efflux pumps for both 
single and multiple drugs. Common inactivation elements were also seen to be 
effective against aminoglycosides, ß-lactams and chloramphenicol. The authors 
were not able to identify any mobile genetic element regions associated with the 
genes found and instead identified the presence of antibiotic biosynthesis 
genes. This, therefore, leads to the assumption that these genes are harboured 
by antibiotic producers and are not readily transferable to their competitors (Van 
Goethem et al. 2018). Finally, D’Costa et al., 2011 used qPCR to investigate 
ARGs in 30,000 year old, Beringian permafrost. The ARGs found were diverse 
but commonly conferred resistance to ß-lactams, glycopeptide and tetracycline 
antibiotics. They concluded, therefore, that antibiotic resistance is an ancient 
phenomenon (D’Costa et al. 2011). 
55 
 
1.2.1.2 Anthropogenic introduction and spread of ARGs into the 
environment 
In contrast to natural resistance, ARGs can enter the natural environment 
through anthropogenic pollution. Figure 2 shows details of some of the many 
ways ARGs can spread. This section will discuss the different ways ARGs can 















This image has been removed by the author of this thesis for copyright 
reasons. 
Figure 2: The spread of antibiotics and antibiotic resistance through the 
environment. The figure shows where antibiotics are deployed (indicated by 
the bottles with pills) and routes antibiotic resistant bacteria can travel through 
the environment (red arrows). A large proportion of the red arrows are also 
applicable to ways in which antibiotic residues can pass into the environment. 
Missing from this diagram is the introduction of antibiotics and antibiotic 





Bacterial contaminants, in contrast to chemical pollutants (which can degrade, 
be diluted or sorb to environmental particles), can multiply and spread through 
the environment and can, subsequently, spread their genes (such as ARGs) to 
other, unrelated, bacterial hosts via HGT (Berendonk et al. 2015).  
Water environments are critical and underappreciated routes for the spread of 
ARGs (Finley et al. 2013). They are prime areas where environmental and 
clinical bacterial species are mixed and able to share their genes through HGT 
(Perry & Wright 2013). Wastewater treatment plants (WWTPs) are one of the 
major locations where ARGs are introduced into the environment. Patients are 
treated with antibiotics and those antibiotics, subsequently, exert a selective 
pressure on commensal gut bacteria to become resistant. These bacteria are 
then excreted and can enter WWTPs (Finley et al. 2013). Treatment of waste in 
a WWTP may remove detectable ARGs and antibiotic resistant bacteria (ARB) 
from treated waste, may reduce the load or may actually increase the load. A 
study in 2011 investigated whether five Michigan based WWTPs, using different 
treatment methods, had detectable ARGs and ARB in the five plants’ final 
effluent and biosolids. A comparison of effluent and biosolids suggested that 
biosolids contribute more greatly to the release and introduction of ARGs and 
ARBs into the environment. A significant reduction in ARGs and ARBs in the 
final effluent occurred, in comparison to the influent. Across the different plants 
tested ARGs and ARBs were still detected in a number of the effluent and 
biosolid samples. Resistance genes and bacteria were subsequently released 
into the environment in some of the effluent and all of the biosolids (Munir et al. 
2011). Another study, conducted in 2009, and, again, in a Michigan WWTP, 
used disk diffusion methods to test the antibiotic susceptibility of Acintobacter 
spp. This study investigated the percentage of resistance to eight antibiotics 
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tested in wastewater influent and effluent and downstream of the WWTP. Four 
of the eight antibiotic resistance classes tested saw a significant increase in 
prevalence at effluent in comparison to influent and a subsequent further 
increase downstream of the WWTP. This suggests that the treatment at this 
plant was selecting for ARB (Y. Zhang et al. 2009). A study published by Amos 
et al., 2018 investigated the impact of a WWTP, on ARGs, in the receiving river. 
This study targeted the class 1 integron using qPCR. The class 1 integron has 
been frequently described as a good marker for pollution from human sources 
as it is often associated with ARGs (Gillings et al. 2015). It was determined that 
there was a significant increase in the prevalence of the class 1 integron at 
three downstream sites after the WWTP, in comparison the samples taken at 
three upstream sites. The class 1 integron prevalence was four times higher in 
the river after receiving effluent than prior to the WWTP. These results suggest 
that this WWTP is directly inputting or selecting for ARGs in the natural 
environment (Amos et al. 2018).  
All of the above studies investigated WWTPs that mainly deal with household 
waste. A study by Bengtsson-Palme et al., 2014 investigated the impact of 
pharmaceutical waste on a lake in India. Using a non-impacted, healthy 
Swedish lake as a comparison, they found 7,000 times more ARGs in the 
polluted Indian lake. The authors provide two hypotheses for why this might be: 
either the high concentrations of antibiotics being released by the 
pharmaceutical production facility select for resistance in environmental bacteria 
or the resistance is a result of direct input from the manufacturing facility 
(Bengtsson-Palme et al. 2014).  
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The high use of antibiotics in livestock production selects for antibiotic 
resistance in the guts of the treated animals (Allen et al. 2010). Manure from 
farm animals is often used as a fertiliser for crops, particularly in organic 
farming. This allows the spread of antibiotic resistant bacteria to both crops and 
soil. A study by Udikovic-Kolic et al., 2014 investigated whether coliform 
bacteria and antibiotic resistant bacteria were significantly higher in soil fertilised 
with manure in comparison to an inorganic fertiliser used as a control. They 
determined that both total colony forming units and resistant colony forming 
units were significantly enriched with use of the manure in comparison to the 
control. Using qPCR, they also determined that the bla-CEP-04 (encoding a ß-
lactamase enzyme) was significantly higher (Udikovic-Kolic et al. 2014).  
There are questions as to whether it is a risk to human health if ARB and ARGs 
are entering the environment and whether these genes and bacteria pass back 
into humans and become a clinical problem. Obtaining conclusive evidence that 
clinically important resistance genes originated from the environment, however, 
is difficult as these genes may undergo many rounds of selection prior to being 
identified in clinical bacteria (Perry & Wright 2013). Previous data has shown, 
however, through metagenome sequencing, that a clinical resistance gene can 
have up to 100% sequence identity to resistance genes found in environmental 
bacteria (Fosberg et al. 2012). For pathogenic bacteria to acquire resistance 
from the environmental settings, close contact of both donor and recipient 
bacteria is key (Perry & Wright 2013). Exposure of the human microbiome to 
environmental bacteria frequently occurs, for example, (Perry & Wright 2013) 
through the food chain (WHO 2017a) (as a result of the high use of antibiotics in 
agriculture (O’Neill 2015a)) or coastal waters that have been contaminated with 
sewage effluent (Finley et al. 2013).  
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Examples of exposure to antibiotic resistant bacteria through the food chain 
include: supermarket pork products found to be contaminated with livestock-
associated MRSA (Hadjirin et al. 2015); 11.4% of E. coli isolated from lettuce 
and a lettuce farm (soil and irrigation water) were resistant to one or more 
antibiotics (Holvoet et al. 2013) and 72.3% of 205 bacterial isolates from lettuce, 
spinach and alfalfa sprouts were found to be resistant to at least one antibiotic 
whilst over 90% of these resistant strains were resistant to ampicillin and 
cephalothin (Bezanson et al. 2008). Although these studies show that humans 
are exposed to environmental ARGs and ARBs they do not show that 
subsequent colonisation of resistant bacteria from these sources occurs. One 
study, however, investigated antibiotic resistance carriage in the guts of surfers 
who swallow the greatest volume of potentially contaminated coastal waters of 
all recreational water users. The study determined that surfers were four times 
more likely to be colonised by E. coli possessing a bla-CTX-M gene (encoding a ß 
lactamase gene) than non-surfers thus suggesting a direct link between 
environmental exposure and human colonisation by ARB and ARGs (Leonard 
et al. 2018). This, however, does not show how long these ARB and ARGs are 
able to persist in the gut after exposure. Work investigating persistence of 
resistant E. coli in international travellers found two months after travel, a 
majority of participants were no longer colonised. However, 18% of participants 
were still colonised six months after travelling (Kennedy & Collignon 2010). 
Length of gut colonisation has not, however, been investigated after 
environmental exposure and it is not clear, therefore, if the same would be true 
after this type of exposure.  
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1.2.2 How antibiotics enter and spread through the environment 
Figure 2 (Section 1.2.1.2) shows the variety of ways in which antibiotic resistant 
bacteria can be disseminated throughout the environment. This diagram can, 
however, also be applied to antibiotic residues and their passage from use 
through to their subsequent entry into environmental compartments. 
Following clinical treatment, antibiotics are often excreted, fully intact and in an 
active form (Kümmerer 2009), and enter WWTPs (Kümmerer 2003). Some 
antibiotics persist at low concentrations throughout the environment and are not 
readily biodegradable. The fate of these pharmaceuticals is dependent on their 
water solubility, their ability to persist in the environment and on their polarity 
(Wellington et al. 2013). In WWTPs antibiotics have three possible fates: they 
may biodegrade to undetectable concentrations; be released fully intact or as 
metabolites into rivers and other receiving waters via effluent or may adsorb to 
sewage sludge (Wellington et al. 2013; Singer et al. 2016). In a paper published 
in 2011, studies investigating removal rates of emerging contaminants by 
investigating the mean concentration in WWTP influent and effluent were 
reviewed. The compiled dataset contained, amongst other emerging 
contaminants, 13 antibiotics. Removal rates, between influent and effluent, 
ranged from 95.1% removal of tetracycline to 1.4% removal of trimethoprim. An 
average removal rate for all antibiotics tested was 51.4%. All antibiotics tested 
were above detection limit in the final effluent and were subsequently released 
into the environment (Deblonde et al. 2011).  
As stated previously, antibiotics are also an integral part of agricultural and 
aquacultural processes for both the treatment and prevention of disease and 
growth promotion in livestock (Chang et al. 2015). Whilst the use of antibiotics 
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as growth promotors has been banned by the European Union the practice still 
persists in many other parts of the world (Levy & Marshall 2004, O’Neill 2015a). 
Implementing these drugs in agriculture is often described as one of the major 
contributors to the clinical problem of antibiotic resistance and hence an 
immediate reduction in the unnecessary use (prophylactically and for growth 
promotion) is needed to help reduce the global impact of resistance (Chang et 
al. 2015). It was estimated that in 2013 global consumption of antibiotics by 
food animals was approximately 131,109 tons. This is set to increase to over 
200,000 tons by 2030 (Schar et al. 2018). In 2010, antimicrobial use in 
agricultural practices accounted for 71% of total antibiotic use in Denmark 
(Finley et al. 2013) 
Both active antimicrobial compounds and gut bacteria from treated animals are 
excreted. The excreta is frequently used in crop production as a fertiliser, 
therefore exerting a selective pressure on environmental bacteria associated 
with crop plants and soil (Aminov 2010; Allen et al. 2010). There is also the 
potential, through the use of manure as a crop fertiliser, that these veterinary 
antibiotics may leach into surface waters and groundwater (Blackwell et al. 
2009). 
Antimicrobials are also used for treatment and prevention of disease in global 
aquaculture. They are usually administered into aquacultural practices as part 
of feed or directly to the water (Heuer et al. 2009; Cabello et al. 2013). In this 
way, they are used for metaphylactic treatment (treating both healthy and 
diseased individuals) as well as being used for the prevention of disease 
outbreaks (Cabello et al. 2013; Santos & Ramos 2018). The use of 
antimicrobials in aquaculture is frequently unregulated (Heuer et al. 2009). 
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Regulation is reported to be particularly poor in South America and parts of Asia 
(Conti et al. 2015). As China is the leading global fish supplier (over 60% of 
aquaculture) this is of particular concern (Henriksson et al. 2018). Antimicrobials 
that are not consumed, and those that are excreted, can accumulate in the 
sediment of the aquaculture tanks or under cages and can leach into 
surrounding sediments and water bodies (Cabello et al. 2013). This does not 
need to be the case, however. In Norway, use of antibiotics in aquacultural 
practices has been reduced drastically (from 48 tonnes to 1 tonne) through the 
implementation of a rigorous vaccination programme (Midtlyng et al. 2011).  
Finally, another potential route of entry into the aquatic environment is through 
effluent from pharmaceutical manufacturing plants during the production and 
formulation of antibiotics. Concentrations of antibiotics have been observed to 
be over 1 mg/L in such effluents and their receiving waters (Larsson 2014). 
1.2.3 Environmental concentrations of antibiotics 
Concentrations of antibiotics in the environment vary considerably depending 
on the location and the local anthropogenic pressures exerted. Generally, 
concentrations of antibiotics in the environment are within the ng/L to µg/L 
range (Andersson & Hughes 2012). Concentrations of mg/L are known to occur 
in environments such as hospital and pharmaceutical waste but ng/L is more 
typical of ground and surface waters (Homem & Santos 2011).  
Many surveillance studies have been carried out to investigate the antibiotic 
concentrations in a variety of environmental settings. An example of this 
includes a study conducted in two WWTPs along the River Thames in the UK 
which investigated concentrations of antibiotics in both the influent and effluent 
of the plants. The highest concentration of 11 antibiotics tested was 2.32 µg/L of 
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ofloxacin in influent and 0.224 µg/L of erythromycin in effluent (Singer et al. 
2014). An example of extremely high concentrations from anthropogenic 
pollution was described in a study by Larsson, de Pedro and Paxeus, 2007. 
This study investigated the concentrations of antibiotics in the effluent of a 
pharmaceutical production plant in India. Even after treatment of the waste from 
this facility, concentrations of 28,000 and 31,000 µg/L of ciprofloxacin was 
detected on the two days on which sampling occurred. These concentrations 
were then, presumably, discharged freely into the environment. The authors 
note that these are unusually high concentrations. The concentration of 31,000 
µg/L is equivalent to 45 kg of ciprofloxacin being discharged from the 
manufacturing plant on a daily basis (Larsson et al. 2007). 
In 2016 the Umweltbundesamt (UBA – German Environment Agency) 
developed a database, collating a significant number of these surveillance 
studies from around the world. The database includes a range of environmental 
concentrations of different pharmaceuticals, including antibiotics, in a number of 
different matrices. Matrices ranged from natural bodies of water, such as lakes 
and rivers, to wastewater from sources such as urban, hospital and 
pharmaceutical manufacturing plant waste. Concentrations shown on the 
database range from undetectable to 200,000 µg/L of sulfamethoxazole found 
in untreated wastewater from a pharmaceutical production facility in Kenya. This 
is, as with Larsson, de Pedro and Paxeus, 2007, an unusually high 
concentration and would presumably have been lower after the waste had been 
treated. Concentrations on the UBA database typically range from ng/L to µg/L 
although occasional higher concentrations are seen in pharmaceutical and 
hospital waste (Umweltbundesamt 2016). 
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1.2.4 Do environmental concentrations of antibiotics select for antibiotic 
resistance? 
There is a question as to whether there could be a selective pressure from 
antibiotic residues entering the environment and whether those concentrations 
of antibiotics are high enough to select for resistance, thus exacerbating the 
problem. 
It is clear that the introduction of antibiotics into the clinic has led to detectable 
concentrations of antibiotics in the environment (Kümmerer 2003) and to 
increased levels of ARGs (Finley et al. 2013). For example, soil samples taken 
in the Netherlands were 2 to 15 times more likely to contain ARGs in 2008 
compared to soil collected in 1970 (Knapp et al. 2010). It is unclear, however, 
whether these resistance genes have been selected for by high concentrations 
of antibiotics in the gut of the treated patients (van Schaik 2015) or animals 
(Marshall & Levy 2011) and subsequently released into the environment, or if 
selection for ARGs is happening at environmental concentrations.  
As discussed in Section 1.2.3, typical environmental concentrations of antibiotic 
are low in comparison to those used to treat infections, ranging from ng – µg/L 
(Kümmerer 2009). These concentrations are significantly lower than minimum 
inhibitory concentrations (MIC) and it was, therefore, assumed that selection for 
resistance genes did not occur in environmental settings (Andersson & Hughes 
2012). If selection occurs at these low concentrations it is important, therefore, 
to determine at what concentration an antibiotic, or any co-selective agent, 
results in increasing resistance gene prevalence (Andersson & Hughes 2012). 
In this way it will be possible to determine if mitigation strategies need to be 
implemented to minimise the selective risk posed by these compounds. 
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Experimental work undertaken by Gullberg et al. 2011 and Gullberg et al. 2014 
used single species competition assays to investigate whether selection may 
occur at much lower antibiotic concentrations than previously thought. These 
concentrations are more representative of concentrations found within an 
environmental setting (Gullberg et al. 2011; Gullberg et al. 2014; Kümmerer 
2009).  
A diagram, published in Gullberg et al. 2011 and shown in Figure 3, describes 
the theory behind selection for resistance at lower concentrations. Here, the 
“Traditional selective window” can be seen in red which shows the traditional 
view of selection from a clinical perspective. Selection was believed only to 
occur between the MIC of susceptible and of resistant bacteria. Growth of the 
susceptible bacteria (here indicated by the blue line) is no longer occurring and 
therefore positive selection for the resistant bacterium is seen. 
Below the traditional window, however, it was hypothesised that selection would 
be seen in a “Sub-MIC selective window,” depicted here in yellow. This occurs 
between the minimal selective concentration (MSC) – defined as the 
concentration of antibiotic “where the resistant mutant is enriched over the 
susceptible strain” (Andersson & Hughes 2011) - and the MIC of the susceptible 
bacteria. As the growth rate of susceptible bacteria (blue line) decreases below 
the growth rate of resistant bacteria, there is less competition from susceptible 
bacteria for resources and, therefore, positive selection for resistant bacteria is 
seen. 
It is hypothesised, therefore, that at concentrations lower than those used 
clinically, and in the range of those concentrations found in the environment, 













In the two studies by this research group, a susceptible and a resistant strain 
were competed against each other at a variety of concentrations of antibiotics.  
 
 
The study published in 2011 investigated resistance elements found within the 
chromosome (Gullberg et al. 2011) and the 2014 research investigated mobile 
genes on plasmids (Gullberg et al. 2014). MSCs were determined, in both 
studies, to be significantly lower than MICs of a number of antibiotics. For 
example, MICs were found to be 10, 230 and 10 times higher than MSCs 
(determined by plotting selection coefficients) for the resistance mutations 
gyrA2 (encodes DNA gyrase subunit A), gyrA1 (encodes DNA gyrase subunit 
This image has been removed by the author of this thesis for copyright 
reasons. 
Figure 3: Antibiotic concentration affects growth rates of susceptible 
and resistance bacteria differently. As antibiotic concentration increases, 
growth rate of the susceptible bacteria (blue line) decreases. This means there 
is less competition for resources for the resistant bacteria (red line). This 
allows for an increase in positive selection to occur. The MSC is defined as 
where the growth rate of the susceptible drops below that of the resistant. 
Graph reproduced from: Gullberg et al., 2011. 
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A) and ΔacrR (deletion of HTH-type regulator gene acrR), respectively, for 
ciprofloxacin (Gullberg et al. 2011). 
Although the work from these two studies suggests that positive selection may 
be occurring at environmental concentrations of antibiotics, a limitation of this 
method is that only single species were studied. This is not representative of the 
mixed communities of bacterial species found in the environment or in human 
and animal microbiomes. Subsequent studies have aimed to determine MSCs 
for a variety of antibiotic compounds using complex communities from 
environmental sources which is, therefore, more representative of the 
environment. 
Two studies have been published investigating the selective potential of two 
compounds, tetracycline (Lundström et al. 2016) and ciprofloxacin (Kraupner et 
al. 2018), in a complex biofilm system. The first study attempted to determine a 
MSC for tetracycline at low concentrations. Tetracycline was the chosen 
compound as it is a broad spectrum antibiotic that is commonly used and “up to 
75% of consumed tetracyclines are excreted in their active form,” meaning that 
it is, therefore, often found in the environment (Lundström et al. 2016). 
Prevalence of the tetracycline resistance genes, tetA and tetG (which both 
encode efflux pumps), was determined in an experimental biofilm mixed 
community system at the end of the experiment. Prevalence of these genes 
were significantly higher at the tetracycline concentration of 1 µg/L in 
comparison to the no antibiotic control. In their second study, the team 
investigated the effects of ciprofloxacin at low concentrations. Again, a biofilm 
model was used but this time alongside a test tube system for comparative 
purposes. In the test tube system, a significant difference in phenotypic 
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resistance was observed at 5 µg/L in comparison to the no antibiotic control. In 
the biofilm system, a significant difference was determined for both genotypic 
and phenotypic resistance in E. coli compared at 10 µg/L in comparison to the 
no antibiotic control (although 5 µg/L was not tested in the biofilm experiment) 
(Kraupner et al. 2018). 
A study published in 2018 used a microcosm method, more similar to the 
method used in Gullberg et al. 2011 and Gullberg et al. 2014, but with a 
wastewater influent bacterial community as the inoculum instead of single 
species. QPCR was used to determine the prevalence of blaCTX-M over the 7 
day experimental period. The MSC for cefotaxime was 0.4 µg/L (Murray et al. 
2018). 
All of these data sets show an effect of antibiotics at environmentally relevant 
concentrations and the importance of the environment as a place where 
selection for AMR can occur. These studies, and their limitations, are discussed 
in more depth in Chapter 6.  
Sub-MIC concentrations also have effects on other bacterial processes, which 
can subsequently exacerbate the carriage of resistance genes. For example, 
studies have shown that sub-MIC concentrations of antibiotics can increase 
growth rate (Migliore et al. 2013), biofilm formation (Waack & Nicholson 2018), 
the rate of spontaneous mutation (Gillespie et al. 2005; Henderson-Begg et al. 
2006; Cortes et al. 2008), the occurrence of HGT (Jutkina et al. 2018; Shun-Mei 
et al. 2018) and, finally, recombination rate (López & Blázquez 2009). The 
ability to increase these processes, as well as selecting for ARGs, means that 
concentrations below the MIC could enhance the spread of these genes 
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through environmental bacterial populations and, subsequently, lead to a 
greater prevalence of ARGs (Sandegren 2014). 
Selection at sub-MIC concentrations may pose a greater risk than selection 
occurring above the MIC of susceptible bacteria (Khan et al. 2017; Andersson & 
Hughes 2012). The fitness cost tends to be high when bacteria evolve 
resistance under concentrations that are above MIC of susceptible strains. At 
sub-MIC concentrations there is a lower fitness cost of adaptation. This means 
that when the selective pressure of the antibiotic is no longer present, the 
resistance that has developed under sub-MIC conditions is less likely to revert 
back to its susceptible state (Sandegren 2014; Andersson & Hughes 2010). 
The studies discussed previously, including those specifically looking at 
selection for resistance at low concentrations and others investigating related 
factors like HGT and mutation rate, provide compelling evidence that selection 
can and does occur at low antibiotic concentrations in the environment. A study 
published in 2019, however, suggested that ARGs found in the environment 
were associated with faecal pollution and not selection from antibiotic residues 
being released into the environment concluding that there were “no clear signs 
of selection in the environment” (Karkman et al. 2019). This study analysed 
publically available metagenome databases searching for crAssphage (a 
bacteriophage that has been associated with faecal metagenomes from 
humans). It determined that ARGs and crAssphage abundances correlated well 
in sewage polluted environments but that there was no correlation between the 
two in human faecal metagenomes. The authors concluded that this meant that 
ARGs in sewage polluted environments are largely explained by faecal pollution 
and that no selective effect may be seen at low environmental antibiotic 
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concentrations. This data appears contradictory, as there is no correlation 
observed in human faecal metagenomes, and the study appears to makes 
claims that are not fully supported by the data. Whilst the study has no 
published data to disprove that selection is occurring in the environment, in the 
introduction to the paper the authors state that “concentrations of selective 
agents in a sewage-impacted environment might not be sufficient to cause 
selection,” citing the Lundström et al., 2016 and Kraupner et al., 2018 studies 
carried out by other members of the same research group. These publications 
clearly do show an effect at environmental concentrations. Their claims appear 
to be an unjustified view of only one subset of the data they have produced. 
Faecal contamination probably does play a substantial, even dominant, role in 
accounting for abundance of ARGs and ARB observed in sewage polluted 
environments. This, however, does not negate the possibility that extremely 
important selection is occurring at environmental concentrations of antibiotics as 
shown by Lundström et al., 2016, Kraupner et al., 2018 and Murray et al., 2018. 
This, to the best of the author’s knowledge, is the only published study to 
present data with the aim of demonstrating that selection does not play a role in 
the environmental dimension of AMR.  
1.2.5 Issues with current environmental risk assessments  
Antibiotics, often released into the environment from excretion by patients via 
WWTPs, were only identified as a risk to the environment in the 1990s. Since 
then, there has been a steady increase in the number of monitoring studies. 
Currently, there are several hundred active pharmaceutical ingredients (APIs) in 
aquatic environmental settings such as ground water, surface water and 
sewage treatment plants. Guidelines on conducting environmental risk 
assessments have, therefore, been developed by the European Medicines 
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Agency (Ågerstrand et al. 2015). These guidelines currently include determining 
the risk of the compound by using the ratio of the predicted environmental 
concentration (PEC) to the predicted no effect concentration (PNEC). This relies 
on environmental testing which includes, for example, growth inhibition tests on 
algae, toxicity tests on early life stage fish and reproduction testing on Daphnia 
spp. (European Medicines Agency (EMEA) 2006). Tests for the effect of 
antibiotics on microbes are limited. Tests include: the ASRIT (activated sludge 
respiration inhibition test), which determines the effect of antibiotics of microbial 
communities in WWTPs (OECD 2010); tests on cyanobacteria which investigate 
the effect antibiotics have on growth rate (OECD 2011) and tests on the effect 
on nitrification of soil bacteria (OECD 2000). These tests and guidelines have 
their limitations. The microbial communities tested are very specific to each test. 
As all microbial communities may react differently in terms of their sensitivity to 
antibiotics, tests may not be applicable to all community compositions (Brandt et 
al. 2015). Also, current guidelines do not include studying selection for antibiotic 
resistance in environmental bacteria from the release of antibiotics and other 
potentially co-selective pharmaceuticals into the environment (Ågerstrand et al. 
2015). Developing an ecotoxicological test for determining the concentration at 
which antibiotics and other co-selective agents will select for antibiotic 
resistance was suggested by Ashbolt et al., 2013 although currently no 
standardised test exists. 
Ågerstrand et al. 2015 have recommended that investigating the selection for 
antibiotic resistance should be made a requirement of studying the effects of 
antibiotics in the environment, as they suggest it will “provide a more accurate 
picture of the risks connected to the environmental occurrence of antibiotics.” 
These recommendations have been made because it is believed that 
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persistence of antibiotic compounds in natural environments will exert a 
selective pressure on environmental, non-pathogenic, bacteria. This could 
potentially select for novel resistance genes, which can then in turn be 
mobilised into clinically relevant pathogenic bacteria (Ågerstrand et al. 2015).  
A study in 2016 used a mathematical approach to set guidelines for the release 
of antibiotics into the environment based on their selective nature. This study 
determined PNECs for the selection of resistance (PNECRs) by using the 
EUCAST database to determine the lowest 1% observed MIC found per 
antibiotic. They then adjusted this concentration for the number of test species 
and applied an assessment factor of 10. Whilst this approach has been useful 
for setting initial guidelines for the safe release of antibiotic compounds (as all 
antibiotics and combinations of antibiotics on the EUCAST database were able 
to be given selective endpoints), the authors do note the limitations of this 
method which needs to be validated using experimental methods to determine 
PNECRs (Bengtsson-Palme & Larsson 2016). 
Developing a straightforward experimental test to determine the selective 
potential of antibiotics in mixed microbial communities, that is relevant to 
environmental conditions and which can, therefore, screen many APIs for 
ecotoxicology testing, is critical for testing antimicrobial agents and other 
potential co-selecting compounds before release into the environment. The data 
produced by such a test will give a better understanding for regulators as to the 
concentrations of these APIs that are safe to release from WWTPs. 
1.3 Aims 
The aim of this the work reported in this thesis was to investigate whether 
environmental concentrations of antibiotics select for antibiotic resistance. All 
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experiments undertaken used a week long experimental evolution assay similar 
to those used in Gullberg et al., 2011 and 2014 and used complex microbial 
communities, instead of single species, to better mimic the microbial 
communities in the environment. QPCR was used to target different ARGs, intI1 
(encoding the class 1 integron) and 16S rRNA (encoding the 30S subunit of the 
bacterial ribosome) to determine the change in prevalence of resistance over 
time. Metagenome analysis was also used during some of the experiments to 
provide additional data. The study had 4 main objectives. These were: 
1. Investigating whether environmental concentrations of three 
macrolide antibiotics (azithromycin, clarithromycin and erythromycin) 
select for resistance. 
2. To investigate the effect of combinations of antibiotics on selective 
concentrations. 
3. To investigate whether temperature affects the selective endpoint of 
an antibiotic. 
4. To investigate whether the experiments used for this study are 
comparable to previously published, more “environmentally relevant” 
methodology by investigating the MSC of tetracycline as in Lundström 
et al., 2016. 
1.4 Co-authored papers 
The two following papers were outputs from a collaboration with the Water 
Research Institute – National Research Council, Italy. The author supervised a 
visiting PhD student on a summer placement, helped to plan projects and 
taught experimental skills needed, such as qPCR, which the PhD student 
employed to produce some of the data included in the papers listed below. The 
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author was also sent samples for qPCR analysis following the placement and 
reviewed and edited the scientific content for the qPCR sections and the 
wording of the entire manuscripts. 
 
Rauseo J., Ademollo N., Cardoni M., Di Lenola M., Gaze W.H., Stanton I.C., 
Grenni P., Pescatore T., Spataro F., Patrolecco L. Dissipation of the antibiotic 
sulfamethoxazole in soil amended with anaerobically digested cattle manure. 
Journal of Hazardous Materials. 2019. 378. 120769. doi: 
10.1016/j.jhazmat.2019.120769 
 
Grenni P., Patrolecco L., Rauseo J., Spataro F., Di Lenola M., Aimola G., 
Zacchini M., Pietrini F., Baccio D., Stanton I.C., Gaze W.H., Caracciolo A.B. 
Sulfamethoxazole effects on river water microbial community, on the spread of 
antibiotic resistance and on the aquatic plant Lemna minor. Accepted - 
Microchemical Journal Special edition.  
 
The author has also participated in work that investigates using a growth rate 
assay to determine MSC. Final week long selection experiments for the three 
macrolide antibiotics presented in Chapter 3 have been included in this 
publication along with the preliminary trimethoprim work from Chapter 4 
(Section 4.4.2.1). 
Murray A.K., Stanton I.C., Zhang L, Snape J., Gaze W.H. A novel experimental 
assay to determine effect concentrations of antibiotics which select for 





Chapter 2: Materials and Methods 
The commonly used methodologies that apply to most of the experiments in this 
thesis are presented here. Any deviation from these will be stated in chapter 
specific method sections. Specifics, such as antibiotic, antibiotic concentration 
and resistance genes, are also presented in chapter specific methods sections, 
alongside any experiments not common to all chapters of this thesis. 
2.1 Complex community sampling methods 
Wastewater influent was used as the bacterial inoculum for all experiments. 
This was predominately collected from a treatment plant serving Falmouth and 
Penryn, Cornwall, UK. This plant serves a population of approximately 43,000 
and two grab samples were taken in October 2015 and October 2017. One 
experiment, undertaken by a placement student Jasmin Rauseo, presented in 
Chapter 4, used wastewater influent from a treatment plant serving Camborne 
and Redruth, Cornwall, UK. That plant serves approximately 34,000 people, 
and was collected in December 2016. Table 1 shows the experiments 
undertaken presented in this thesis and the corresponding inoculum. Figure 78 
(Page 300 - Appendix) shows the sampling sites. The two sites were similar to 
each other, serving predominantly domestic waste and one community hospital 
each. 
Table 1: Details of location and sampling date of wastewater inoculum 
used, corresponding thesis section and experiment 
Inoculum Thesis Section Experiment description 
Falmouth/Penryn  
October 2015 
Chapter 3 All selection experiments 
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Wastewater samples were frozen at -80 °C in 40 ml aliquots that consisted of 
20 ml of wastewater and 20 ml of 40% glycerol (Fisher Scientific). For growth 
rate experiments, smaller volumes (4 ml) were frozen in a 1:1 ratio with 40% 
glycerol, to prevent freeze-thawing or wastage of large volumes. Aliquots from 
the same wastewater treatment plant taken during the same sampling session 
were presumed to be pseudo-replicates for subsequent experiments. 
2.2 Selection experiments 
Wastewater samples were processed to remove existing chemicals and other 
non-bacterial substances, such as potentially selective compounds. This was 
undertaken by centrifuging samples at 2,730 xg for 10 minutes to pellet the 
bacteria. The supernatant was then removed and the pellet was resuspended in 
0.85% saline solution of the same volume. This was repeated once. This 
method was used as it was advised from the industrial partner, Jason Snape. 
Iso-sensitest broth (Oxoid) was inoculated with the washed wastewater at a 
10% v/v and with an appropriate concentration of antibiotic. Iso-sensitest was 
used as it is used for antibiotic susceptibility testing and therefore does not bind 
to the antibiotics. This meant that the concentration of antibiotic spiked is the 
concentration that is bioavailable to the bacteria. Antibiotics and their 
concentrations used can be found in relevant chapters. All experiments were 




Samples most commonly consisted of 5 replicates per concentration of 
antibiotic (of 5 ml each), although, in some preliminary studies, 3 replicates 
were used. This is stated in the relevant chapters. Samples were incubated 
shaking at 180 rpm for 24 hours (unless otherwise stated). For the majority of 
the experiments, samples were incubated at 37 °C. This was to allow for a 
relatively rapid experiment as this was hoped that this could be regularly used 
as an assay for the risk assessment of antibiotics. Where a different 
temperature is used, this is indicated in the relevant section. After 24 hours, 50 
µl of culture was passaged into fresh iso-sensitest broth and appropriate 
concentrations of antibiotic. Passaging was repeated once a day over 7 day 
period. This was to allow a large number of generations of the bacteria to be 
exposed to the appropriate antibiotic concentration and, therefore, provide the 
most evident dose response. 
At the beginning and the end of the selection experiment, two 1 ml samples 
were centrifuged at 21,000 xg for 3 minutes, the supernatant was removed and 
the pellet was resuspended in 1 ml of 20% glycerol. Samples were frozen at -80 
°C until further processing. The day 0 samples were frozen as quickly as 
possible on the same day, usually within 2 hours. Samples were kept on ice 
until frozen to minimise growth, change in population structure and change in 
antibiotic resistance genes.  
2.3 DNA extraction 
DNA was extracted, as per the manufacturer’s instructions, from frozen 
bacterial samples sampled at day 0 and day 7 using the MO Bio UltraClean® 
Microbial DNA Isolation Kit (now the QIAGEN DNeasy UltraClean Microbial Kit). 
DNA was frozen at -20 °C until use. 
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2.4 Real-time PCR (qPCR) 
2.4.1 Genes, primers and gBlocks 
A variety of antibiotic class specific resistance genes were quantified using 
qPCR. The antibiotic class specific genes chosen and reasons for choosing the 
various genes can be found in the relevant chapters. The class 1 integron-
integrase gene (intI1) was also targeted. Class 1 integrons have the ability to 
integrate a wide range of antibiotic resistance genes, and may be located on the 
host genome or plasmid. For this reason, they have frequently been described 
as a good indicator both for anthropogenic pollution and for the presence of 
AMR genes in the environment (Gillings et al. 2015; Kotlarska et al. 2015; Gaze 
et al. 2011; Abella et al. 2015; Jechalke et al. 2014). Finally, the 16S rRNA gene 
was amplified. This encodes the 16S ribosomal RNA in the small unit of the 
ribosome of prokaryotic cells and is primarily used as the target housekeeping 
gene for identification and taxonomy of bacterial species (Clarridge 2004). In 
the experiments presented in this thesis, the 16S rRNA gene was used as a 
proxy for bacterial cell count (Lundström et al. 2016; Murray et al. 2018). 
Molecular prevalence was calculated by dividing resistance gene and the intI1 
gene copy number by 16S rRNA copy number.  







Table 2: List of genes targeted by qPCR, corresponding forward and 
reverse primers, target region in gene and reference. Degenerate base 
codes: H = A or C or T, K = G or T, M = A or C, R = A or G, W = A or T, Y = C 
or T. 
Gene Forward (5’  
– 3’) 
Reverse (5’  
– 3’) 
Target region 









































































1299 to 1363 Isobel Stanton 













































1102 to 1172 Zhu et al. 
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Primers developed for this work were designed by obtaining a number of 
sequences of the target gene from GenBank 
(https://www.ncbi.nlm.nih.gov/genbank/) and using the primer design program 
Primer Express 3.0.1. This program generated many primer options and these 
options were tested by aligning potential primer sequences with a number of 
gene variants in the web program MUSCLE 
(https://www.ebi.ac.uk/Tools/msa/muscle/) to determine if the primers were in 
conserved regions of the gene. If no conserved primer sequences were 
determined, degenerate bases were used (as per IUPAC codes) (Johnson 
2010). Genbank sequences that were used to design these primers in this study 




Table 3: Genbank sequence references used to design primers 
Gene Genbank sequences 
mef family mefA: AY071835.1, AY064722.1, AY064721.1, 
NG_04959.1, AY319932.1, NG_047976.1, DQ304773.1, 
KJ809088.1, NG_047961.1, NG_047957.1, AF227521.1, 
AF227520.1 
mefE: EU870854.1, EU870853.1, U83667.1 
mefI: HG965092.1, EU870852.1 
mefO: DQ016305.1 
unclassified mef genes: DQ445271.1, AY355405.1 
mphA JQ824049.1, NC_019375.1, JN233704.1, AB262968.1, 
AY522923.1, AF188331.1, KU665641.1, GQ402463.2, 
HE616910.2, CYCH01000073.1, AB261016.2, 
KP453775.1, CYFJ01000056.1, CYFT01000096.1, 
NC_009981.1, KP987215.1, CU928163.2, NC_014615.1, 
D16251.1, AB366440.1, JX442974.1, CP006663.1, 
NC_021576.1 
msrD AJ715499.2, KJ809088.1, NG_048005.1, KU180707.1, 
KM194596.1, KC669392.1, KX077898.1 
macB subtype 1 AB071146.1, KY689638.1 
macB subtype 2 KN150735.1, KN150733.1 
macB subtype 3 KT613918.1, JQ309921.1 
macB subtype 4 JQ309920.1 
 
Standards for qPCR were designed for each gene and ordered as gBlocks from 
IDT technologies. These were designed by aligning primers to a sequence of 
the gene and taking the region they amplify together with a number of bases (at 
least 10 bp) on each end. Sequences for these can be found in Table 4. 
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Table 4: List of genes and associated gBlock sequences used as 
standards in qPCR assay, with reference 





































































































































2.4.2 qPCR protocol 
QPCR was undertaken on the Applied Biosystems StepOneTM machine.  
Each well consisted of: 
• 10 µl of Brilliant III Ultra-Fast Sybr® Green QPCR Master Mix (Agilent 
Technologies)  
• 1 µl of each of forward and reverse primer pairs (IDT Technologies) at a 
concentration of 10 µM for all primer sets except 16S rRNA which was 
used at a concentration of 9 µM 
• 0.6 µl of diluted ROX dye (provided with the master mix – Agilent 
Technologies)  
• 5 µl of template (standards, water or experimental DNA) 
• Nuclease Free Water (Ambion) up to a final volume of 20 µl 
Experimental DNA was diluted 5 times before addition of 5 µl to the well. A total 
of 1 µl of neat DNA, therefore, was added but pipetting error was minimised. 
The cycling conditions consisted of an initial cycling step of 95°C for 20 
seconds, followed by 50 cycles of 95°C for 10 seconds and 60°C for 30 
seconds. Melt curves were also initially run to determine that the primers were 
specific to the gene. Quality of the qPCR results was checked by the Efficiency 
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being between 90 and 110 % and an RQ value of greater than 0.99; only data 
meeting these requirements underwent further analysis. 
2.5 Metagenome sequencing and analyses 
Metagenome sequencing was undertaken on a subset of samples from 
selection experiments in Chapters 3 and 6. Details of subsets of samples 
selected for sequencing and the rationale behind choosing those samples can 
be found in the relevant chapter.  
DNA was extracted as described in Section 2.3. To purify DNA, an initial RNase 
step was undertaken using 2 µl of 20 mg/ml RNase A (QIAGEN). Subsequently, 
AMPure XP beads (Beckman Coulter) were used. A 1:1 volume of AMPure XP 
beads were added into the extracted DNA sample and mixed thoroughly by 
pipetting and incubated for 10 mins at room temperature. Samples were then 
placed on a magnetic stand to attract the beads. Supernatants were discarded 
and beads were washed with ethanol. Purified DNA was eluted in 10 mM Tris-
HCL by incubating the beads for 10 mins at 50°C before placing samples back 
on the magnetic stand and allowing for beads to pellet. The pellet was 
discarded and purified DNA (supernatant) was tested with the QUBIT BR assay 
or HS assay (Thermo Fisher Scientific) to check for a suitable concentration of 
DNA for sequencing. This was subsequently frozen at -20 °C until sent for 
sequencing.  
Samples were sent to and processed by Exeter Sequencing Service. The 
Nextera XT DNA Library Prep Kit was used to prepare the libraries and the 
libraries were sequenced on either a MiSeq v2 250 PE (Chapter 3) or HiSeq 




The raw sequence data for Chapter 3 was analysed by Aimee Murray and by 
the author for Chapter 6 as described in Murray et al. 2018. Both forward and 
reverse sequence reads were trimmed of adapter sequences using the 
programme Skewer (H. Jiang et al. 2014) in the paired-end mode. 
First, FastQC (Andrews 2010) and MultiQC (Ewels et al. 2016) were used to 
analyse the raw sequencing data to ensure robustness. This analysis provided 
information whether adapter sequences had been removed and on sequence 
quality. Only when sequences had been deemed to be of good quality and 
adapter sequences had been successfully removed, were subsequently 
analyses undertaken. “Good quality” was determined if the sequence had not 
“failed” any section of the analysis performed by FastQC and MultiQC, with the 
exception of GC content. GC content occasionally did not “pass” the quality 
check for all sequences. This can often be interpreted as an indication of 
contamination. However, as the samples here were a mixed microbial 
community it is expected that GC content might vary.  
For data presented in Chapter 3, 16S rRNA gene sequences were extracted 
from the raw sequence data. FLASH version 2 (Magoc & Salzberg 2011) was 
used to combine the paired-end reads. Bacterial species were assigned using 
MetaPhlAn2 (Truong et al. 2015).  
For both data from Chapter 3 and Chapter 6, Antibiotic Resistance Gene Online 
Analysis Pipeline (ARGs-OAP) version 2 was used to identify ARGs in the 
sequences produced by the metagenome (X. Yin et al. 2018) using default 
settings (blastx alignment length cut-off = 25, blastx alignment evalue cut-off = 
1e-07 and blastx alignment identity = 80). 
89 
 
All subsequent analyses were performed by the author. Statistical analyses 
were performed on all data sets produced from the metagenome as per Section 
2.6.  
2.6 Data analysis 
All graphs were produced by the author using the ggplot2 package (Wickham 
2016) in R studio (RStudio Team 2016) except the 16S community structure 
graphs (Chapter 3) which were generated by Aimee Murray as part of the 
metagenome analysis pipeline. This was produced using HClust2 (Segata 
2018) (with Bray-Curtis distance measurements used between species. Figure 
77 in Chapter 6, which adapted an image from Gullberg et al. 2011, was 
produced by the author using InkScape 0.92.2. 
R Studio (RStudio Team 2016) was used to perform all statistical analyses. 
Data were tested for normality using the Shapiro-Wilk test. Parametric datasets 
were analysed using ANOVA and Dunnett’s tests (using the multcomp package 
(Hothorn et al. 2008)) and for non-parametric data, Kruskal-Wallis and Dunn’s 
tests (using the dunn.test package (Dinno 2017)) were used. Dunnett’s and 
Dunn’s tests were chosen as they compare each group of replicates (in this 
case each concentration) to the first group of replicates entered into the data 
matrix (in this case the no antibiotic control). These tests were performed on 
day 7 prevalence data unless otherwise stated. For qPCR data, 
ANOVA/Kruskal-Wallis tests were also undertaken on the prevalence of genes 
at day 0 to ensure that there was minimal variation in prevalence between 
replicates. Where day 0 samples were significantly different from each other, 
post-hoc tests were undertaken on the difference between day 0 and 7, rather 
than the prevalence at day 7. This was to ensure that a significant change in 
90 
 
prevalence at day 7 was observed because of a dose response rather than 
difference in starting prevalence. This is indicated where applicable.  
If, due to natural variation in the samples, the Dunnett’s/Dunn’s test did not align 
with the biological effect observed, Generalised Linear Models (GLM) were 
performed. Both Gaussian and Gamma families were explored, with various link 
functions, and the best fit model was selected based on diagnostic plots and 
AIC values. Using a different statistical approach to determine significance was 
undertaken to ensure that the most conservative selective endpoint estimate 
was determined. This would allow the estimate to be the most protective of 
selection for antibiotic resistance genes in the environment and to, therefore, 
minimise the risk that antibiotics test pose to the environment.  
Where possible, selection coefficient graphs were produced as described in 
Gullberg et al. 2011. The formula used was: selection coefficient = 
[LN(prevalence at day 7/prevalence at day 0)]/number of days. Selection 
coefficients were plotted and the MSC was defined where the line of best fit 
crosses the x axis. Linear and polynomial models were plotted to the data 
points using the polynom package (Venables et al. 2019) in RStudio (RStudio 
Team 2016). To determine which line of best fit to use, a summary of the model 
fit was obtained. The R2 value was used to find the model that best correlated 
with the data and a one way ANOVA was used to determine whether models 
were significantly different to each other. A limited range of concentrations is 
occasionally plotted, or concentration values have been transformed (square 
root transformation), to provide a more accurate MSC value as the spread of 
concentrations can skew the line of best fit. This will be noted in the appropriate 
section. For certain replicates, the prevalence at day 0 was 0. This, however, 
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was not truly the case as prevalence had increased in the same biological 
replicate by the end of the 7 days. This suggested that the gene was in the 
initial sample, but was below the limit of detection. Due to the nature of the 
formula (having to divide by prevalence at day 0, where the prevalence was 0 
this was mathematically impossible) and that certain genes were below the limit 
of detection rather than completely absent, a pseudo value was used. To 
determine the best estimate for the possible range of values between the limit of 
detection and zero, the pseudo-value was calculated as half of the detection 
limit.  
2.7 Definitions of selective endpoints 
To avoid confusion between selective endpoints determined by different means 
(either statistically or by selection coefficient), they will, henceforth, be referred 
to by different names and acronyms. All selective endpoints determined by 
statistical means will be described as a LOEC (lowest observed effect 
concentration). This is the lowest concentration where significant positive 
selection for a gene was observed to 95% confidence using qPCR data. The 
immediately preceding test concentration (the highest concentration where no 
selection is seen) is referred to as the NOEC (no observed effect 
concentration). If a selective endpoint is able to be determined by a selection 
coefficient, this will be defined as the MSC, as previously described and used in 
Gullberg et al. 2011, Gullberg et al. 2014 and Murray et al. 2018. If the 
prevalence of a gene increases over time in the no antibiotic control, it is 
impossible to determine a MSC for this gene as the line of best fit never crosses 
the x axis. This will be highlighted in the relevant sections. PNEC (predicted no 
effect concentration) will be used when an assessment factor has been applied 
to the NOEC or the MSC. Throughout this thesis an assessment factor of 10 is 
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applied to all NOEC and MSC values. This is the assessment factor 
recommended by the EMEA to determine PNEC values for surface water 

















Chapter 3: The potential for macrolide antibiotics to 
select for antibiotic resistance 
Author contributions 
The author conducted all experimental work in this chapter under the 
supervision named supervisors. DNA was sent to Exeter Sequencing Service 
who sequenced the samples. Aimee Murray checked the quality of the 
sequences, ran them through two pipelines to analyse the 16S and antibiotic 
resistance gene data. Aimee Murray also produced the 16S diversity graphs. 
The author analysed the raw data from the antibiotic resistance gene analysis 
pipeline. 
3.1 Abstract 
In 2015, the European Commission created the first watch list of 10 
compounds, or groups of compounds, that evidence suggests are emerging 
pollutants in the aquatic environment. The macrolide antibiotics, azithromycin, 
clarithromycin and erythromycin, were included on this list as one of the ten 
groups identified as potentially posing a risk to the environment. Currently, there 
is no requirement to determine, or a standardised test for determining, the 
selective potential of antibiotics or other co-selective compounds at 
environmental concentrations. The aim of this investigation was, therefore, to 
determine the selective potential of the three macrolide antibiotics in a complex 
community assay, as all previous work has only investigated this in single 
species experiments.  
This chapter includes a literature review of environmental macrolide 
concentrations; an assessment of resistance gene host diversity; nine week 
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long selection experiments for three macrolides at a wide range of 
concentrations; extensive qPCR analysis for key genes; a culture based 
analysis; metagenome data analyses; identification of additional qPCR gene 
targets from metagenome data and further qPCR analysis for these targets. 
Week-long selection experiments, using wastewater influent as the inoculum, 
were performed at various concentrations of the three macrolides tested. 
Samples were taken at the beginning and end of the experiment and qPCR was 
used to track the change in prevalence of macrolide resistance genes and the 
class 1 integron gene intI1 over the 7 day period. Metagenome culture based 
analyses were used to validate qPCR results. Metagenome analysis also 
investigated the co-selective properties of the macrolides tested and of any 
changes in community structure as a result of increasing antibiotic 
concentration.  
A LOEC of 750 µg/L was determined for clarithromycin, with a NOEC of 500 
µg/L. LOECs for azithromycin and erythromycin were both 1,000 µg/L with 
NOECs of 750 µg/L. In addition, a MSC of approximately 514 µg/L was 
estimated for erythromycin. These values are significantly higher than current 
measured environmental concentrations and, therefore, based on results from 
this experimental system, these compounds do not currently pose an 
environmental risk in terms of selection for resistance. These values should, 
however, be used in conjunction with ecological endpoints to decide whether 
these compounds should be removed from the watch list. 
3.2 Introduction 
Macrolides are a clinically important class of antibiotic. In 2014 they were the 
third highest prescribed antibiotic in England accounting for 15% of all antibiotic 
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prescriptions (Public Health England 2015). Erythromycin (ERY) was the 
original macrolide antibiotic and is a natural product isolated from 
Saccharopolyspora erythraea (formerly known as Streptomyces erythraeus) in 
1952 by McGuire et al. (McGuire et al. 1952; Shryock et al. 1998; Wright et al. 
2014). The term “macrolide” was coined in 1957 as the metabolite produced by 
S. erythraea contained a macrolactone ring (Wright et al. 2014). ERY is 
comprised of many components with the active ingredient being erythromycin A 
(Hawkyard & Koerner 2007). Erythromycin A consists of the lactone ring (14-
membered) as well as an amino sugar and L-cladinose. Semi-synthetic 
macrolides that are derived from erythromycin A have 14-membered lactone 
rings and include clarithromycin (CLA), dirithromycin and roxithromycin. 
Azithromycin (AZ) has a modified 15-membered lactone ring with the addition of 
a nitrogen atom and there are also 16-membered lactone ring macrolides 
(myocamycin, midecamycin, spiramycin, josamycin and tylosin) (Leclercq & 
Courvalin 2002). Semi-synthetic derivatives, such as AZ and CLA, offer better 
tolerability and pharmacokinetics due to the alterations of the erythromycin A 
molecule (Leclercq & Courvalin 1991; Amsden 1996; Leclercq 2002). 
Macrolides inhibit bacterial growth by targeting protein synthesis and are 
bacteriostatic. In vitro experiments have shown, however, that AZ, CLA and 
ERY have bactericidal effects against certain Streptococcus spp. (Pankey & 
Sabath 2004). They achieve bacteriostatic effects by binding to the 23S rRNA of 
the large subunit of ribosomes (50S). This binding prevents peptides that have 
been newly synthesised from entering and passing through the tunnel of the 
ribosome and this, in turn, prevents translation (Kannan & Mankin 2011; Mazzei 
et al. 1993).  
96 
 
In the clinic, macrolides are used to treat a wide range of infections caused by 
both Gram-positive and Gram-negative bacteria. For example, AZ is 
recommended for treatment of shigellosis in children (CDC 2006; DuPont 2009) 
and as a secondary treatment for adult patients (WHO 2005); and is often 
considered for use against invasive non-typhoidal salmonella (Sjölund-Karlsson 
et al. 2011). All three compounds, AZ, CLA and ERY, are used to treat 
respiratory infections, for example for both post-exposure prophylaxis and 
treatment of pertussis (CDC 2005). CLA is also used in combination with a 
proton pump inhibitor and either metronidazole or amoxicillin to treat 
Helicobacter pylori infections (Chey et al. 2017). Finally, the CDC recommends 
a single dose of 1 g of AZ to treat the sexually transmitted infection, chlamydia 
(Geisler et al. 2015) and, as recommended by the British Association for Sexual 
Health and HIV, a single 1 g oral dose of AZ in combination with 500 mg of 
cefriazone to treat gonorrhoeae (Bignell & FitzGerald 2011).  
Macrolides are also used in agricultural and veterinary practices. Tylosin, a 16-
membered macrolide, was a feed additive used as a growth promotor in the 
European Community until it was banned (along with other antibiotics) in 1999 
(Hao et al. 2014; Butaye et al. 2003). In a 2015 list by the World Organisation 
for Animal Health (OIE), the macrolide antibiotics were classed as “Critically 
Important Antimicrobial Agents” for veterinary practice where they are deployed, 
for example, to treat both haemorrhagic digestive disease and Mycoplasma 
infections in pigs. In cattle they are used to treat respiratory infections and liver 
abscesses (OIE 2015). 
As with all antibiotic classes, macrolides have not escaped the rise of antibiotic 
resistance. A study published in 2016 investigated CLA-resistant H. pylori from 
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4 regions of the United States and found 32.3% of these isolates were resistant 
(and a range from 23.1-45.8% between different sites) (Park et al. 2016). In 
2017 the WHO produced a list of priority pathogens where research and 
development of new antibiotics was important. These pathogens were 
categorised into three priority levels; “Priority 1: CRITICAL, Priority 2: HIGH and 
Priority 3: MEDIUM.” On this list, CLA – resistant Helicobacter pylori are classed 
as “Priority 2: HIGH” (WHO 2017b). A further study in 1991 tracked macrolide 
resistance in Streptococcus pneumoniae in the United States between 1979 
and 1987 and determined that 0.3% of S. pneumoniae were resistant to ERY 
(Spika et al. 1991; Lonks 2004). Two surveillance studies published in the early 
2000s determined significantly higher rates of resistance (Thornsberry et al. 
2002; Jacobs et al. 2003; Lonks 2004). The study published in 2002 evaluated 
levels of various antibiotic resistant pathogens from 1999-2000 in the United 
States and suggested that 19.4% of S. pneumoniae isolates were now resistant 
to ERY, with a further 7.2% resistant to both ERY and clindamycin (Thornsberry 
et al. 2002). The Alexander project, which collected data from a range of 
countries worldwide, determined that 24.6% of S. pneumoniae isolates were 
resistant to ERY during the study period from 1998-2000 (Jacobs et al. 2003). 
In addition, between 2004 and 2008, an increase in AZ resistant N. 
gonorrhoeae was seen from 0.3% and 3.9% in Scotland (Palmer et al. 2008). 
Furthermore, a study published in 2018 retrospectively looked at isolates in the 
China Gonococcal Resistance Surveillance Programme collected between 2013 
and 2016. Here they saw an average AZ resistance prevalence for these 
isolates of 18.9% (Yin et al. 2018).  
Resistance to macrolides can occur by mutations (specifically, base 
substitutions) in the 23S ribosomal RNA, allowing for macrolide target site 
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modification (Vester & Douthwaite 2001). There are also a high number of 
acquired resistance genes that protect bacteria in a variety of ways. These 
include rRNA methylases, macrolide 2’-phosphotransferases, esterases and 
efflux pumps (both major facilitators and ATP-binding). Genes that encode 
rRNA methylases include a variety of erm genes (ermA, ermB, ermC, ermF 
etc). These work by adding methyl groups (one or two) to a single adenine 
within the 23S rRNA. As of 2008, 33 erm genes had been identified with this 
group of genes able to confer resistance to lincosamides and streptogramin B 
antibiotics, as well as the macrolides (Roberts 2008). Macrolide 2’-
phosphotransferases inactivate the macrolides on 14-,15- and 16-membered 
rings by enabling the transfer of phosphate from ATP onto the 2’-hydroxyl group 
which include mphA, B, C and D (Achard et al. 2008; Taniguchi et al. 2004). 
While esterases, such as ereA and ereB, are not the most common macrolide 
resistance mechanism deployed, they can produce extremely high levels of 
resistance with MICs greater than 1,600 µg/ml. They work by breaking down an 
ester bond that is key in forming the lactone ring (Wright 2005). Efflux pumps, 
such as mefA and msrD (Roberts 2008), work by physically pumping the 
antibiotic out of the bacterial cell. They can be specific to an antibiotic class or 
can work against multiple classes (Webber & Piddock 2003). 
Macrolides are frequently detected in a range of aquatic environments at ng/L to 
µg/L concentrations. A review of typical environmental macrolide concentrations 
(excluding unusually high concentrations from pharmaceutical effluents, for 
example) was undertaken during this study and is reported in this chapter. 
Average and maximum concentrations for AZ, CLA, ERY and erythromycin – 
H2O (ERY-H2O) can be seen in the results (Section 3.4.1). Individual 
concentrations and references can be found in the full Table in the Appendix, 
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Table 11 (Page 301). The maximum value of all these 4 compounds in typical 
aquatic environments was 4 µg/L for ERY-H2O which was measured in the 
surface waters of the Jianhan Plain in China (Tong et al. 2014). ERY-H2O is a 
metabolite of ERY and is thought to be able to select for resistance (Majer 
1981; Fan et al. 2009). 
In a study published in 2009, the location of antibiotic resistance genes in 
environmental bacteria was reviewed. These included a range of erm genes 
and mphA. This group of macrolide resistance genes were found in bacteria 
inhabiting a variety of aquatic environments including activated sludge, 
wastewater treatment plant (WWTP) effluent and “special wastewater” which 
included agricultural, aquacultural and hospital wastewater. This review only 
considered 10 macrolide resistance genes from 4 previous surveillance studies 
and this, therefore, demonstrates the range of aquatic environments in which 
bacteria harbouring macrolide resistance genes can be found (X. X. Zhang et 
al. 2009).  
A list of compounds of concern, that required better monitoring in the aquatic 
environment, was produced by The European Commission in 2015. This list 
consisted of 10 priority substances or groups of substances. Compounds were 
chosen for the priority list based on their risk quotient (RQ) values. RQ values 
were calculated by comparing predicted environmental concentrations (PECs) 
and measured environmental concentrations (MECs) of compounds to 
predicted no effect concentrations (PNECs) in freshwater. PNECs for AZ, CLA 
and ERY were calculated using the test species Ceriodaphnia dubia, Anabaena 
flos-aquae and Synechococcus leopoldenisis, respectively. The PECs and 
MECs of all three macrolide antibiotics were found to have always exceeded the 
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PNECs, leading to RQs > 1 for each compound. These RQs were 6.48, 4.96 
and 3.07 for AZ, CLA and ERY, respectively and these compounds were, 
therefore, deemed to pose a significant risk to the aquatic environment 
(European Commission 2015b). In 2018, a review of this priority substances list 
was undertaken. The macrolide antibiotics remained on the new 2018 list and 
two further antibiotics, ciprofloxacin and amoxicillin, were added (European 
Commission 2018).  
Work to date on the macrolide antibiotics’ effect on the environment has either 
consisted of single species assays, mathematical predictions of selective 
endpoints or traditional ecotoxicology testing of acute toxicity to aquatic 
organisms to calculate PNECs.  
Gullberg et al. 2014 determined two MSCs for ERY using a single species 
competition assay. An E. coli wildtype strain was competed in a 1:1 ratio with an 
isogenic resistant mutant at various concentrations of antibiotic. Susceptible 
and resistant strains had different fluorescent protein genes inserted to allow 
identification using flow cytometry, after the competition experiment had been 
undertaken. In this study, an mph cassette was used in an experiment with the 
cassette on a plasmid and an experiment with the cassette on the chromosome 
which determined MSCs of 3,000 and 200 µg/L of ERY, respectively (Gullberg 
et al. 2014).  
A study by Bengtsson-Palme & Larsson in 2016 calculated a PNEC for 
selection of resistance (PNECR). To do this, a mathematical approach was 
used. MIC values were obtained for all antibiotics and combinations of 
antibiotics that were available on the EUCAST database (122 MIC values in 
total). The lowest 1% of the MICs were identified, adjusted for number of 
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species tested and an assessment factor of 10 applied to calculate PNECR 
values. For the macrolide antibiotics, PNECRs of AZ, CLA and ERY were 
determined to be 0.25 µg/L, 0.25 µg/L and 1 µg/L, respectively (Bengtsson-
Palme & Larsson 2016), which are significantly lower than experimental data 
generated by Gullberg et al., 2014. 
A meta-analysis was conducted in 2017 on previously published PNECs for 
freshwater organisms in surface waters. This took the lowest reliable no 
observable effect concentration (NOEC) data from a number of studies using a 
range of different ecotoxicology tests and applied an assessment factor of 10 to 
derive PNECs. For AZ, the PNEC for surface water was 0.019 µg/L, for CLA it 
was 0.084 µg/L and finally, for ERY the PNEC was 0.2 µg/L. All of these values 
were calculated from ecotoxicology tests using cyanobacteria from the studies 
Vestel et al. 2015, Baumann et al. 2015 and Ando et al. 2007 for AZ, CLA and 
ERY, respectively (Le Page et al. 2017).  
In the European Commission’s 2015 report, PNECs were derived when the 
macrolide antibiotics were placed on the Water Framework Directive’s priority 
watch list, giving PNECs for AZ (0.09 µg/L), CLA (0.13 µg/L) and ERY (0.2 
µg/L) using the test species mentioned above (European Commission 2015b). 
The aim of the work undertaken and reported in this chapter was to investigate 
selection and co-selection for resistance and to define selective endpoints 
(LOECs/MSCs) for the three macrolide antibiotics placed on the European 
Commission’s priority watch list (AZ, CLA and ERY). This was done across a 
range of antibiotic concentrations in complex microbial communities, rather than 




3.3.1 Antibiotics and antibiotic concentrations 
The antibiotics used were AZ (Sigma-aldrich), CLA (Molekula) and ERY (Acros 
Organics). AZ and ERY were both dissolved in ethanol absolute (Fisher) and 
CLA was dissolved using acetone (Acros Organics).  
Three experiments were undertaken:  
• “Preliminary experiment 1 – low macrolide concentrations” – this 
consisted of concentrations 0.1, 1, 10 and 100 µg/L of each of the three 
macrolides. These concentrations were based on typical environmental 
concentrations determined by a literature search presented in Section 
3.4.1.  
• “Preliminary experiment 2 – high macrolide concentrations” was run at 
1,000 and 10,000 µg/L for AZ and CLA and at 1,000, 10,000 and 
100,000 µg/L for ERY.  
• The “Final selection experiments” which were undertaken across a range 
of these concentrations (100, 250, 500, 750, 1,000, 10,000 and 100,000 
µg/L) for all three compounds. 
3.3.2 Macrolide resistance genes for qPCR 
The macrolide resistance genes ermB, ermF, mphA, msrD and mef family 
(which targeted the mefA, mefE, mefI and mefO genes) were quantified using 
qPCR. These specific macrolide resistance genes were targeted as they have 
been reported in a wide range of bacteria, both Gram-positive and Gram-
negative species (Roberts 2008). In terms of specific genes, the ermB and 
ermF genes were described by Berendonk et al. 2015 to be genetic marker 
determinants for assessing macrolide resistance in the environment (Berendonk 
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et al. 2015). In addition, a study from 2009 found that mphA was the most 
common macrolide resistance gene found in clinical isolates of E. coli (Nguyen 
et al. 2009). IntI1 (as it has been described as a good proxy for ARGs (Gillings 
et al. 2015)) and 16s rRNA (as a proxy for bacterial cell count) were also 
quantified. 
3.3.3 Culture-dependent (plating) experiment 
Culture dependent methods were also used to capture information potentially 
missed by qPCR (for example, spontaneous mutations). Overnight bacterial 
cultures at day 7, that had been grown with 100, 1,000, 10,000 and 100,000 
µg/L of AZ, as well as cultures of the no antibiotic control, were plated onto 3 
different agars. These were Muller-Hinton agar (Oxoid) to capture all culturable 
bacteria; Chromocult Coliform Agar Enhanced Selectivity (Merck) enriching for 
Enterobacteriacae spp. and Mannitol-salt agar (HiMedia Laboratories Technical 
Data protocol: http://himedialabs.com/TD/M118.pdf) to enumerate 
Staphylococcus spp.  
Serial dilutions of 100 µl of day 7 bacterial cultures were plated onto the three 
types of agar, both with and without AZ in the media. In this way, prevalence 
was calculated for phenotypic resistance (number of colonies on agar with 
AZ/number of colonies on agar without AZ).  
The AZ concentration used in the Chromocult agar to determine phenotypic 
resistance was 16 mg/L. This is the clinical breakpoint for Shigella spp. and 
Salmonella Typhi taken from the EUCAST database (EUCAST, Clinical 
breakpoints – bacteria (v 7.1)). For Muller-Hinton agar and Mannitol-salt agar, 
the clinical breakpoint for Staphylococcus spp. was used (2 mg/L). This value 
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was also obtained from the EUCAST breakpoint database (EUCAST, Clinical 
breakpoints – bacteria (v 7.1)). 
3.3.4 Samples sent for metagenome analysis 
Three replicates of the day 7 samples from the final selection experiment were 
sequenced. Concentrations included 250, 750, 1,000, 10,000 and 100,000 µg/L 
of AZ, CLA and ERY as well as the no antibiotic control. Replicates sent for 
sequencing were those with the highest intI1 prevalence, with the aim of 
capturing the highest variety of resistance genes that had not been targeted 
using qPCR and of seeing the largest co-selective effect on other antibiotic 
resistance gene classes. 
3.4 Results 
3.4.1 Macrolide environmental concentrations  
A literature review was conducted to determine an environmental concentration 
range to test. Studies were found by searching for papers that reported the 
levels of pharmaceuticals in aquatic environments. Studies were eliminated if 
they did not test for macrolides or concentrations were below detection limit. As 
the searches were undertaken to determine typical environmental 
concentrations of macrolide antibiotics, unusually high concentrations, for 
example, from pharmaceutical plant effluents were excluded as not being 
indicative of the general pattern of macrolide concentrations in the environment. 
Instead, the search focused on surface waters, ground waters, WWTP influent 
and WWTP effluent. A total of 29 studies were used to calculate the mean and 
maximum concentrations. The results of this search are summarised in Table 5 
and the full list of concentrations and references can be found in Table 11 
(Page 301, Appendix). 
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Table 5: Measured environmental concentrations of macrolide antibiotics 
where detected. Concentrations are in µg/L. 1 = Number of studies used to 
calculate the mean concentration. 2 = Number of studies where antibiotic was 
below the limit of detection. N.B. Some studies are included in both of these 
categories if multiple sites were tested and/or multiple antibiotics were tested. 
 
3.4.2 Preliminary experiment 1 – low macrolide concentrations 
Based on the review of environmental macrolide concentrations undertaken 
(see Section 3.4.1) an initial range finding experiment was conducted to 
encompass both the mean and maximum concentrations seen in the 
environment. The concentrations 0.1, 1, 10 and 100 µg/L were chosen for all 
three macrolides and were run alongside a no antibiotic control. QPCR was 
used to quantify 5 macrolide genes (ermB, ermF, mef family, mphA and msrD) 
and the 16S rRNA gene was a proxy for bacterial cell count allowing a 
molecular prevalence to be calculated at the beginning and at end of the 7 day 
experiment. 
Figure 4A-E shows the effect AZ has at low concentrations. No significant 
positive selection was seen for any of the 5 macrolide specific genes at any of 
the concentrations tested compared to the no antibiotic control. A significant 
increase in prevalence was observed at 100 µg/L (p = 0.0142, Dunn’s test) of 
AZ for mef family (Figure 79, Page 309 - Appendix). The error bar seen here is 




AZ 0.193 1.5 27 9 
CLA 0.140 1 42 8 
ERY 0.225 2.42 50 12 
ERY – H2O 0.412 4 34 1 
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large and overlaps with the error bar of the corresponding day 0 prevalence. 
One high outlier replicate was observed in this dataset and when this was 
removed, no significant increase was seen at any concentration (Figure 4C). No 
significant increase in prevalence, in comparison to the no antibiotic control, 





Figure 4A: ermB as a function of low azithromycin concentrations. 4B: 
ermF as a function of low azithromycin concentrations. 4C: mef family as 
a function of low azithromycin concentrations. 4D: mphA as a function of 
low azithromycin concentrations. 4E: msrD as a function of low 




There was also no significant selection seen at low concentrations for CLA (see 
Figure 5A-E) or ERY (see Figure 6A-E). A significant increase, in comparison to 
the no antibiotic control, was seen for ermB to 90% confidence at 0.1 and 10 
µg/L of CLA (p = 0.0721 and 0.0855, respectively, Dunn’s test) and for the mef 
family to 95% confidence at 100 µg/L of CLA (p = 0.0414, Dunn’s test). This 
was, however, not an increase over the starting prevalence of these genes. One 
high outlier replicate has been removed from the no antibiotic control sample at 
































A similar response was seen for ermB in the presence of ERY. A significant 
increase in comparison to the no antibiotic control was seen to 95% confidence 
at 0.1 µg/L (p = 0.0233, Dunn’s test) and to 90% confidence at 100 µg/L (p = 
0.0603, Dunn’s test). Again, this was not higher that the starting inoculum of 
Figure 5A: ermB as a function of low clarithromycin concentrations. 5B: 
ermF as a function of low clarithromycin concentrations. 5C: mef family as 
a function of low clarithromycin concentrations. 5D: mphA as a function 
of low clarithromycin concentrations. 5E: msrD as a function of low 
clarithromycin concentrations. x = significant increase in comparison to the 
control to 90% confidence.  xx = significant increase in comparison to the 
control to 95% confidence. Standard error is represented by the error bars. 
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ermB. One high outlier replicate has been removed from the no antibiotic 

















Higher, more clinically relevant concentrations were, therefore, tested (Section 
3.4.3.) 
Figure 6A: ermB as a function of low erythromycin concentrations. 6B: 
ermF as a function of low erythromycin concentrations. 6C: mef family as 
a function of low erythromycin concentrations. 6D: mphA as a function of 
low erythromycin concentrations. 6E: msrD as a function of low 
erythromycin concentrations. x = significant increase in comparison to the 
control to 90% confidence.  xx = significant increase in comparison to the 
control to 95% confidence. Standard error is represented by the error bars. 
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3.4.3 Preliminary experiment 2 – high macrolide concentrations 
As no significant positive selection for any gene was seen at a range of typical 
environmental concentrations for any of the three macrolide compounds (see 
Section 3.4.2), a higher range of concentrations was tested. For AZ and CLA, 
1,000 and 10,000 µg/L were tested and for ERY 1,000, 10,000 and 100,000 
µg/L were tested. A 10-fold higher concentration was used for ERY as it has 
been suggested that it is less potent than some semi-synthetic derivatives (Jelić 
& Antolović 2016). 
Results showing the effect of AZ on all 5 macrolide resistance genes can be 
seen in Figure 7. Again, no significant selection was seen for the mef family or 
for msrD. Significant positive selection was seen for ermF and mphA. For ermF, 
significant selection was seen to 90% confidence at 1,000 (p = 0.0784, Dunn’s 
test) and to 95% confidence at 10,000 µg/L (p = 0.0153, Dunn’s test) compared 
to the no antibiotic control. For mphA, a significant selective effect was not seen 
until 10,000 µg/L (p = 0.0368, Dunn’s test), however a stronger response was 
seen in terms of increase in prevalence in comparison to the response of ermF. 
For ermB, however, there was a significant difference between prevalence at 
10,000 µg/L (p = 0.007, Dunn’s test) in comparison to the no antibiotic control 



























Figure 7A: ermB as a function of high azithromycin concentrations. 7B: 
ermF as a function of high azithromycin concentrations. 7C: mef family as 
a function of high azithromycin concentrations. 7D: mphA as a function of 
high azithromycin concentrations. 7E: msrD as a function of high 
azithromycin concentrations. xx = significant increase in comparison to the 
control to 95% confidence.   * = significant positive selection to 90% confidence, 
** = significant positive selection to 95% confidence. Standard error is 




CLA showed a similar pattern to AZ. Graphs for this data can be seen Figure 8A 
- 8E for ermB, ermF, mef family, mphA and msrD, respectively. Again, no 
positive selection was seen for ermB, msrD and mef family. A significant 
increase was observed in comparison to the no antibiotic control for ermB at 
10,000 µg/L (p = 0.0104, Dunn’s test) but, as with AZ, this did not increase 
above the starting prevalence.  
For ermF, the Dunnett’s test did not match with biological effect seen. No 
significant selection was observed at any concentration. A Generalised Linear 
Model (GLM) (Gamma, link = log) was performed. This aligned better with the 
biological effect. Significant selection for ermF was seen at 1,000 µg/L (p = 
0.00953, GLM (Gamma, log)) and at 10,000 µg/L (p = 0.00375, GLM (Gamma, 
log)).   
Significant selection for mphA by CLA was observed to 90% confidence at 
10,000 µg/L only (p = 0.0680, Dunn’s test), although a biological effect can be 






























Figure 8A: ermB as a function of high clarithromycin concentrations. 8B: 
ermF as a function of high clarithromycin concentrations. 8C: mef family 
as a function of high clarithromycin concentrations. 8D: mphA as a 
function of high clarithromycin concentrations. 8E: msrD as a function of 
high clarithromycin concentrations. x = significant increase in comparison to 
the control to 90% confidence.  * = significant positive selection to 90% 
confidence, ** = significant positive selection to 95% confidence. Standard error 
is represented by the error bars. 
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As with AZ and CLA, no significant positive selection was seen for ermB, mef 
family and msrD at any of the concentrations of ERY (Figure 9A, C and E, 
respectively). A significant increase in prevalence of ermB, in comparison to the 
no antibiotic control, was observed to 90% confidence at 1,000 (p = 0.0705, 
Dunn’s test) and 10,000 µg/L (p = 0.0565, Dunn’s test) of ERY and to 95% 
condfidence at 100,000 µg/L (p = 0.0157, Dunn’s test). None of these were 
found to be higher than the prevalence found in the day 0 samples and, 
therefore, no positive selection was occurring. 
For ermF (Figure 9B), significant selection was seen to 90% confidence at 
1,000 µg/L (p = 0.0745, Dunn’s test) and to 95% confidence at 10,000 (p = 
0.0108, Dunn’s test) and 100,000 µg/L (p = 0.0163, Dunn’s test) of ERY. 
Finally, significant selection for mphA (Figure 9D) was first observed to 90% 
confidence at 10,000 µg/L (p = 0.0606, Dunn’s test) and to 95% confidence at 






























Figure 9A: ermB as a function of high erythromycin concentrations. 9B: 
ermF as a function of high erythromycin concentrations. 9C: mef family as 
a function of high erythromycin concentrations. 9D: mphA as a function of 
high erythromycin concentrations. 9E: msrD as a function of high 
erythromycin concentrations. x = significant increase in comparison to the 
control to 90% confidence.  xx = significant increase in comparison to the 
control to 95% confidence.   * = significant positive selection to 90% confidence, 
** = significant positive selection to 95% confidence. Standard error is 
represented by the error bars. 
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3.4.4 Final selection experiments 
The preliminary data for ermF showed no significant selection at 100 µg/L but 
significant selection at 1,000 µg/L for all three macrolides. It was decided, 
therefore, to target a concentration range between these two values to enable a 
more accurate MSC to be determined for the three macrolide compounds. This 
concentration range was 100, 250, 500, 750, 1,000, 10,000 and 100,000 µg/L. 
Based on preliminary data (as seen in Section 3.4.2 and 3.4.3), mef family, 
ermB and msrD were no longer tested. The integron gene intI1, however, was 
included in the analysis alongside ermF and mphA. The qPCR results can be 
seen in Section 3.4.4.1.  
To determine whether spontaneous mutations or other macrolide resistant 
genes, not being quantified by qPCR, were selected for at concentrations lower 
than was seen with the current qPCR targets, culture dependent methods were 
used (see Section 3.4.4.3) and metagenome libraries were produced (see 
Section 3.4.4.4). Metagenome libraries were also analysed for the 16S rRNA 
community structure change with increasing concentration of macrolides, and 
for the co-selective ability of AZ, CLA and ERY to select for antibiotic resistance 
genes specific to other classes of antibiotics. 
3.4.4.1 Real-time PCR analysis 
Azithromycin 
ermF 
The gene that showed positive selection at the lowest AZ concentration was 
ermF. As can be seen in Figure 10, no significant selection was seen compared 
to the no antibiotic control at 100, 250 and 500 µg/L, but significant selection 
was seen to 90% confidence at 750 µg/L (p = 0.0616, Dunn’s test) and to 95% 
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confidence at 1000 µg/L (p = 0.0015, Dunn’s test) and 10,000 µg/L (p = 0.0242, 
Dunn’s test). At 100,000 µg/L, no significant selection was seen. The LOEC 















The graph showing the response of mphA to AZ can be seen in Figure 11. A 
strong biological effect can be seen at 1,000, 10,000 and 100,000 µg/L. When 
the Dunn’s test was undertaken, however, only 10,000 µg/L showed a 
significant response (p = 0.0839, Dunn’s test). This was, presumably, due to the 
Figure 10: Selection for ermF by azithromycin. A LOEC of 
1,000 µg/L is determined. Standard error is represented by the 
error bars. * = significant positive selection to 90% confidence, 
** = significant positive selection to 95% confidence. 
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high variation between the biological replicates. This variation can be seen in 
Figure 80, Appendix. As a result, instead of using the Dunn’s tests, a GLM was 
used to analyse this data. This produced more credible statistical significance.  
Positive selection by AZ was, therefore, observed at 1,000 (p = 9.21E-5, GLM 
(Gamma, log)), 10,000 (p = 0.000413, GLM (Gamma, log)) and 100,000 µg/L (p 






Figure 11: Selection for mphA by azithromycin. A LOEC of 1,000 
µg/L was determined. Standard error is represented by the error bars. 





Similarly to mphA, the Dunnett’s/Dunn’s post hoc test did not align to the 
biological effect seen by AZ on intI1. GLM was, therefore, undertaken. No 
LOEC could be determined as significant selection was not observed to 95% 
confidence at any concentration. AZ positively selected for intI1, to 90% 
confidence, in comparison to the no antibiotic control, at 1,000 µg/L (p = 0.0886, 
GLM (Gamma, inverse)), 10,000 µg/L (p = 0.0886, GLM (Gamma, inverse)) and 
100,000 µg/L (p = 0.0932, GLM (Gamma, inverse)), Figure 12. This was a more 
credible, and more protective, result than the Dunn’s test which only determined 
significant selection at 10,000 (p = 0.0174, Dunn’s test) when a clear biological 




























As with AZ, ermF showed a response to CLA at the lowest concentration 
(Figure 13). At 100, 250 and 500 µg/L no significant selection was seen 
compared to the no antibiotic control. Significant selection was seen to 95% 
confidence at 750 (p = 0.0336, Dunn’s test), 1,000 (p = 0.0018, Dunn’s test) and 
10,000 µg/L (p = 0.0242, Dunn’s test). Again, as with AZ, no significant 
selection was seen at 100,000 µg/L. A LOEC of 750 µg/L was, therefore, 
determined. 
Figure 12: Selection for intI1 by azithromycin. No LOEC could be 
defined. Significant positive selection was seen to 90% confidence at 
1,000 µg/L. Standard error is represented by the error bars. * = 







Variation was observed in prevalence at day 0 (p = 0.001574, Kruskal Wallis). 
The difference in prevalence between day 0 and day 7 was, therefore, used for 
statistical analyses. A LOEC for mphA selection by CLA was 100,000 µg/L (p = 
0.0446, Dunn’s test (difference)), although a biological effect was seen at 
10,000 µg/L, Figure 14. This was a significantly higher concentration of CLA in 
comparison to the concentration (750 µg/L) of CLA needed to positively select 
for ermF. A much stronger response was seen, however, in terms of prevalence 
Figure 13: Selection for ermF by clarithromycin. A LOEC of 750 
µg/L of CLA was determined. Standard error is represented by the 




at day 7 and change in prevalence over the 7 day period of mphA by CLA in 





As with the selection for intI1 and mphA by AZ, the Dunnett’s/Dunn’s test did 
not align to the biological effect seen when intI1 was selected by CLA. Variation 
was observed in the prevalence at day 0 (p = 0.0018, Kruskal Wallis) and 
therefore the change in prevalence was used for statistical analysis. Because, 
at certain concentrations prevalence decreases over time, the Gamma GLM 
Figure 14: Selection for mphA by clarithromycin. A LOEC of 100,000 
µg/L of CLA was determined. Standard error is represented by the error 




was not used as this model cannot fit to negative numbers. Significant positive 
selection was observed at 100,000 µg/L of CLA only for intI1 (p = 1.46e-05, 















For ERY, the gene that illustrated significant selection at the lowest antibiotic 
concentration was, again, ermF. Again, no significant selection was seen at 
100, 250 or 500 µg/L. Significant selection was seen to 90% confidence at 750 
µg/L (p = 0.0663, Dunn’s test) and to 95% confidence at 1000 (p = 0.0164, 
Figure 15: Selection for intI1 by clarithromycin. A LOEC of 100,000 
µg/L of CLA was determined. Standard error is represented by the error 
bars. ** = significant positive selection to 95% confidence. 
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Dunn’s test) and 10,000 µg/L (p =0.0049, Dunn’s test). As with AZ and CLA, no 
significant selection was seen at 100,000 µg/L. A LOEC was, therefore, 






Similarly to CLA, significant positive selection for mphA by ERY was not 
observed until 100,000 µg/L (p = 0.0361, Dunn’s test). A biological effect can be 
seen at 10,000 µg/L, although this was not statistically significant (Figure 17). 
Figure 16: Selection for ermF by erythromycin. A LOEC of 1,000 µg/L was 
determined. Standard error is represented by the error bars. * = significant 





The effect ERY has on mphA was at a higher concentration, than what was 
observed with ermF, but the response of mphA was significantly stronger in 




Here, statistical analysis was undertaken on the difference between day 0 and 
day 7 as there was a significant difference in prevalence between each of the 
day 0 samples (p = 0.0002008, Kruskal Wallis). Only 100,000 µg/L was 
Figure 17: Selection for mphA by erythromycin. A LOEC of 100,000 
µg/L of ERY was determined. Standard error is represented by the error 




statistically significant, to 95% confidence, compared to the no antibiotic control 
(p = 0.0142, Dunn’s test (difference)). A biological effect can be seen at 10,000 
µg/L, but, as a result of variability between the biological replicates, this was not 
statistically significant (Figure 18). Although the response of intI1 occurs at a 
higher concentration of ERY than ermF, the response shown by intI1 was 







Figure 18: Selection for intI1 by erythromycin. A LOEC of 100,000 µg/L 
was determined. Standard error is represented by the error bars. ** = 




3.4.4.2 Selection coefficients 
Using selection coefficient graphs can be a useful tool to evaluate the selective 
potential of antibiotics and other antimicrobial compounds. It may also offer a 
lower and, therefore, more protective value than the LOECs determined by 
statistical analysis. As significant selection was observed at the lowest 
concentration of AZ, CLA and ERY for the ermF gene, selection coefficients are 
only determined for this gene. Selection coefficients have their limitations, 
however. For example, it was only possible to determine a MSC (where the 
trendline crosses the x-axis) for ermF for ERY. For AZ and CLA, determining a 
MSC in this way was impossible as positive selection was observed in the no 
antibiotic control. This meant that the trendline for the selection coefficient graph 
for ermF by AZ was above the x axis at all concentrations. Not crossing the x 
axis at any point meant that no MSC value could be determined. Determining a 
selection coefficient for ermF by CLA had a similar problem. Again, the line of 
best fit was always above x axis although in some samples individual replicates 
were seen to be decreasing. The graphs for AZ and CLA can be seen in Figure 
81 and 82 (Page 310 - Appendix), respectively. The LOECs were, therefore, 
used as the selective endpoint. 
For ERY, however, a selection coefficient, and therefore MSC, was calculated 
(Figure 19). A polynomial order 4 curve was determined to be the line of best fit 
(R2 = 0.1709, standard error = 0.3612). The equation of the line (y = -2.544e-
12x4 + 1.564e-09x3 + 2.59e-06x2 - 0.001432x + 0.01684) was used to determine a 
MSC of approximately 514 µg/L for ERY (x intercept = 514.1). The natural 
variation between biological replicates meant that the MSC value could only be 
















3.4.4.3 Culture dependent analysis 
A plating experiment was undertaken using the day 7 samples in the presence 
of AZ. This was to determine whether significant selection occurred below the 
LOEC determined by qPCR either by spontaneous mutations or by genes not 
targeted by qPCR analysis. Three types of agar were tested: Chromocult agar; 
Mannitol-salt agar and Muller-Hinton (Figure 20). No significant selection was 
seen at the concentration of 100 µg/L of AZ on any agar. For Mannitol-salt and 
Muller-Hinton agar, no significant selection was observed at any concentration 
of AZ. Bacteria plated on Chromocult agar saw a significant increase in 
Figure 19: Selection coefficient of ermF in the presence of 
erythromycin. A MSC was determined to be approximately 514 µg/L. The 
blue line is the polynomial line of best fit (order 4), the grey shading 
represents the confidence intervals and the purple points represent the 
selection coefficients for each replicate. 
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phenotypic resistance at 10,000 (p = 0.0493, Dunn’s test) and 100,000 µg/L (p 












3.4.4.4 Metagenome analysis  
Metagenome analysis was undertaken for a selection for samples taken from 
day 7 of the final selection experiment for AZ, CLA and ERY. As mentioned in 
Chapter 2, Aimee Murray undertook the raw sequence data analysis and 
produced spreadsheets that contained raw gene prevalence data per sample 
library (normalised to 16S rRNA copy number). All subsequent data analysis 
was undertaken by the author. By looking at the macrolide class as a whole, 
and by looking at individual macrolide resistance genes, the aim was to 
determine whether selection was occurring at a concentration lower than 
Figure 20: Selection for phenotypic resistance on three 
agars by azithromycin. Standard error is represented by the 
error bars. ** = significance to 95% confidence. 
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determined by qPCR (LOECs of 1,000, 750 and 1,000 µg/L for AZ, CLA and 
ERY, respectively, and a MSC of approximately 514 µg/L for ERY). 
Metagenome analysis produced a large amount of data on relative abundance 
of all ARGs and, therefore, it was possible to examine the co-selective nature of 
AZ, CLA and ERY by investigating the change in other antibiotic class 
resistance genes and determine how increasing concentration of AZ, CLA and 
ERY affected bacterial community structure. 
Investigating the change in prevalence of MLS genes using metagenomics 
First, the effect of macrolide selection on MLS gene prevalence was 
investigated. The group MLS genes encode resistance to macrolide, 
lincosamide and streptogramin antibiotics. These antibiotics are often grouped 
together in the literature as, although they are chemically different compounds, 
they all have a similar mode of action inhibiting protein synthesis within the 
bacterial cell (Leclercq & Courvalin 1991). Here, the ARGs-OAP v2 pipeline 
groups them as one class.  
Azithromycin 
For AZ (Figure 21), a significant increase in prevalence, compared to the no 
antibiotic control, was seen to 95% confidence at 10,000 (p = 0.0280, Dunn’s 
test) and 100,000 µg/L (p = 0.0047, Dunn’s test) but at no AZ concentration 
lower than this.  A biological effect was seen at 1,000 µg/L but, as a result of 

























Figure 21: MLS gene prevalence as a function of 
azithromycin concentration. A LOEC of 10,000 µg/L of AZ 
was determined. Standard error is represented by the error 




MLS genes only demonstrated a significant increase in prevalence, to 95% 


















Figure 22: MLS gene prevalence as a function of 
clarithromycin concentration. A LOEC of 100,000 µg/L was 
determined. Standard error is represented by the error bars. ** = 




Finally, ERY only showed a significant increase in prevalence of MLS genes, 
compared to the no antibiotic control, to 90% confidence at 10,000 (p = 0.0843, 
Dunn’s test) and, to 95% confidence, at 100,000 µg/L (p = 0.0109, Dunn’s). This 




Figure 23: MLS gene prevalence as a function of erythromycin 
concentration. A LOEC of 100,000 µg/L was determined. Standard error is 
represented by the error bars. * = significance to 90% confidence, ** = 




Investigating the change in prevalence of individual macrolide resistance 
genes 
Heatmaps showing log(prevalence) of the individual macrolide resistance genes 
at various concentrations of AZ, CLA and ERY can be seen in Figure 24, 25 
and 26, respectively. Genes that were below the detection limit or not present at 
every concentration of antibiotic were eliminated from heatmaps. The colour 
white on all three graphs represents where the genes were below the limit of 
detection in the samples taken for that concentration of macrolide. The raw 
prevalence data used to generate the heatmaps can be found in Tables 12, 13 
and 14 (Page 312 – Appendix) for AZ, CLA and ERY, respectively. 
To test whether there was any selection occurred below LOECs and MSC 
defined by qPCR data, the concentration 250 µg/L of AZ, CLA and ERY was 
investigated for all macrolide resistance genes. A secondary aim was to 
compare qPCR and the metagenome data as it has been stated that qPCR 
analysis is a more sensitive method to determine MSCs than metagenomics 
(Lundström et al. 2016). Investigation was, therefore, also undertaken into the 
response of ermF and mphA when analysed by metagenomics and how this 
compared to the qPCR data in Section 3.4.4.1. 
Azithromycin 
The metagenome analysis of individual macrolide resistance genes in the 
presence of AZ showed no significant increase in prevalence, to 95% 
confidence, of any of the genes in the ARG-OAP v2 database at 250 µg/L. A 
significant increase in prevalence was observed, to 90% confidence, at 250 
µg/L for ermX (encoding a rRNA methylase enzyme) and macA (encoding a 
subunit of an efflux pump). There were no detectable ermX genes in the no 
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antibiotic control samples. The abundance of ermX in two of the three samples 
at 250 µg/L was extremely low. There was a correlation between the response 
of ermF and mphA in metagenome analysis and in the qPCR data presented in 
Section 3.4.4.1. From the metagenome data, a significant increase in 
prevalence of ermF was seen at 750 (p = 0.0131, Dunn’s test), 1,000 (p = 
0.0193, Dunn’s test) and 10,000 µg/L (p = 0.0459, Dunn’s test) and no 
detectable genes at 100,000 µg/L of AZ. From the qPCR results, a significant 
increase to 90% confidence was observed at 750 µg/L, the LOEC (significance 
to 95% confidence) was 1,000 µg/L for ermF, a significant increase to 95% 
confidence was observed at 10,000 µg/L and a complete reduction at 100,000 
µg/L. The metagenome data was, therefore, relatively consistent with the qPCR 
results. In the metagenome data, a significant increase in mphA prevalence was 
first observed, to 95% confidence, at 10,000 µg/L (p = 0.0393, Dunn’s test) and 
to 90% confidence at 100,000 µg/L (p = 0.0968, Dunn’s test) in comparison to 
the no antibiotic control. QPCR determined a LOEC of 1,000 µg/L and 
significant positive selection at all subsequent concentrations, 10,000 and 
100,000 µg/L. 
Only a significant increase (** = to 95% confidence and * = to 90% confidence) 
is represented on the heatmap. Significant decreases, compared to the no 
antibiotic control, have not been represented. For example, the prevalence of 
ereA drops to undetectable in every sample with AZ present and significant 

























Figure 24: Heatmap showing the change in prevalence of macrolide 
resistance genes at various concentrations of azithromycin. The 
heatmap does not show the macrolide resistance genes that were below 
detection limit at every concentration of AZ. White represents where genes 
were below detection limit. The log(prevalence) is displayed here. Only a 
significant increase in prevalence is represented here (* = significance to 




For CLA, significant selection, to 95% confidence, was seen at 250 µg/L for the 
genes ermB (p = 0.0037, Dunn’s test), ermC (p = 0.0462, Dunn’s test) and 
mefA (p = 0.0446, Dunn’s test).  
For ermF a significant increase in prevalence was seen, to 95% confidence, at 
1,000 µg/L (p = 0.0273, Dunn’s test) and to 90% confidence at 10,000 µg/L (p = 
0.0669, Dunn’s test). No significant increase in prevalence was observed at 750 
µg/L, the LOEC determined by qPCR. The qPCR data gives, therefore, a lower 
estimation than the metagenome data. For mphA, no significant increase in 
prevalence compared to the no antibiotic control was observed until 100,000 

































Figure 25: Heatmap showing the change in prevalence of macrolide 
resistance genes at various concentrations of clarithromycin. The 
heatmap does not show the macrolide resistance genes that were below 
detection limit at every concentration of CLA. White represents where genes 
were below detection limit. The log(prevalence) is displayed here . Only a 
significant increase in prevalence is represented here (* = significance to 




The metagenome results for ERY showed significant increase in prevalence 
compared to the no antibiotic control to 95% confidence at 250 µg/L for ermC (p 
= 0.0037, Dunn’s test) and macB (p = 0.0109, Dunn’s test). For ermF, no 
significant increase in prevalence was seen at 250 and 750 µg/L. A significant 
increase compared to the no antibiotic control was, however, seen to 95% 
confidence at 1,000 (p = 0.0233, Dunn’s test) and 10,000 µg/L (p = 0.0462, 
Dunn’s test). This was consistent with the qPCR data which showed a LOEC of 
1,000 µg/L and a significant increase to 95% confidence at 10,000 µg/L. With 
the qPCR data significant selection was seen at 750 µg/L to 90% confidence 
but this was not replicated in the metagenome data. For mphA, no significant 
selection was seen at any concentration of ERY until 100,000 µg/L, where 
significant selection was seen to 90% confidence (p = 0.0541, Dunn’s test), 
similarly to the qPCR results.  
The statistical analysis for ermB did not match the biological effect seen. As can 
be observed in both the heatmap (Figure 26) and in the bar graph (Figure 83, 
Page 311 - Appendix) there was an increase in prevalence of ermB at all 
concentrations of 250 µg/L in comparison to the no antibiotic control. This was 
similar to the response seen when ermB was in the presence of CLA, although 


























Figure 26: Heatmap showing the change in prevalence of macrolide 
resistance genes at various concentrations of erythromycin. The 
heatmap does not show the macrolide resistance genes that were below 
detection limit at every concentration of ERY. White represents where genes 
were below detection limit. The log(prevalence) is displayed here. Only a 
significant increase in prevalence is represented here (* = significance to 




As sequencing was not undertaken on the day 0 samples and because qPCR 
has been suggested to be more sensitive than metagenome analysis 
(Lundström et al. 2016), it was decided to use qPCR to target macB and ermB. 
The purpose was to investigate whether there was a positive selective effect on 
these genes or if these significant differences may be due to differential rates of 
negative selection. Also, as has been seen from some of the metagenome data, 
such as ermF in the presence of CLA, qPCR is a more sensitive method than 
metagenome analysis.  
The macA gene was not targeted as macA and macB encode 2 subunits (MacA 
and MacB, respectively) of the ABC-type efflux pump, MacAB (Rouquette-
Loughlin et al. 2005; Bogomolnaya et al. 2013) and are, therefore, always found 
in combination. The macB primers can be found in Table 2 in Section 2.3.4.1. 
The gene is not well conserved and four subtypes of the gene were identified 
from sequences obtained on GenBank and aligned in MUSCLE 
(https://www.ebi.ac.uk/Tools/msa/muscle/). Four sets of primers were, 
therefore, designed. Rather than testing the whole range of antibiotic 
concentrations for all 3 macrolides, ERY was tested as an example, as the 
macrolides have behaved in a similar way for ermF which has been used to 
define the LOEC. It was also decided to only test the ERY concentration at 
1,000 µg/L as if no significant positive selection was seen at this concentration, 
then there was no need to test lower concentrations.  
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For two of the macB subtypes (subtypes 3 and 4) no genes were detected in 
these samples. For subtype 1 and 2, however, the results can be seen in Figure 
27A and B, respectively. For macB subtype 1, positive selection was observed 
in both the no antibiotic control and at 1,000 µg/L but no significant difference 







The ermB gene was targeted as it showed a similar response to ermC. It is also 
one of the genes targeted in the preliminary experiments undertaken in Section 
3.4.2 and 3.4.3. The qPCR, as with macB, was run on samples selected for by 
1000 µg/L of ERY and the no antibiotic control. The results of the qPCR can be 
seen in Figure 28. Similarly to macB, and the response to ermB seen in the 
preliminary range finding experiments in Section 3.4.2 and 3.4.3, no positive 
Figure 27A: macB subtype 1 as a function of erythromycin 
concentration. No significant positive selection was observed in 
comparison to the no antibiotic control. Figure 27B: macB subtype 2 as a 
function of erythromycin concentration. No significant positive selection 
was observed in comparison to the no antibiotic control Standard error is 




selection was observed for ermB at 1000 µg/L. Therefore, none of the genes 
tested using qPCR, that showed an increase in relative abundance in the 













Investigating the co-selective potential of macrolides 
Heatmaps showing the change in prevalence of resistance genes belonging to 
different classes of antibiotic can be seen in Figures 29, 30 and 31 in the 
presence of increasing concentrations of AZ, CLA and ERY, respectively. 
Significant increase in prevalence compared to the no antibiotic control has 
been displayed on the graphs to 95% confidence = ** and to 90% confidence = 
Figure 28: ErmB as a function of erythromycin concentration. 
No significant positive selection was observed in comparison to 




*. Significant decreases have not been represented. The raw prevalence data 
used to make the heatmaps can be found in Tables 15, 16 and 17 (Page 313 – 
Appendix) for AZ, CLA and ERY, respectively. 
Certain gene classes have been removed from these heatmaps, specifically the 
MLS gene class (as this was previously described in depth earlier in this 
section) and gene classes where prevalence was either below the limit of 
detection or not present at all concentrations. The white areas on all three 
graphs represent a lack of detectable genes. 
Azithromycin 
No genes were detected at any concentration of AZ for carbomycin, fusidic-
acid, puromycin, rifamycin, spectinomycin and tetracenomycin C resistance. No 
significant co-selective effect was seen at any concentration of AZ for the 
resistance gene classes of bleomycin or fosfomycin compared to the no 
antibiotic control.  
No significant increase in prevalence, compared to the no antibiotic control, was 
seen until 1,000 µg/L for any antibiotic resistance gene class. The class 
kasugamycin saw a significant increase in prevalence to 95% confidence at 
1,000 (p = 0.0462, Dunn’s test) and 10,000 µg/L (p = 0.0280, Dunn’s test). 
Polymyxin (p = 0.0631, Dunn’s test), sulfonamide (p = 0.0631, Dunn’s test) and 
unclassified (p = 0.0938, Dunnett’s test) resistance genes demonstrated a 
significant increase to 90% confidence at 1,000 µg/L. Polymyxin (p = 0.0393, 
Dunn’s test) and unclassified (p = 0.0309, Dunnett’s test) classes both 
increased significantly, to 95% confidence, at 10,000 µg/L but no significant 
increase in the presence of 100,000 µg/L of AZ was observed. Sulfonamide 
resistance genes saw a significant increase, compared to the no antibiotic 
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control, to 10,000 (p = 0.0058, Dunn’s test) and 100,000 µg/L (p = 0.0234, 
Dunn’s test).  
Seven gene classes saw an initial increase in the prevalence of resistance 
genes at 10,000 µg/L. These classes consisted of aminoglycosides (p = 0.0133, 
Dunn’s test), beta-lactams (p = 0.0332, Dunn’s test), chloramphenicol (p = 
0.012, Dunnett’s test), quinolones (p = 0.0385, Dunn’s test), tetracycline (p = 
0.0195, Dunn’s test), trimethoprim (p = 0.0133, Dunn’s test) and vancomycin (p 
= 0.0233, Dunn’s test). Only the classes bacitracin and fusaric-acid saw no 
significant increase until 100,000 µg/L. This data can be seen in the heatmap - 































As with the metagenome results from the selection experiment with AZ, no 
resistance genes were detected at any concentration of CLA for the antibiotic 
classes carbomycin, fusidic-acid, puromycin, rifamycin, spectinomycin and 
tetracenomycin C. No significant increase in prevalence of resistance genes 
Figure 29: Heatmap showing the co-selection for antibiotic resistance 
gene classes at various concentrations of azithromycin. The heatmap 
does not show the classes that were below detection limit at every 
concentration of AZ. White represents where genes were below detection 
limit. The log(prevalence) is displayed here. Only a significant increase in 
prevalence is represented here (* = significance to 90% confidence, ** = 
significance to 95% confidence). 
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was determined at any of the CLA concentrations tested for the antibiotic 
classes bleomycin, fosfomycin, quinolone or vancomycin. Significance was 
seen at 10,000 and 100,000 µg/L for fosmidomycin (p = 0.0388 and 0.0436, 
respectively, Dunnett’s test), kasugamycin (p = 0.0192 and 0.0304, respectively, 
Dunnett’s test), polymyxin (p = 0.0427 and 0.0390, respectively, Dunnett’s test) 
and unclassified genes (p = 0.0418 and 0.0208, respectively, Dunnett’s test).  
Bacitracin saw a significant increase, to 90% confidence, at 10,000 µg/L (p = 
0.06320, Dunnett’s test) and to 95% confidence at 100,000 µg/L (p = 0.00302, 
Dunn’s test) compared to the no antibiotic control. 
Each of the seven other gene classes first saw a significant increase at 100,000 
µg/L. These included aminoglycoside (p = 0.0161, Dunn’s test), fusaric-acid (p = 
0.0416, Dunn’s test), sulfonamide (p = 0.0332, Dunn’s test), tetracycline (p = 
0.0393, Dunn’s test) and trimethoprim (p = 0.0393, Dunn’s test) to 95% 
confidence. Resistance to beta-lactams (p = 0.0541, Dunn’s test) and 



























For all concentrations of ERY, and similar to the results seen for AZ and CLA, 
there were no detectable resistance genes for the classes of carbomycin, 
fusaric-acid, fusidic-acid, puromycin, rifamycin, spectinomycin and 
tetracenomycin C. These classes were, therefore, eliminated from the heatmap 
Figure 30: Heatmap showing the co-selection for antibiotic resistance 
gene classes at various concentrations of clarithromycin. The 
heatmap does not represent the classes that were below detection limit at 
every concentration of CLA. White represents where genes were below 
detection limit. The log(prevalence) is displayed here. Only a significant 
increase in prevalence is represented here (* = significance to 90% 
confidence, ** = significance to 95% confidence). 
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(Figure 31). No significant selection was seen at any concentration of ERY for 
resistance genes from the classes’ fosfomycin, quinolone and vancomycin. 
Neither was any significant selection seen for multidrug resistance.  
Significant selection to 95% confidence was seen at 250 µg/L for bacitracin and 
fosmidomycin, although if the individual bar graphs are considered (Figure 32 
and Figure 33), this does not appear to be correct, particularly as no significant 
selection was observed in some higher concentrations of ERY. This looks, 
therefore, to be more like natural variation in the biological samples and also 
appears to be true for the significance seen at 750 µg/L for the classes 
kasugamycin, polymyxin and unclassified. An example (bacitracin) of an 
individual bar graph for these can be seen in the (Figures 32). It is possible that 
there is a difference in the prevalence of these class specific resistance genes 
in the starting inoculum that accounts for the variation observed at day 7. As 
day 0 samples were not sequenced, however, it cannot be established for 
certain. If other classes, such as aminoglycoside, sulfonamide, tetracycline and 
trimethoprim, are viewed as bar graphs a true dose response is evident. An 
example of one of these graphs (aminoglycosides) can be seen in Figure 33. 
This is in contrast to the data presented in Figure 32.  
The beta-lactam class of antibiotics saw a significant increase in gene 
prevalence to 90% confidence at 100,000 µg/L (p = 0.0843, Dunn’s test). The 
remaining classes saw a significant increase in prevalence, to 95% confidence, 
in the presence of 100,000 µg/L of ERY. These classes were aminoglycoside (p 
= 0.0089, Dunn’s test), sulfonamide (p = 0.0109, Dunn’s test), tetracycline (p = 













Figure 31: Heatmap showing the co-selection for antibiotic resistance 
gene classes at various concentrations of erythromycin. The heatmap 
does not represent the classes that were below detection limit at every 
concentration of ERY. White represents where genes were below detection 
limit. The log(prevalence) is displayed here. Only a significant increase in 
prevalence is represented here (* = significance to 90% confidence, ** = 























Figure 32: Bacitracin resistance gene prevalence as a 
function of ERY concentration. * = significance to 90% 
confidence, ** = significance to 95% confidence. Standard error 
is represented by the error bars. 
Figure 33: Aminoglycoside resistance gene prevalence as a 
function of ERY concentration. ** = significance to 95% 
confidence. Standard error is represented by the error bars. 
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Investigating the effect of concentration of AZ, CLA and ERY on 16S 
community structure 
The analysis of community structure was run by Aimee Murray as part of the 
metagenome analysis pipeline. Heatmaps showing the abundance (colour 
scale) of the top 25 most abundant species grouped by relatedness (y axis) 
found in each experiment can be seen in Figures 34, 35 and 36 for AZ, CLA 
and ERY (x axis), respectively. Heatmaps showing all species detected in these 
samples can be seen in Figures 84, 85 and 86 (Page 316, 319 and 322, 
respectively - Appendix), for AZ, CLA and ERY, respectively, and tables 
showing the raw data that corresponds for the top 25 most abundant species 
heat maps can be found in Table 18, 19 and 20 (Page 317, 320 and 323, 
respectively - Appendix) for AZ, CLA and ERY, respectively.  
Azithromycin 
By far the most abundant species in these libraries were Escherichia 
(unclassified species), Escherichia coli and Proteus mirabilis. For both of the 
Escherichia groups, abundance was high in all of the libraries produced, from 
no antibiotic control samples to all samples treated with all concentrations of AZ 
tested. For Proteus mirabilis, abundance of species was high in the no antibiotic 
control samples and all AZ treated samples except 100,000 µg/L where AZ 
becomes toxic and no P. mirabilis is detected. 
Similarly to Proteus mirabilis, other species have similar abundances in the AZ 
treated samples to the no antibiotic treated control except at 100,000 µg/L, 
where AZ becomes toxic. These species were Morganella morganii and 
Bacteroides uniformis, neither of which were detected at 100,000 µg/L of AZ. 
Klebsiella pneumoniae saw an increase in abundance when in the presence of 
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AZ compared to the no antibiotic control at all antibiotic concentrations except 
10,000 and 100,000 µg/L where this species was detected infrequently.  
Other species proved to be more sensitive to AZ, being present in libraries from 
samples not treated with AZ and becoming less abundant as the concentration 
of AZ increased. These species included Bacteroides taiotaomicron, 
Bacteroides fragilis, Eubacterium limosum, Bacteroides dorei and 
Fusobacterium ulcerans. The species Streptococcus infantarius, Peptoniphilus 
harei, Staphylococcus aureus, Veillonella ratti and Acinetobacter baumannii 
were even more sensitive and were all present in the no antibiotic control 
samples. Except for the occasional sample, these species were completely lost 
when samples were treated with AZ. 
The species Enterobacter cloacae, Enterococcus faecium and Enterococcus 
avium were seen in low abundance in the no antibiotic control samples but 
increased slightly in abundance in certain samples that had been treated with 
AZ. 
The remaining species Enterococcus faecalis, Providencia alcalifaciens, 
Cronobacter phage CR5 and Staphylococcus haemolyticus saw no real pattern 
with the application of AZ. Certain samples showed the presence of the 
species, and in the case of Cronobacter phage CR5 and S. haemolyticus at 
very high abundance, but in the vast majority of samples these species were 
below the limit of detection. 
Overall, with the application of AZ the samples get less diverse compared to the 
samples that have not been treated with AZ. A correlation can also be seen 

















Similarly to AZ, the most abundant species found in this set of libraries was 
Escherichia unclassified and Escherichia coli. Not only were these the most 
abundant species, but they were found in high numbers throughout, at every 
concentration of CLA. No dose dependent response to CLA was observed here 
for these two species.  
Proteus mirabilis is also seen with similarly high abundance to Escherichia coli 
and Escherichia unclassified. The abundance of this species started to 
Figure 34: Heatmap showing the change in community structure at 
increasing concentrations of azithromycin. Heatmap shows the top 25 
most abundant species (y axis) in the samples. Scale represents relative 
abundance in the community. Community structure is shown for individual 
replicates. Individual replicates are represented by 1, 2 or 3. For example, 0 – 
1 is the first replicate of the not antibiotic control. 
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decrease, however, at 1,000 µg/L and higher. By 100,000 µg/L, none of this 
species was detected in any of the samples. 
Other species also saw a dose dependent response to CLA. These included 
Morganella morganii, Bacteriodes uniformis and Klebsiella pneumoniae. Both B. 
uniformis and K. pneumoniae saw a small increase in abundance at 250, 750 
and 1,000 µg/L compared to the abundance seen in the no antibiotic control. A 
decrease in abundance was then seen at 10,000 µg/L compared to the no 
antibiotic control and both species were completely absent from 100,000 µg/L of 
CLA. M. morganii was seen at similar levels of abundance to the no antibiotic 
control at concentrations up to 1,000 µg/L of CLA. At 10,000 and 100,000 µg/L, 
this species was not detected.  
Other bacterial species were more sensitive to the presence of CLA. Species 
such as Staphylococcus aureus and Streptococcus infantarius were detected in 
most of the no antibiotic control samples but were rarely detected in any sample 
where CLA had been used.  
One species, Bifidobacterium pseudolongum, was below detection limit in any 
of the no antibiotic control samples but low abundance of this species was 
detected at low concentrations of CLA. This bacterial species then disappears 
in samples at higher CLA concentrations. 
The remaining species shown in Figure 35 showed no pattern. These were 
grouped into three categories. The first group of bacterial species were detected 
in every no antibiotic control sample but were detected sporadically throughout 
the rest of the samples when CLA was present. These species included 
Bacteroides fragilis and Bacteroides dorei. The second group consisted of 
bacterial species that were found sporadically throughout the libraries no matter 
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the treatment. These species were Peptoniphilus harei, Bacteroides ovatus, 
Enterococcus raffinosus, Enterococcus asini, Enterococcus faecium, Klebsiella 
unclassified, Enterobacter cloacae, Citrobacter freundii, Bacteroides 
thetaiotaomicron, Staphylococcus simulans, Staphylococcus haemolyticus and 
Enterococcus faecalis. The final category consisted of just Enterococcus avium 
and had low abundance throughout treatments but with no pattern able to be 
determined. 
Overall, a dose response relationship between CLA and diversity of species can 
be seen. There is a substantial reduction (and often complete loss) in 
abundance in a number of species at 100,000 µg/L. In addition, a reduction in 












Figure 35: Heatmap showing the change in community structure at 
increasing concentrations of clarithromycin. Heatmap shows the top 25 
most abundant species (y axis) in the samples. Scale represents relative 
abundance in the community. Community structure is shown for individual 
replicates. Individual replicates are represented by 1, 2 or 3. For example, 0 




Similarly to AZ and CLA, Escherichia unclassified and Escherichia coli were 
found at high abundances throughout all libraries independent of treatment with 
ERY. As with AZ and CLA, Proteus mirabilis was also found at high abundance 
in the no antibiotic control samples. However, unlike the community structure 
with AZ and CLA treatment, when P. mirabilis was in the presence of ERY a 
decrease in abundance was seen at 250 µg/L and subsequent higher 
concentrations and was below the detection limit at 100,000 µg/L. 
Other species that saw a dose dependent reaction to ERY were Bacteroides 
uniformis and Klebsiella pneumoniae. B. uniformis had similar abundance in the 
samples treated with ERY and without, except at the higher concentrations of 
10,000 and 100,000 µg/L where one and two samples, respectively, had 
undetectable levels of this species. K. pneumoniae had similar abundance in all 
treatments and the no antibiotic control except at 100,000 µg/L where no 
bacteria were detected.  
Species that were more sensitive to ERY include Staphylococcus simulans and 
Streptococcus infantarius. These species were seen in the no antibiotic control 
treatment but were seen only sporadically or not at all in any of the samples 
treated with ERY. 
The vast majority of species detected displayed no association between 
concentration of ERY and abundance. The species that were found sporadically 
throughout samples with no pattern included Veillonella ratti, Enterobacter 
clocae, Bifidobacterium longum, Bifidobacterium pseudolongum, Enterococcus 
faecium, Enterococcus faecalis, Klebsiella unclassified, Enterococcus 
gallinarum, Bifidobacterium pseudolongum, Streptococcus gallolyticus, 
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Streptococcus pastuerianus. Other species, including Bacteroides 
thetaoitaomicron, Bacteroides ovatus and Morganella morganii were found to 
be present in the no antibiotic control samples but only sporadically in the 
presence of ERY. Finally, Enterococcus avium was found in most of the 
samples with no distinct pattern. 
Overall, unlike with AZ and CLA, there was no clear pattern in terms of 
reduction in diversity with increasing concentrations of ERY. More species were 
seen at higher abundance at the highest concentration of ERY and there was a 
mixed effect at lower concentrations. In other words, there was no obvious dose 
response with increasing application of ERY although samples in the presence 












Figure 36: Heatmap showing the change in community structure at 
increasing concentrations of erythromycin. Heatmap shows the top 25 
most abundant species (y axis) in the samples. Scale represents relative 
abundance in the community. Community structure is shown for individual 
replicates. Individual replicates are represented by 1, 2 or 3. For example, 0 – 




3.5.1 Comparison to current measured environmental concentrations 
The data presented in this chapter suggests that, using this experimental 
system, no selection for macrolide resistance is likely to occur at the measured 
environmental concentrations (MEC) gleaned from the results of the literature 
search reported in Section 3.4.1.  
A LOEC was determined, by investigating selection for ermF, as 750 µg/L for 
CLA (with a NOEC of 500 µg/L) and a LOEC of 1,000 µg/L for both AZ and ERY 
(with a NOEC of 750 µg/L for both). The LOEC of AZ was 666.6 times and the 
NOEC 500 times higher the maximum MECs (MECmax) of AZ (1.5µg/L (Bartelt-
Hunt et al. 2009)) calculated through the analysis of the literature review of 
MECs (Section 3.4.1). According to that analysis, the MECmax of CLA was 1 
µg/L (Morasch et al. 2010). The LOEC was, therefore, 750 times higher than the 
MECmax and the NOEC was 500 times higher. Finally, the MECmax for ERY, 
according to the literature review analysis, was 2.42 µg/L (Yao et al. 2015) and 
4 µg/L for ERY-H2O (Tong et al. 2014). The LOEC for ERY was, therefore, 
approximately 446.4 times higher and the NOEC was 334.8 times higher than 
the MECmax ERY and was 250 times (LOEC) and 187.5 times (NOEC) higher 
the MECmax of ERY-H2O. The MSC of 514 µg/L was, therefore, 229.5 times 
higher than the MECmax of ERY and 128.5 times higher than that of ERY-H2O. 
After the literature search was conducted (2015), the Umwelt Bundesamt (UBA) 
released a database of measured environmental concentrations from around 
the world (Umweltbundesamt 2016). Maximum, mean and median values were 
determined for AZ, CLA and ERY by searching for surface waters, ground 
waters, WWTP influent and effluent and hospital, urban and industrial sewage. 
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Values that were below the detection limit were eliminated when calculating 
mean and medians although for there were many undetectable hits for all three 
compounds. A maximum value of 9.7 µg/L (WWTP influent) was observed for 
AZ. Mean and median values were determined from this table to be 0.36 and 
0.098, respectively. For CLA, the maximum concentration on this database was 
62.241 µg/L. This is an unusually high concentration found in untreated hospital 
wastewater. The mean of CLA was 1.47 µg/L and a median of 0.057 µg/L was 
determined. For ERY, a MECmax of 7.84 µg/L was determined from industrial 
sewage in China. MECmean and MECmedian were determined to be 0.3336 µg/L 
and 0.058 µg/L, respectively, for ERY. Finally, for ERY-H2O a maximum 
concentration of 10.025 µg/L was measured in untreated wastewater in Wales. 
MECmean and MECmedian values for ERY-H2O were determined to be 1.335 µg/L 
and 0.038 µg/L, respectively. Similar to the literature search undertaken in 
2015, except for the one unusually high CLA concentration from hospital 
wastewater, the concentrations determined from this database were 
significantly lower than the LOECs and MSC for the macrolide compounds 
determined. 
If a 10-fold assessment factor is applied to the NOEC for each macrolide 
antibiotic, a PNEC can be determined. This allows for a conservative safe 
release limit to be determined. The PNEC for AZ and CLA was, therefore, 75 
and 50 µg/L, respectively. To be the most protective of selection in the 
environment, the assessment factor was applied to the MSC (514 µg/L) of ERY, 
as it was lower than the NOEC. A PNEC of 51.4 µg/L of ERY was, therefore, 
determined. All of these PNECs are approximately an order of magnitude higher 
than current MECmax seen for typical environmental concentrations. 
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3.5.2 Comparison to previously published endpoints 
If the LOECs and the MSC of the individual macrolide compounds presented 
here are compared to previously published selective endpoints, similar results 
were determined to the single species assays by Gullberg et al. 2014 but were 
significantly higher than those in Bengtsson-Palme & Larsson 2016 which are 
estimated by applying a 10-fold assessment factor to MICs from the EUCAST 
database. In Gullberg et al. 2014, MSCs for both plasmid and chromosomal 
based resistance against ERY were determined. MSCs were 200 µg/L and 
3000 µg/L for a chromosomal resistance element and the same resistance 
element on a plasmid, respectively, and, therefore, span the LOECs, NOECs 
and the MSC determined here. However, the endpoints determined here were 
significantly higher than the PNECRs that were calculated by a mathematical 
approach by Bengtsson-Palme & Larsson 2016 as 0.25 µg/L (AZ), 0.25 µg/L 
(CLA) and 1 µg/L (ERY).  
The method used to produce the LOECs and MSC presented in this chapter 
uses a complex, environmental microbial community. For this reason, this 
methodology is the most representative of what may be occurring in the 
environment in comparison to the endpoints presented in Gullberg et al. 2014 
and Bengtsson-Palme & Larsson 2016. The method used in Gullberg et al. 
2014 used single species competition experiments and the method used in 
Bengtsson-Palme & Larsson 2016 applied a mathematical model to clinical MIC 
values and these, therefore, may not produce representative results that are 




3.5.3 intI1 and mphA 
The LOECs determined by intI1 and mphA were significantly higher than those 
determined by ermF for AZ, CLA and ERY. The total prevalence observed at 
day 7 for these two genes was, however, significantly higher than the 
prevalence of ermF determined. In addition, a stronger response in regards to 
the increase in prevalence over the 7 day period, at concentrations where 
positive selection was observed, was seen in both of these genes compared to 
ermF. This was the case for AZ, CLA and ERY for both intI1 and mphA. It was 
concluded, therefore, that these antibiotics, whilst having a selective effect on 
ermF at lower concentrations, have a significantly increased selective effect on 
intI1 and mphA at higher concentrations. The reason this was seen for intI1 is 
presumably because it is often associated with many different ARGs and 
MGEs. The class specific macrolide resistance gene, ereA, for example, is often 
found linked to class 1 integrons (Roberts 2008). Selection for many genes that 
have not been targeted by qPCR may be represented by selection for intI1. The 
number of resistance genes that are associated with intI1 may, therefore, 
explain the much greater prevalence of intI1 compared to ermF. The mphA 
gene has been found linked to class 1 integrons (Roberts 2008) and this could 
explain the similar pattern to where selection was first seen and the high 
prevalence of both genes. 
3.5.4 ermB, msrD and mef family 
Of the 5 macrolide class specific genes tested by qPCR, three did not undergo 
any positive selection at any concentration tested of any of the three macrolides 
tested, including higher, clinically relevant, concentrations. These genes were 
ermB, msrD and mef family. In a majority of the experiments for ermB and for 
one of experiments for the mef family, a significant increase in comparison to 
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the no antibiotic control was observed of concentrations typical of the 
environment but this increase was never higher than the starting prevalence of 
the gene. There are a variety of reasons why positive selection may not occur. 
One explanation, for example, could be there was low prevalence of these 
genes in the original inoculum used for this experiment. This was not the case, 
however, as the average prevalence at day 0 for ermF was lower than all of the 
macrolide resistance genes tested (except for msrD, which was only 0.002 
lower).  
Another explanation might be that the genes that did not undergo selection 
were more clinically relevant and exert a high fitness cost so are not maintained 
in complex microbial populations as opposed to single species infections. MsrD 
has, for example, been detected in the clinical strain Ureaplasma urealyticum 
isolates in Guanzhou, China (Lu et al. 2010). In Japan, ermB, mefA and mefE 
have all been found in clinical isolates of macrolide resistant Streptococcus 
pneumoniae (Isozumi et al. 2007; Hotomi et al. 2005). However, as previously 
mentioned, ermB (along with ermF) was suggested to be a genetic indicator for 
macrolide resistance in the environment (Berendonk et al. 2015). This was one 
of the reasons it was chosen to study as it was expected to be maintained in 
environmental bacterial populations. Alternatively, the genes that are not 
positively selected for might be harboured in bacterial species that do not 
survive well in the experimental conditions used: they may be outcompeted by 
bacterial species that thrive in those conditions and reduced, therefore, over the 
experimental period.  
A final plausible explanation may be that these genes are maintained in 
bacterial populations by other antibiotics or co-selective compounds. MsrD, for 
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example, provides resistance to both macrolide and streptogramin antibiotics 
(Lu et al. 2010). A streptogramin antibiotic may, therefore, exert a selective 
pressure on msrD.  
MefA and msrD are often found in association with each other (Roberts 2008), 
this may, therefore, explain the similarities observed in regards to the lack of 
positive selection seen between msrD and the mef family. 
3.5.5 Culture based and metagenome analysis 
The culture based assay and metagenome data were used to verify the qPCR 
data. Although the class specific genes were chosen for the reasons outlined in 
the methods section, there are many other macrolide resistance genes and 
potential point mutations that convey phenotypic macrolide resistance that were 
not targeted by qPCR. For this reason, a culture based assay was used to 
capture any phenotypic resistance (including resistance genes and point 
mutations), and metagenome analysis was used to identify any other macrolide 
resistance genes that were being selected, occurring below the LOECs and 
MSC determined by qPCR.  
The metagenome and culture based data were able to verify the qPCR data, as 
previously found in Murray et al. 2018. Overall MLS resistance, determined by 
metagenome analysis, and the change in phenotypic resistance on Chromocult 
agar (the only agar where a significant difference in phenotypic resistance was 
observed) aligned well. Both MLS resistance and phenotypic resistance saw a 
biological increase at 1,000 µg/L, but this was not significant, and significantly 
increased at 10,000 and 100,000 µg/L. Both of these changes were observed at 
higher concentrations than that of LOECs/MSC determined by the qPCR assay 
for ermF and aligned better with the intI1 and mphA data. Significant selection 
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for ermF was seen (compared to the no antibiotic control) at a lower 
concentration of all three antibiotics than selection for intI1 and mphA. The latter 
two genes increased to a higher prevalence than ermF over the 7 day period. 
MphA and intI1 could, therefore, be having a stronger effect on the overall MLS 
resistance and phenotypic resistance, as their prevalence at the end of the 7 
day experiment is significantly higher than ermF, and this could, therefore, 
account for the results observed in the metagenome and plating analysis.  
There were a number of macrolide resistance genes found in the libraries. 
There appeared to be no trend between which type of resistance gene (for 
example, efflux pump or enzyme) was selected. Some genes were seen to be 
increasing, compared to the no antibiotic control, at concentrations below the 
LOECs defined by qPCR. However, in some instances, this was because the 
gene was undetectable in the no antibiotic control but present in one replicate 
run at 250 µg/L. The statistical analysis then deemed this to be significant 
selection, although the gene is never detected at any other concentration or any 
other replicate at that concentration. This was not, therefore, determined to be 
positive selection. 
In other cases, such as macB and ermB, genes were tested by qPCR to 
determine whether positive selection was taking place. Based on the 
preliminary range finding experiments, it was expected that the increase seen in 
ermB was would not be positive selection. Preliminary range finding 
experiments found that a significant increase was observed in comparison to 
the no antibiotic control but that ermB did not increase over the starting 
inoculum. This concept is discussed further in Chapter 6. QPCR was used to 
verify this. It was also used to verify that no positive selection for macB was 
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occurring. This shows the benefits of quantifying the prevalence of the target 
gene at the beginning of the experiment as only then can positive selection over 
time be determined (this is discussed further in Chapter 6).  
Metagenome analysis also found that macrolides have the potential to co-select 
for resistance genes of other classes of antibiotics at high concentrations. AZ 
appeared to be the most co-selective, in comparison to CLA and ERY. The 
dose response aligns well with the qPCR data investigating the selection for 
intI1 as integrons are known to harbour various resistance genes from multiple 
antibiotic resistance gene classes. Common classes that are often found in 
association with class 1 integrons are sulfonamides and trimethoprim (Moura et 
al. 2009). Genes resistant to these classes are enriched at concentrations 
similar to those where significant selection for the intI1 gene is seen. Co-
selection for other classes is observed only at high concentrations of the three 
macrolide antibiotics tested. Previous data by Murray et al. 2019 showed the 
co-selective potential of ciprofloxacin and trimethoprim at 500 and 2,000 µg/L, 
respectively, although these were the only concentrations of these antibiotics 
investigated by the authors. These concentrations are similar to where the co-
selective potential of AZ is first observed for certain classes of antibiotic 
resistance genes (1,000 µg/L) but are significantly lower than that of CLA and 
ERY (predominantly at 100,000 µg/L) (Murray et al. 2019). 
In all samples, the community was dominated by E. coli and Escherichia 
(unclassified species), irrespective of macrolide concentration. This was 
unsurprising as the bacterial sample used was raw wastewater and E. coli is a 
faecal coliform bacteria that is regularly used by environment agencies/drinking 
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water companies as an indicator for contamination by faeces (Edberg et al. 
2000). 
A decrease in species diversity was seen in the presence of all three 
macrolides, in comparison to samples grown without antibiotic, particularly for 
samples passaged at 100,000 µg/L of AZ and CLA. This could explain the 
significant decrease in the ermF gene at 100,000 µg/L. The bacterial species 
harbouring this gene were, presumably, the bacteria that are significantly 
affected at this concentration and this is why a complete loss of ermF is 
observed at this concentration. For example, ermF has been found in clinical 
isolates of a Bacteroides species (McArthur et al. 2013; Kangaba et al. 2015). A 
number of different Bacteroides species are found in the samples from the AZ, 
CLA and ERY experiments. These species, with the exception of two instances, 
are never found in the replicates passaged at 100,000 µg/L of antibiotic 
supporting the above hypothesis.  
One interesting discovery was the presence of Cronobacter phage 5 (CR5) in 
the top 25 most abundant species heatmap in the presence of AZ. CR5 is a 
phage that infects the bacterial species Cronobacter sakazakii (also known as 
Enterobacter sakazakii) (Lee et al. 2016; Healy et al. 2010). This phage is not 
found in the top 25 most abundant species of CLA or ERY and C. sakazakii, the 
species it infects, is not found in the top 25 most abundant species for any of 
the 3 macrolide compounds. If all of the species present in the day 7 samples 
are looked at, however, (Figures 84, 85 and 86, Page 316, 319 and 322 - 
Appendix) instead of only the top 25 most abundance species, CR5 is found in 
samples from both the AZ and CLA experiments and C. sakazakii is found in 
the experiments passaged in the presence of CLA and ERY. As the 
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experiments are run with pseudo replicates of the same wastewater influent 
inoculum, these results suggest that both CR5 phage and C. sakazakii were 
present in the wastewater when the inoculum sample was taken. Although C. 
sakazakii is commonly associated with food products such as formula milk 
(Zuber et al. 2008), it has been previously isolated from wastewater 
(Thulasinathan et al. 2019). 
3.5.6 Difference in response to AZ, CLA and ERY 
For some of the work presented here, it appears that CLA and ERY correlate 
well with each other, whereas AZ was often selecting for resistance at a lower 
concentration. This appears to be particularly true for the genes intI1 and mphA. 
AZ was seen to positively select at 1,000 µg/L for both genes (for mphA to 95% 
confidence and for intI1 to 90% confidence), whereas significant selection by 
CLA and ERY was not observed until 100,000 µg/L (both to 95% confidence).  
A similar correlation was seen for MLS resistance data from the metagenome 
analysis. A significant increase was seen in comparison to the no antibiotic 
control (to 95% confidence) at 10,000 µg/L of AZ. A clear biological effect was 
also seen at 1,000 µg/L, although this was not statistically significant. For CLA, 
a significant increase was seen (to 95% confidence) at 100,000 µg/L and for 
ERY, a significant increase was observed at 100,000 µg/L (95% confidence) 
although a significant increase (to 90% confidence) was also seen at 10,000 
µg/L. No biological effect was observed at 1,000 µg/L for CLA or ERY in 
contrast to what was seen for AZ. 
One possible explanation for why this could be is the different chemical makeup 
of the three antibiotics. CLA and ERY both have 14 member lactone rings, 
whereas AZ has a 15 member ring (Leclercq & Courvalin 2002). This similarity 
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in the chemistry of CLA and ERY may be the reason for similar patterns in 
selection compared to AZ. In addition, AZ has been shown to be a significantly 
more potent drug than ERY (Jelić & Antolović 2016). One study showed that 
increased potency was seen in a number of different bacterial species including 
many of the Enterobacteriacae family. Furthermore, MIC concentrations of AZ 
were also shown to be lower than those of ERY (Retsema et al. 1987). A lower 
MIC of AZ in comparison to the MIC of ERY seen in Retsema et al. 1987 
mimics the pattern observed in the selective endpoint data of mphA, intI1 and 
the MLS resistance data presented in this chapter when comparing AZ and 
ERY. 
3.5.7 Future work 
This study has not considered the effects of mixtures of antibiotics on 
LOECs/MSCs/PNECs/sub-MSC effects. The many studies investigated to 
produce typical MEC values (Table 5, Section 3.4.1) show that these antibiotics 
are never found in isolation, whether that be, for example, in WWTPs or in 
surface waters. In addition, macrolide antibiotics all target bacteria by deploying 
the same mechanism, preventing protein synthesis by binding to 23S rRNA 
region of the large ribosomal subunit (Kannan & Mankin 2011; Mazzei et al. 
1993). Furthermore, the semi-synthetic derivatives of ERY were developed for 
better tolerability and pharmacokinetics in patients, not to overcome the 
development of ERY resistance. Resistance mechanisms are, therefore, able to 
resist all three compounds (Leclercq 2002; Leclercq & Courvalin 2002). As a 
result, it can be assumed that the combination of these 3 compounds would 
produce an additive effect. It might, therefore, be more sensible to determine 
the safe release level PNEC as 51.41 µg/L as a conservative estimate of the 
total concentration of macrolide antibiotic until more information is determined to 
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ensure the most stringent protection of the development of selection in the 
environment. If the maximum environmental concentrations determined in Table 
5 are combined, a total maximum concentration of 8.92 µg/L is determined, 
which is only 5.8 times the PNEC suggested for total macrolide concentration. 
The selective potential of mixtures of macrolides was determined in Chapter 4. 
3.6 Conclusions 
The LOECs, MSCs and PNECs determined for the three macrolide antibiotics, 
AZ, CLA and ERY, in the assay using a complex microbial community, were 
similar to those previously reported in a single species assays and significantly 
higher than estimated PNECRs and MECs for these antibiotics. 
Basing a recommendation exclusively on the selective endpoint, this data would 
appear to suggest that these compounds could safely be removed from the 
watch list produced by the European Commission (European Commission 
2015b) if only selective potential was a concern. The recommendation for 
removal should, however, consider ecological endpoints, as well as the 
potential to develop resistance. PNECs for ecological endpoints were 
determined by the European Commission in 2015 when considering whether to 
include these compounds on their watch list. PNECs were derived for 
freshwater to be 0.09, 0.13 and 0.2 µg/L for AZ, CLA and ERY, respectively. 
These PNECs were derived from ecotoxicology data with an assessment factor 
of 50-fold applied. Without the assessment factor, NOECs of these compounds 
are 4.5 (AZ), 6.5 (CLA) and 10 µg/L (ERY). Both the PNECs and NOECs 
determined by the European Commission were of a similar order of magnitude 
as current environmental concentrations (European Commission 2015b) and 
were significantly lower than LOEC/NOEC/MSCs determined for selection here. 
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Similarly, a meta-analysis by Le Page et al. (2017) determined PNECs for 
surface water (PNECSW) as 0.019 µg/L (AZ), 0.084 µg/L (CLA) and 0.2 µg/L 
(ERY). Here they determined the PNECSW values by using the lowest NOEC 
found for all three by investigating data from many different studies and applied 
a 10-fold assessment factor. The NOECs determined were, therefore, 0.19 µg/L 
(AZ), 0.84 µg/L (CLA) and 2 µg/L (ERY). Again, as with data from the European 
Commission 2015, both these NOEC and PNEC values are typical of current 
environmental concentrations and significantly lower than the values that have 
been determined here for selection. Taking ecotoxicology endpoints into 
account, these compounds should remain on the watch list for better monitoring 
as the PNECs from European Commission 2015 and Le Page et al. 2017 are 
more protective than the work presented here and similar to concentrations 
found in the environment.  
It is not the case, however, that all antibiotics have LOECs, NOECs and MSCs 
higher than environmental concentrations. The study by Murray et al. 2018 
determined a MSC for cefotaxime of 0.4 µg/L. This is significantly different than 
the LOECs/MSCs determined here for the macrolides. The MSC of cefotaxime, 
unlike the selective endpoints determined for the macrolides, is similar to MECs. 
For example, according to the UBA database the MECmax of cefotaxime is 1.1 
µg/L in wastewater influent (in typical environmental concentrations and 
eliminating pharmaceutical wastewater from the search criteria) 
(Umweltbundesamt 2016). Similarly, selective endpoints for ciprofloxacin have 
been determined by Aimee Murray and will be published alongside the 
macrolide antibiotics in Stanton et al., 2019. Data from this experiment can be 
seen in Figure 87 and 88 (Page 325 - Appendix). A MSC of approximately 11 
µg/L was found. This is, again, significantly lower than the concentration of 
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macrolide needed to select for resistance and similar to the range of 
ciprofloxacin concentrations seen in the environment (Umweltbundesamt 2016). 
This demonstrates the need for compound specific testing of the selective 
potential of antimicrobial agents at a range of concentrations.  
Determining the selective concentration of new and existing antibiotics, and 
potential co-selective agents is highly important. Assessment of the risk these 
compounds pose to the environment should be used in combination with other 
ecological endpoints as one may not always be protective of the other. This 
allows for a more informed assessment of the risk that compounds, such as the 














Chapter 4: The effect of combinations of antibiotic 
compounds on selective endpoints 
Author contribution 
The selection experiment and DNA extraction for TRMP experiment 1 was 
undertaken by the author and Jessica Wright (placement student). The qPCR 
analysis on this experiment was undertaken by Aimee Murray. The author 
undertook the statistical analyses on the results from this experiment.  
All aspects of SMX experiment 1 was undertaken by placement student, Jasmin 
Rauseo, under the supervision and direction of the author.  
All other experiments (macrolide mixing, macrolide verification, TRMP-SMX 
mixing, TRMP experiment 2 and SMX experiment 2) were undertaken by the 
author under the supervision of names supervisors. 
4.1 Abstract 
Antibiotics are rarely found in isolation in the environment. They are often 
observed in complex mixtures with their degradation products, other antibiotics, 
pharmaceutical compounds and co-selecting agents such as heavy metals or 
biocides. Antibiotics are reported as acting synergistically when found in 
combination. This assertion is based on their clinical bacteriostatic or 
bactericidal effects and not on their ability to select for resistance. However, 
mixtures could have additive or potentially antagonistic effects. The aim of the 
work presented in this chapter was, therefore, to investigate simple 
combinations of antibiotics to determine if selective endpoints are affected when 
mixtures are used in comparison to endpoints of individual compounds.  
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Selection experiments were used to investigate two combinations. These were 
azithromycin, clarithromycin and erythromycin used in a 1:1:1 ratio and 
trimethoprim and sulfamethoxazole used in a 1:4 ratio. QPCR was used to 
quantify macrolide specific resistance genes and intI1 in the macrolide 
experiment. Additionally, intI1 was targeted by qPCR for the trimethoprim and 
sulfamethoxazole experiment. Change in prevalence over a 7 day period was 
observed to determine the difference in selective endpoints when compounds 
were used in isolation and when they were combined.  
It was not possible to determine with certainty whether a synergistic effect 
occurred when investigating the selection for resistance genes by the 
macrolides but an additive response was clear. An additive and synergistic 
effect was observed, however, when investigating the difference in ermF 
prevalence response when comparing average prevalence for the individual 
compounds to the prevalence for the mixed compounds at each concentration 
tested. The selective endpoints of both trimethoprim and sulfamethoxazole were 
observed to behave synergistically when combined in a 1:4 combination. 
Further, a varied response was observed when investigating the sum of intI1 
prevalence for individual compounds in comparison to prevalence for the 
mixture. 
Work on selective endpoints for the macrolide antibiotics using ermF (presented 
in Chapter 3) suggests that no selection is likely at current environmental 
concentrations. An additive effect created by combining these antibiotics would 
considerably reduce the lowest observable effect concentrations (LOECs) and, 
subsequently, predicted no effect concentration (PNEC) values so that 
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mitigation strategies may need to be implemented if these antibiotics are found 
in combination at current environmental concentrations.  
When trimethoprim was used in isolation, selection for resistance was observed 
at current environmental concentrations. Combining trimethoprim with 
sulfamethoxazole reduced its LOEC by 2-fold. Sulfamethoxazole, however, was 
not selective at current environmental concentrations when in isolation. When 
combining sulfamethoxazole with trimethoprim, however, both the LOEC and 
minimal selective concentration (MSC) decreased to concentrations similar to 
those found in the environment. 
It is clear that risk assessment should take mixtures of antibiotics into account 
when determining the threat posed to the environment. Based on these two 
datasets, combining antibiotics can allow for selection of resistance at 
environmental concentrations even where it is not observed for individual 
compounds. 
4.2 Introduction 
Chemicals from anthropogenic pollution are rarely found in isolation in 
environmental settings (Brandt et al. 2015). Complex mixtures of chemical 
pollutants tend to be the “rule rather than the exception” (Altenburger et al. 
2015). A number of these anthropogenic pollutants, such as pharmaceuticals 
(including, antibiotics), cleaning products and personal care products, are found 
in combinations along with their degradation products in wastewater treatment 
plants (WWTPs) and receiving waters (Backhaus & Faust 2012; Marx et al. 
2015).  
A considerable number of surveillance studies have determined that complex 
chemical mixtures are found in many environmental settings (Mitosch & 
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Bollenbach 2014; Backhaus & Faust 2012). For example, one study undertook 
an investigation into pharmaceuticals in a Spanish river and found the presence 
of 57 different compounds, 17 of which were antibiotics belonging to 5 different 
classes (Proia et al. 2013). Another study determined the occurrence of 
pharmaceuticals in 4 European sewage treatment plant effluents. They found 
an average of 18 out of 26 of the chemicals they were testing for (69.23% 
detection rate). Of these 26 compounds, 7 were antibiotics from 3 different 
classes. Except for sulfamethoxazole in one of four sewage treatment plants, 
the concentrations of all 7 antibiotics tested were above detection limits in every 
effluent tested. Detectable concentrations ranged from 0.01 to 0.58 µg/L of 
antibiotic (Andreozzi et al. 2003). Finally, a further study investigated the 
presence of 56 pharmaceuticals (of which 7 were antibiotics) in the effluent of 
50 wastewater treatment plants. The average detection rate for all antibiotics in 
the 50 WWTPs tested was 56%. This ranged from two antibiotics that were 
undetected in all WWTPs to sulfamethoxazole which had a detection rate of 
89.8%. These antibiotics were found in combination with each other and with 
many other pharmaceuticals (Kostich et al. 2014). Although only three 
surveillance studies have been presented here, the presence of mixtures of 
pharmaceuticals in hotspots such as WWTPs and receiving waters is the norm 
rather than the exception. Many other similar surveillance studies show complex 
mixtures of chemical compounds are introduced to the environment.  
In 2006, a group of stakeholders, including industry, academic and government 
organisations gave their views on how to manage pharmaceuticals in 
environmental settings. They stated that the potential detrimental effect that 
mixtures posed was unknown and that research into the effects of mixed 
pharmaceuticals is important (Doerr-MacEwen & Haight 2006). Further, the 
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Council of the European Union has been aware, for almost a decade, of the 
dangers posed to human health and the environment by mixtures of chemical 
compounds as stated in their Council conclusions document from a meeting in 
2009 (Council of the European Union 2009; Altenburger et al. 2015). 
Documents produced by the European Commission have also stated that there 
is an “almost infinite number of possible combinations of chemicals” (European 
Commission 2012), and that a systematic approach to evaluating the risk of 
these chemicals must, therefore, be developed (SCHER et al. 2012; 
Altenburger et al. 2015). Although the dangers that mixtures pose to the 
environment and to human health have been in discussion in Europe for over a 
decade, environmental risk assessments still only require the investigation of 
the dangers posed by anthropogenic contaminants on an individual basis 
(Backhaus & Faust 2012). 
There are three possible outcomes when chemicals interact in combination: the 
effect may be additive (a linear relationship is observed), synergistic (a stronger 
effect is observed than when the chemicals are in isolation) or antagonistic (a 
weaker effect is observed than when the chemicals are in isolation) (Mitosch & 
Bollenbach 2014; Marx et al. 2015). The effect of individual chemicals must first 
be characterised to determine whether additive, synergistic or antagonistic 
effects are seen when chemicals are in combination (Marx et al. 2015). Data 
suggests that antibiotics tend to display a synergistic effect when found in 
combination (Marx et al. 2015). 
To date, no studies have investigated the effect that combining antibiotics has 
on their selective endpoints in a mixed microbial community. A number of 
studies have focused on the effects that antibiotic combinations have on non-
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target organisms such as zooplankton (Freitas et al. 2018), algae (Hagenbuch 
& Pinckney 2012) and zebrafish (Zhang et al. 2016). Some studies have also 
looked at the effect on bacteria, although data has so far focused on change in 
community structure (Brosche & Backhaus 2010) or toxicity to a specific 
bacterial species (Backhaus et al. 2000; Long et al. 2016). A study that has 
determined selective endpoints for combinations of antibiotics is a mathematical 
study by Bengtsson-Palme and Larsson, 2016. In this study the EUCAST 
database of clinical breakpoints was used to calculate a Predictive No Effect 
Concentration for selection of resistance (PNECR). As EUCAST is a clinical 
database, it also has breakpoints for combinations of antibiotics that are 
frequently used in the clinic, for example trimethoprim (TRMP) with 
sulfamethoxazole (SMX). The same mathematical approach was, therefore, 
able to be applied to MIC values for combinations to calculate PNECRs 
(Bengtsson-Palme & Larsson 2016). Gullberg et al., 2014 also investigated how 
combining two antibiotics affected MSCs in a single species assays. Here, they 
investigated a mixture of erythromycin (ERY) and TRMP and found a 
synergistic effect on selection and combining the two reduced MSC (Gullberg et 
al. 2014).  
The aim of work presented in this chapter was to explore the effect combining 
antibiotics has on experimentally defined minimal selective concentrations 
(MSCs) and lowest observable effect concentrations (LOECs) in a complex 
microbial community. The effect of two different mixtures of antibiotics was 
explored. These were the three macrolide antibiotics in combination and a 
combination of TRMP and SMX. 
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The macrolide antibiotics were chosen as their LOECs (defined by ermF), the 
response of other macrolide specific resistance genes and of intI1 to the 
individual compounds were defined in Chapter 3. The macrolides are a class of 
antibiotics that target protein synthesis by binding to the large subunit of the 
ribosome and preventing synthesis of new peptides (Kannan & Mankin 2011; 
Mazzei et al. 1993). New generations of macrolides have been developed for 
improved pharmacokinetics and tolerability in patients, rather than to overcome 
pre-existing resistance mechanisms developed to ERY (Leclercq 2002; 
Leclercq & Courvalin 2002). As all three compounds tested in Chapter 3 have 
the same mode of action and bacteria deploy the same resistance mechanisms 
to combat them, it follows that when the macrolide antibiotics are mixed 
together they would produce at least a combined additive effect on any 
macrolide specific resistance genes.  
Results generated in Chapter 3 demonstrate that current measured 
environmental concentrations of macrolide antibiotics may not select for 
resistance. The LOECs of azithromycin (AZ), clarithromycin (CLA) and ERY 
associated with increased ermF prevalence were 1,000, 750, 1,000 µg/L, 
respectively. It would be of interest, therefore, to investigate whether the LOEC 
of the total concentration of those combined macrolide antibiotics (termed AZ-
CLA-ERY) would be similar to the LOECs determined in Chapter 3. There is no 
available data to determine how macrolide antibiotics influence each other. 
Studies tend to focus on whether synergism occurs between a macrolide and 
another antibiotic from a clinical perspective (Saiman et al. 2002; Drago et al. 
2011; Descours et al. 2011; van der Paardt et al. 2015). 
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TRMP and SMX were chosen for investigation as they are commonly used in 
combination in the clinic. This combination (TRMP-SMX) was first introduced in 
the United States in 1973 (Foltzer & Reese 1987). TRMP-SMX works as a 
broad spectrum antibiotic and is effective against a range of infections 
(Woormser et al. 1982). Both of these antibiotics work by disrupting the 
synthesis of folic acid, but use different methods to do so (Eliopoulos & 
Huovinen 2001). SMX’s mode of action is to inhibit the penultimate step in the 
formation of dihydrofolate. It achieves this by binding the dihydropteroate 
synthase enzyme and thereby preventing the formation of dihydropteroic acid 
from PABA and DHPPP (Sköld 2000). TRMP works by inhibiting a different 
enzyme: the dihydrofolate reductase. This enzyme converts dihydrofolate into 
tetrahydrofolate (Eliopoulos & Huovinen 2001) which is extremely important in a 
number of biological processes, such as the formation of purines (Bermingham 
& Derrick 2002). 
TRMP and SMX have both mutation based resistance and transferable genes 
that confer resistance to them (Eliopoulos & Huovinen 2001). Transferable 
resistance to TRMP is conferred by dihydrofolate reductases (dfr genes) 
(Domínguez et al. 2019). There are in excess of 20 different dfr genes 
(Eliopoulos & Huovinen 2001) and these are commonly found associated with 
integrons which means they spread and integrate into many bacterial species 
(Domínguez et al. 2019; Brolund et al. 2010). In comparison to the substantial 
number of TRMP resistance genes, SMX has only 3 resistance genes. These 
are sul1, sul2 and sul3 which all encode dihydropteroate synthases. The sul1 
and sul3 genes are often found in association with the class 1 integron as part 
of its genetic cassette, whereas the sul2 gene is more commonly associated 
with plasmids (Domínguez et al. 2019).  
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TRMP-SMX is used in combination in the clinic as the two antibiotics act 
synergistically to treat infections. Clinical administration occurs in a 1:5 ratio of 
TRMP:SMX as this leads to the optimal serum ratio in regards to best 
synergistic effect of the drug to allow for the most effective treatment (1:19 and 
1:20, TRMP:SMX, dependent on the reporting study) (Woormser et al. 1982; 
Masters et al. 2003).  
A previous study has tested whether TRMP-SMX produced a synergistic effect 
on the minimum inhibitory concentration (MIC) of a number of bacterial strains 
when using these antibiotics in the serum ratio. Of every bacterial strain tested, 
a synergistic effect was produced and a reduction in MICs observed (Bushby 
1975). It is hypothesised, therefore, that their interaction could also produce a 
synergistic effect on MSCs/LOECs and thereby reduce the concentration 
needed for the selection of resistance genes. 
The objectives of the work presented in this chapter were, therefore, to 
determine the combined effect on the MSCs of the individual antibiotics both of 
the 3 macrolide antibiotics in a 1:1:1 ratio and of TRMP-SMX in a 1:4 ratio. 
4.3 Methods 
4.3.1 Growth rate experiment 
The growth rate assay used for this work is the one developed in a study by 
Murray et al., unpublished. This assay is able to determine a LOEC of an 
antibiotic or combination of antibiotics. The study found that as growth of 
bacteria enters the exponential phase, a dose dependent response is observed 
in regard to growth rate that is comparable to LOECs determined by selection 
experiments and qPCR. This assay was used during this work to predict the 
concentration range that should be targeted for selection experiments.  
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Iso-sensitest broth was inoculated with 10% v/v of washed wastewater (as in 
the set up for the week long selection experiments described in Section 2.2). 
200 µl was used per well in a 96-well plate. Antibiotics were diluted in a 2-fold 
serial dilution with 6 replicates per concentration, alongside a no antibiotic 
control and a broth only control. The BioTek Synergy 2 or Varioskan Flash plate 
reader was used to determine optical density (OD) at 600 nm. Plates were left 
shaking at “medium” speed or 120 rpm, respectively, for 24 hours at 37 °C. 
Readings were taken every hour. 
Pearson’s correlation/Spearman’s rank correlation (for parametric and non-
parametric data, respectively) was used to determine where the dose response 
was most evident and subsequently, Dunnett’s/Dunn’s tests (for parametric and 
non-parametric data, respectively) were used to compare the OD of those in the 
presence of antibiotics to the no antibiotic control. The lowest concentration at 
which a significant difference was observed to the no antibiotic control was 
defined as the MSC.  
4.3.2 Antibiotic and antibiotic concentrations 
4.3.2.1 Macrolides 
Macrolides used were AZ (Sigma-aldrich), CLA (Molekula) and ERY (Acros 
Organics). AZ and ERY were dissolved in ethanol absolute (Fisher) and CLA in 
acetone (Acros Organics). 
This experiment was run at a concentration range where it was expected that 
significant selection would be observed, based on previous results. The total 
concentration of macrolide of 500, 750, 1,000 and 10,000 µg/L was again run in 
a 1:1:1 ratio of AZ:CLA:ERY and was compared to a no antibiotic control. As 
this was a new batch of sewage in comparison to the work undertaken and 
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presented in Chapter 3, individual compounds were run alongside the mixture 
experiment to ensure direct comparison.  
A verification experiment was undertaken using ERY at a concentration range 
of 100, 250, 500, 750, 1,000, 10,000 and 100,000 µg/L. 
4.3.2.2 Trimethoprim and Sulfamethoxazole 
TRMP (Sigma-Aldrich) was dissolved in DMSO (Sigma-Aldrich) and SMX 
(Molekula) in methanol (Fisher). 
TRMP experiment 1 
The initial TRMP selection experiment, performed by the author together with a 
placement student, Jessica Wright, used concentrations of TRMP from the 
EUCAST breakpoint for Enterobacteriaceae and used a 2-fold dilution down to 
environmental concentrations of TRMP. These concentrations were 4,000, 
2,000, 1,000, 500, 250, 125, 62.5, 31.25, 15.625 µg/L of TRMP. 
SMX experiment 1 
The initial SMX growth rate experiment, performed by the author and Jasmin 
Rauseo, used the same approach as TRMP experiment 1. The top 
concentration of SMX used was the EUCAST breakpoint for 
Enterobacteriaceae. A 2-fold dilution was performed and the concentrations 
used here were: 76,000, 38,000, 19,000, 9,500, 4,750, 2,375, 1,187.5, 593.75, 
296.8, 148.4, 74.21, 37.1, 18.55 and 9.27 µg/L. 
The results from these growth rate experiments then influenced the 
concentrations used in the SMX selection experiment 1. These were 2, 20, 200, 
2,000, 20,000 µg/L alongside a no antibiotic control.  
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TRMP-SMX mixture experiment 
The results from both of these preliminary selection experiments (TRMP 
experiment 1 and SMX experiment 1) were used to inform the concentrations 
used for both the mixture growth rate and mixture selection experiments. The 
concentrations used were: 1,000, 500, 250, 125, 62.5, 31.25 and 15.625 µg/L of 
TRMP and 4,000, 2,000, 1,000, 500, 250, 125 and 62.5 µg/L of SMX. These 
concentrations were combined in a 1:4 ratio of TRMP-SMX for the mixture 
experiments leading to total antibiotic concentrations of 78.125, 156.25, 312.5, 
625, 1,250, 2,500 and 5,000 µg/L. The ratio of these antibiotics was based on 
their median surface water concentrations in Europe from the studies Straub, 
2013 and Straub, 2015 (0.012 and 0.049 µg/L for TRMP and SMX, 
respectively).  
In addition to the mixture selection experiment (TRMP-SMX experiment) the 
antibiotics were also run in isolation as a different inoculum was used to the 
preliminary experiments (TRMP experiment 1 and SMX experiment 1). These 
isolation experiments will be referred to as TRMP experiment 2 and SMX 
experiment 2 and will be reported alongside the TRMP-SMX experiment. 
4.3.3 Resistance genes for qPCR quantitation 
4.3.3.1 Macrolides 
Based on the results from Chapter 3, the only class specific resistance genes 
tested were ermF and mphA. This was alongside the intI1 gene and the 16S 




4.3.3.2 Trimethoprim and Sulfamethoxazole 
For both of these compounds for all experiments (TRMP experiment 1, SMX 
experiment 1, TRMP experiment 2, SMX experiment 2 and TRMP-SMX mixing 
experiment), no class specific resistance genes were tested. QPCR was used 
to target intI1 and 16S rRNA genes. For both SMX and TRMP, most of the class 
specific resistance genes associated with resistance to these drugs are 
commonly associated with the intI1 gene (Moura et al. 2009).  
4.3.4 Data analysis 
Shapiro-Wilk test was used to find if data was parametric or non-parametric. A 2 
– tailed t test was used on parametric data, and a Mann Whitney U test on non-
parametric data, to compare gene prevalence in the individual and mixture 
experiments. This was undertaken to establish whether the effect on gene 
prevalence was synergistic, additive or antagonistic. Average gene prevalence 
in the two experiments (individual or mixed) were determined to be different 
from each other if p < 0.05. 
4.4 Results 
4.4.1 Macrolides mixing experiment 
A limited range of antibiotic concentrations were used to determine LOECs for 
AZ, CLA, ERY and all three in a 1:1:1 mixture. Concentrations targeted ranged 
from the lowest NOEC for ermF from Chapter 3 (500 µg/L of CLA) to 10,000 
µg/L for AZ, CLA, ERY and all three mixed in a 1:1:1 ratio. 
For this experiment, as a positive increase was seen in the no antibiotic control 
for every gene tested, MSCs were not defined. Graphs produced from the 
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qPCR data and the LOECs derived from statistical analysis are presented 
below. 
ermF 
Figure 37A, B, C and D show the selection experiment data for ermF 
prevalence when in the presence of AZ, CLA, ERY and AZ-CLA-ERY, 
respectively. Here, significant positive selection was determined for all 
antibiotics and the combination of antibiotics at 500 µg/L (p = 0.0323, 0.0023, 
0.0056 and 0.0034, Dunn’s test, for AZ, CLA, ERY and AZ-CLA-ERY, 
respectively) and every subsequent concentration for all 3 antibiotics and the 
mixture. No concentration was, however, tested below 500 µg/L (no observable 
effect concentration (NOEC) in Chapter 3) and it was, therefore, impossible to 












Therefore, a verification experiment was undertaken for a more extensive range 
of concentrations using ERY, which illustrated the greatest response at 500 
µg/L, Figure 38. As no concentration was tested below 500 µg/L, this 
experiment was undertaken to see if ermF significantly increased at any 
concentrations below this. A LOEC of 500 µg/L (p = 0.0291, Dunn’s test) was 
determined, although a biological effect was seen at lower concentrations. 
 
 
Figure 37: A comparison of the selection for ermF by (A) AZ, (B) CLA, (C) 
ERY and (D) AZ-CLA-ERY in a 1:1:1 ratio. Standard error is represented by 
















The average prevalence in the individual compound experiment was compared 
to the prevalence in the mixed experiment (Figure 39) and a significant 
difference between prevalence was observed at 500 (p = 0.0418, Mann-
Whitney U test) and 1,000 µg/L (p = 0.03277, Mann-Whitney U test) indicating a 
synergistic response may occur. No significant difference was observed 




Figure 38: Mixing verification experiment graph showing ermF in 
the presence of ERY using Falmouth/Penryn 2017 wastewater as 
the inoculum. A LOEC of 500 µg/L was determined (p = 0.0291, 
Dunn’s test). Standard error is represented by the error bars. * = 
significant positive selection to 90% confidence. ** = significant positive 














Data on the change in prevalence of mphA over 7 days is shown in Figure 40A, 
B, C and D for AZ, CLA, ERY and AZ-CLA-ERY, respectively. For AZ, no LOEC 
was determined as positive selection to 95% confidence occurred at 500 µg/L (p 
= 0.0391, Dunn’s test) and no concentration was tested lower than list. 
Subsequent higher concentrations of 750, 1,000 and 10,000 also demonstrated 
significant selection (p = 0.004, 0.0127, <0.0001, respectively, Dunn’s test).  
For CLA, a significant difference was observed in the prevalence of mphA at 
day 0 (p = 0.001834, Kruskal Wallis). The post-hoc analysis was, therefore, 
undertaken on the difference in prevalence between day 0 and day 7. A LOEC 
was determined to be 10,000 µg/L of CLA for mphA (p = 0.007, Dunn’s test 
(difference)) although significant selection was observed to 90% confidence at 
Figure 39: A comparison of the average ermF prevalence from the 
individual compound experiments to the prevalence from the mixed 




500 µg/L (p = 0.0914, Dunn’s test (difference)). A LOEC of 10,000 µg/L was 
also determined for ERY (p = 0.0391, Dunn’s test). Finally, the combination of 
AZ-CLA-ERY determined a LOEC of 750 µg/L (p = 0.0217, Dunn’s test) and 
significant selection was seen at all subsequent higher concentrations (1,000 
and 10,000 µg/L (p = 0.0391 and 0.0001, respectively, Dunn’s test)). 
No statistical significant difference was observed between the average mphA 
prevalence in the individual antibiotics experiments compared to the mixture 
experiment. This suggested an additive effect.  
 
Figure 40: A comparison of the selection for mphA by (A) AZ, (B) CLA, (C) 
ERY and (D) AZ-CLA-ERY in a 1:1:1 ratio. * = significant positive selection to 





Graphs showing intI1 as a function of AZ, CLA, ERY and AZ-CLA-ERY 
concentration can be seen in Figure 41A, B, C and D, respectively. A LOEC 
was determined for intI1 selection to be 10,000 µg/L of AZ to 95% confidence (p 
= 0.0081, Dunn’s test) although a biological effect was observed at all 
concentrations tested. A significant difference between prevalence was 
observed for intI1 at day 0 for both CLA and ERY (p = 0.01312 and 0.003518, 
respectively, Kruskal Wallis). The post-hoc tests were, therefore, undertaken on 
difference between the prevalence of intI1 between day 0 and day 7. For CLA, a 
LOEC of 1,000 µg/L was determined (p = 0.0196, Dunn’s test (difference)) 
although no significant difference was observed between the control and 10,000 
µg/L for the difference between day 0 and day 7 and significance was observed 
to 90% confidence at 500 µg/L (p = 0.0663, Dunn’s test (difference)). For ERY, 
no significant selection was observed at any concentration tested. No LOEC 
was able to be determined for the combination of AZ-CLA-ERY. Significant 
selection to 90% confidence was observed, however at 10,000 µg/L (p = 









No statistical significant difference was observed between the average intI1 
prevalence for individual compounds compared to the antibiotic mixture, 




Figure 41: A comparison of the selection for intI1 by (A) AZ, (B) CLA, (C) ERY 
and (D) AZ-CLA-ERY in a 1:1:1 ratio. Standard error is represented by the error 
bars. * = significant positive selection to 90% confidence. ** = significant positive 




4.4.2 Trimethoprim and Sulfamethoxazole 
4.4.2.1 TRMP experiment 1 
The selection experiment and DNA extractions for this work was undertaken by 
the author and a Nuffield bursary school student, Jessica Wright. The qPCR 
analysis was undertaken by Aimee Murray.  
QPCR was used to investigate selection for intI1 by TRMP. This can be seen in 
Figure 42. The prevalence of intI1 at day 0 showed a significant difference (p = 
0.005621, Kruskal Wallis), therefore the post-hoc analysis was undertaken on 
the difference in prevalence between day 0 and day 7. No significant increase in 
prevalence was determined at 15.625 and 31.25 µg/L of TRMP compared to the 
no antibiotic control. Significant selection to 90% confidence was observed at 
62.5 (p = 0.0951, Dunn’s test) and 125 µg/L (p = 0.0774, Dunn’s test 
(difference)) compared to the no antibiotic control. Significant selection to 95% 
confidence was first observed at 250 (p = 0.0074, Dunn’s test) and this was, 















An MSC was determined as approximately 26 µg/L by plotting a selection 
coefficient with polynomial order 2 of best fit (y = -0.11 + 0.0045x – 1e-05x2, R2 = 
0.5227, standard error = 0.5227, x intercept = 25.9). This graph can be seen in 
Figure 43. As a result of the natural variation between the biological replicates, 
only an approximate MSC can be calculated. 
 
 
Figure 42: Selection of intI1 by trimethoprim – TRMP experiment 1. 
Standard error is represented by the error bars. * = significant positive 

















4.4.2.2 SMX experiment 1 
This experiment was undertaken by Jasmin Rauseo, a visiting PhD student 
from the Water Research Institute – National Research Council in Italy. During 
her time at the University of Exeter, her project was planned by and she was 
supervised by the author who instructed her on the methodology of the 
experiment and assisted her with the analysis of her work.  
Figure 43: Selection coefficient graph of intI1 in the 
presence trimethoprim – TRMP experiment 1. The blue line 
represents the line of best fit, the grey shading is the 
confidence intervals and the selection coefficient for each 
replicate is represented by the purple dots. 
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4.4.2.2.1 Preliminary growth rate experiment 
An initial growth plate experiment was run to determine the best concentration 
range to target. The greatest variation in regards to dose response was 
observed at hour 7 (determined by Spearman’s rank correlation). A significant 
difference, in comparison to the antibiotic control was observed to 90% 
confidence at 1,187.5 µg/L (p = 0.0664, Dunn’s test) and to 95% confidence at 
2,375 µg/L (p = 0.0179, Dunn’s test) and every subsequent concentration. A 
graph showing the exponential growth phase of this can be seen in Figure 44. 













Figure 44: Growth rate as a function of SMX concentration.  Graph 
shows OD over a limited time frame to best show exponential phase. 
Standard error is represented by the error bars.  
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4.4.2.2.2 Selection experiment 
Based on this growth rate data, a week long evolution experiment was 
conducted, targeting the concentrations 2, 20, 200, 2,000 and 20,000 µg/L of 
sulfamethoxazole. QPCR showed significant positive selection for intI1 to 95% 
confidence for the concentrations of SMX of 2,000 (p = 0.0006, Dunn’s test) and 
20,000 µg/L (p = 0.0001, Dunn’s test). A LOEC of 2,000 µg/L and a NOEC of 
200 µg/L was, therefore, determined. The results can be seen in Figure 45. A 
significant increase in intI1 prevalence was seen at 200 µg/L to 90% confidence 
(p = 0.0806, Dunn’s test) in comparison to the no antibiotic control although this 




Figure 45: Selection of intI1 by sulfamethoxazole. Standard error is 
represented by the error bars. x = significant increase, in comparison to no 
antibiotic control, to 90% confidence. ** = significant positive selection to 




A MSC of approximately 840 µg/L of SMX for selection of intI1 was determined 
using a selection coefficient with a polynomial order 2 line of best fit (y = -0.2 + 
0.0047x + 7.6e-05x2, R2 = 0.471, standard error = 0.1543, x intercept = 839.6). 
Only an approximate MSC value can be calculated as a result of the natural 
variation between biological replicates. The selection coefficient graph can be 
















Figure 46: Selection coefficient of intI1 in the presence of 
sulfamethoxazole. The concentrations plotted equate to the absolute values 
of 0, 2, 20, 200 and 2,000 µg/L. 20,000 µg/L was eliminated to determine the 
most accurate MSC. The blue line represents the line of best fit, the grey 
shading is the confidence intervals and the selection coefficient for each 
replicate is represented by the purple dots. 
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4.4.2.3 TRMP and SMX mixture experiment 
4.4.2.3.1 Preliminary growth rate experiment 
A growth rate experiment was set up, as in section 4.4.2.2, to determine if the 
planned concentration range was appropriate before undertaking the selection 
experiment. Graphs showing growth rate over the full 24 hour experiment can 
be found in Figures 90, 91 and 92 (Page 327 - Appendix) for TRMP, SMX and 
TRMP-SMX, respectively. 
Trimethoprim 
The highest variation in growth rate was seen at hour 6 (r = - 0.810284, 
Spearman’s rank correlation) for TRMP. Dunn’s test was then undertaken on 
this time-point. A significant difference, in comparison to the control, was first 
observed at 31.25 µg/L (p = 0.0454, Dunn’s test) and at every subsequent 
higher concentration (62.5, 125, 250, 500 and 1,000 µg/L of TRMP (p = 0.0051, 
0.0051, 0.0007, 0.0001 and <0.0001, respectively, Dunn’s test)). Figure 47 























For SMX, the greatest variation was also seen at hour 7 (r = - 0.872382, 
Spearman’s rank correlation). A significant difference was observed to 90% 
confidence at 500 µg/L (p = 0.0759, Dunn’s test) and to 95% confidence at 
1,000 µg/L (p = 0.003, Dunn’s test) and subsequent higher concentrations 
(2,000 and 4,000 µg/L (p = 0.0002 and <0.0001, respectively, Dunn’s test)), 
Figure 48.  
 
 
Figure 47: Growth rate as a function of TRMP 
concentration. Graph shows OD over a limited time frame to 
best show exponential phase. Standard error is represented by 















The greatest variation in samples was observed at hour 5 (r = - 0.9475483, 
Spearman’s rank correlation). No significant difference was seen for the lowest 
concentration of total antibiotic (78.125 µg/L). A significant difference was first 
seen to 90% confidence at 156.25 µg/L (p = 0.0986, Dunn’s test) of total 
antibiotic (31.25 µg/L of TRMP and 125 µg/L of SMX) and a significant 
difference to 95% confidence was observed at 312.5 µg/L (p = 0.0155, Dunn’s 
test) of total antibiotic (62.5 µg/L of TRMP and 250 µg/L of SMX) and every 
subsequent higher concentration. A significant difference from the no antibiotic 
control was observed to 90% confidence at 156.25 µg/L (p = 0.0986, Dunn’s 
test) and to 95% confidence at 312.5, 625. 1250. 2500 and 5000 µg/L of total 
Figure 48: Growth rate as a function of SMX 
concentration. Graph shows OD over a limited time frame 
to best show exponential phase.  Standard error is 
represented by the error bars.  
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antibiotic (p = 0.0155, 0.0024, <0.0001, <0.0001 and <0.0001, respectively, 















4.4.2.3.2 Selection experiment 
As with the preliminary growth rate experiment (section 4.4.2.3.1), selection 
experiments with TRMP and SMX were undertaken in isolation as well as the 
mixture experiment in a 1:4 ratio of TRMP:SMX. This was to ensure that any 
difference seen with the mixture experiments, in comparison to the compounds 
Figure 49: Growth rate as a function of TRMP-SMX 
concentration (in a 1:4 ratio of TRMP:SMX). Graph shows 
OD over a limited time frame to best show exponential phase. 
Concentrations are expressed as the total antibiotic 
concentration. They consist of TRMP and SMX in a 1:4 ratio. 
Standard error is represented by the error bars.  
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in isolation, was seen because of the mixing of compounds and not because of 
difference in inoculum (as the inoculum used was different to the two 
preliminary experiments presented above). 
Trimethoprim experiment 2 
No positive selection for intI1 was observed at 15.625 and 31.25 µg/L of TRMP. 
Significant positive selection was observed to 95% confidence at 62.5 (p = 
0.0186, Dunn’s test) and every subsequent higher concentration of TRMP (125 
(p = 0.0064, Dunn’s test), 250 (p = 0.0021, Dunn’s test), 500 (p = 0.0004, 
Dunn’s test) and 1000 µg/L (p < 0.0001, Dunn’s test)), Figure 50. The LOEC of 
TRMP was, therefore, determined to be 62.5 µg/L. 
 
 
Figure 50: Selection for intI1 by trimethoprim. Standard error is 






Sulfamethoxazole experiment 2 
Significant variability was determined between prevalence at day 0 at various 
concentrations of SMX (p = 0.00285, ANOVA). The difference between 
prevalence at day 0 and day 7 was, therefore, used to determine where 
significant positive selection was observed. No positive selection of intI1 was 
observed at 62.5, 125, 250 and 500 µg/L of SMX. Significant positive selection 
was first observed at 1,000 µg/L (p = 0.0186, Dunn’s test (difference)), 2,000 (p 
= 0.0417, Dunn’s test (difference)) and 4,000 µg/L (p = 0.004, Dunn’s test 




Figure 51: Selection of intI1 by sulfamethoxazole. Standard error is 







The selection experiment graph presented for the mixture experiment (Figure 
52) displays the total antibiotic concentration (TRMP concentration + SMX 
concentration) used for the experiment. To clarify exact proportions of TRMP 
and SMX in the selection experiment, the table displayed immediately below the 
graph indicates the proportion of both TRMP and SMX at each total antibiotic 
concentration displayed.  
When the compounds are mixed together, no significant selection was observed 
at 78.125 µg/L of total antibiotic concentration (15.625 and 62.5 µg/L of TRMP 
and SMX, respectively). Significant positive selection was first observed at 
156.25 µg/L (p = 0.0017, Dunn’s test) of total antibiotic concentration (31.25 
µg/L of TRMP and 125 µg/L of SMX) and at all subsequent higher 
concentrations (312.5, 625, 1,250, 2,500 and 5,000 µg/L (p = 0.0025, 0.001, 













The prevalence from the individual experiments was totalled and compared to 
the prevalence in mixture experiments (Figure 53), no significant difference was 
observed at 78.125, 312.5, or 625 µg/L of total antibiotic, suggesting an additive 
effect. A significant difference was observed at 156.25 (p = 0.02055, t test), 
suggesting a synergistic effect. A significant difference was also observed at 
1,250 (p = 0.002098, t test), 2,500 (p = 0.0001937, t test) and 5,000 µg/L (p = 
0.007937, Mann Whitney U test), suggesting an antagonistic effect. 
Figure 52: Selection of intI1 by trimethoprim and sulfamethoxazole in a 
1:4 ratio. Standard error is represented by the error bars. ** = significant 









Selection coefficient graphs were used to determine MSCs for intI1 selection by 
TRMP and SMX when used in isolation and for each of those when in 
combination. 
For TRMP, when the experiment was run in isolation (TRMP experiment 2), the 
line of best fit (polynomial order 3, y = - 0.232 - 0.0065x + 0.000571x2 – 6.27e-
06x3, R2 = 0.7544, standard error = 0.07675, x intercept = 37.8) estimated a 
MSC of approximately 38 µg/L. When in combination, the MSC of TRMP 
Figure 53: A comparison of the total intI1 prevalence from the 
individual compound experiments to the prevalence from the mixed 





decreased by approximately half and the line of best fit (polynomial order 3, y = 
-0.33 + 0.0259x – 0.000488x2 + 2.82e-06x3, R2 = 0.6759, standard error = 
0.1282, x intercept = 18.5) estimated a MSC of approximately 19 µg/L. This can 
be seen in Figure 54. MSC values are approximations as a result of the natural 













When SMX was used in isolation (SMX experiment 2), the line of best fit 
(polynomial order 3, y = -0.148 – 0.0305x + 0.00206x2 – 2.87e-05x3, R2 =0.698, 
standard error = 0.08743, x intercept = 841.2) determined the MSC as 
approximately 841 µg/L. In the mixed experiment, however, the MSC decreased 
by approximately 12 times to 69 µg/L (Figure 55), as defined by the line of best 
Figure 54: Selection coefficient of intI1 in the presence of 
trimethoprim for the individual antibiotic and when mixed 




fit (polynomial order 3, y = -0.33 + 0.00647x – 3.05e-05x2 + 4.4e-08x3, R2 = 
0.6758, standard error = 0.1282, x intercept = 68.5). The MSC values calculated 














Confidence intervals have not been included on the two graphs that display the 
MSCs for TRMP and SMX when in combination and in isolation. Displaying both 
the individual and mixed lines of best fits on the same graph, for comparative 
purposes, meant that the confidence intervals overlapped and the graph 
became confusing to visualise. A graph for each dataset displaying the 
selection coefficient data points, the line of best fit and the confidence interval 
Figure 55: Selection coefficient of intI1 in the presence of 
sulfamethoxazole for the individual antibiotic and when mixed with 
trimethoprim. The square root of SMX concentration was plotted. This equates 
to absolute concentrations of 0, 62.5, 125, 250, 500, 1000 and 2000 µg/L for 




area can be found in the supplementary data in Figures 93 – 96 (Page 329 - 
Appendix).  
A MSC, defined as where the line of best fit (polynomial order 3, y = - 0.33 + 
0.00517x – 1.95e-05x2 + 2.25e-08x3, R2 = 0.6795, standard error = 0.1282, x 
intercept = 92.9) crosses the x axis, of approximately 93 µg/L was determined 
for the total antibiotic concentration acting on intI1 when TRMP and SMX are 
used in combination. Again, only an estimation of MSC can be calculated as a 













Figure 56: Selection coefficient of intI1 in the presence of 
trimethoprim and sulfamethoxazole in a 1:4 ratio. The blue line 
represents the line of best fit, the grey shading is the confidence 
intervals and the selection coefficient for each replicate is 





The data presented in this chapter suggests that antibiotics found in 
combination in the environment pose a greater risk than when found in isolation. 
This is cause for concern as current ecotoxicology testing only requires tests to 
assess the risks posed by active pharmaceutical ingredients (APIs) to be 
undertaken in isolation.  
4.5.1 Synergistic, additive or antagonistic? 
Macrolides 
Defining the mixing effect on the selective endpoint when the macrolides are 
used in combination was difficult. A limited range of concentrations for each 
antibiotic and combination of antibiotics was undertaken in order to keep the 
size of the experiment manageable. This was to ensure that inoculum was 
homogenised and that the differences that were seen were as a result of the 
experimental treatment rather than an inoculum or experimental bias. For ermF, 
all concentrations of antibiotics showed a significant increase in prevalence 
compared to the no antibiotic control. This included the combination of the three 
antibiotics. Having not determined a NOEC, it was not possible to say with 
certainty what response occurred for the LOEC. By running a verification 
experiment, it was shown that ERY had a LOEC of 500 µg/L with this inoculum. 
It can be said with some certainty, therefore, that an antagonistic effect on the 
LOEC was not observed with the AZ-CLA-ERY. It cannot be determined, 
however, whether the AZ-CLA-ERY was acting synergistically or additively on 
the LOEC defined by ermF.  
When investigating the effect on gene prevalence, an additive or synergistic 
effect (depending on the concentration tested) was observed when the 
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antibiotics were combined in a 1:1:1 ratio, in comparison to the average 
prevalence for individual antibiotics treatments.  
For intI1, a LOEC of 10,000 µg/L was determined for AZ. A biological effect was 
seen, however, at concentrations lower than this. For CLA, a LOEC of 1,000 
µg/L was determined but no significant selection was observed at the higher 
concentration of 10,000 µg/L. No significant selection was observed at any 
concentration tested for ERY. This matches the response of intI1 observed to 
ERY in Chapter 3 (the LOEC defined here was 100,000 µg/L). No LOEC was 
determined for the combined antibiotics but significant selection to 90% 
confidence was observed at 10,000 µg/L. It was not possible, therefore, to 
determine whether AZ-CLA-ERY acts synergistically, additively or 
antagonistically on intI1 LOEC as, currently, there was insufficient data.  
An additive effect was observed, however, comparing average intI1 prevalence 
in the presence of the individual compounds to the prevalence in the presence 
of the mixed antibiotics.  
For mphA, a LOEC of 10,000 µg/L was determined for both CLA and ERY. A 
LOEC of 500 µg/L was determined for AZ, although as a concentration lower 
than this was not tested it was impossible to say with certainty that this was the 
lowest concentration at which selection would be observed. When the 
antibiotics were combined in a 1:1:1 ratio, the LOEC was 750 µg/L of total 
antibiotic (or 250 µg/L of each). This means the effect concentration for CLA 
and ERY has reduced in the mixture. Without testing lower concentrations of AZ 
it was impossible to determine whether the LOEC of AZ had also been reduced. 
One possible explanation for this reduction of LOEC in CLA and ERY was that 
the combined LOEC of 750 µg/L (defined by mphA) was being driven by AZ, as 
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this was more selective for mphA than CLA and ERY in isolation. Without 
testing pairs of antibiotic combinations, however, it was not possible to conclude 
whether an additive or synergistic effect occurred.  
An additive effect was observed, however, comparing average mphA 
prevalence in the presence of the individual compounds to the prevalence in the 
presence of the mixed antibiotics.  
Trimethoprim and sulfamethoxazole 
Combining TRMP and SMX had a synergistic effect on the MSC of both 
antibiotics in comparison to when used in isolation (TRMP/SMX experiment 2). 
Approximately half the TRMP concentration was required to see the same 
response in intI1 LOEC and MSC when in combination with SMX in comparison 
to the response when using TRMP on its own. The MSC of SMX when found in 
combination with TRMP was approximately 1/11th and the LOEC was 
approximately 1/12th of values determined in isolation.  
When investigating the effect mixing TRMP and SMX had on prevalence a 
varied response was observed depending on the concentration. At the 
concentration defined as the LOEC for the mixing experiment, a synergistic 
effect was seen in comparison to the sum of the responses for the individual 
antibiotics. The response changed to an additive effect as concentration 
increases and to an antagonistic effect at even higher concentrations. This may 
be as a result of the complexity of class 1 integron ecology and genetics. For 
example, they may or may not carry a sul1 gene in their backbone, the 
integrated gene cassettes will vary between integrons and host identity will vary.  
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Previous data suggests that, as a general rule, antibiotics act synergistically, in 
terms of bactericidal or bacteriostatic effect, when used in combination (Marx et 
al. 2015). Although whether this is true in terms of selection for resistance was 
previously unknown. Based on the preliminary data from the macrolide mixing 
experiment and the data from the TRMP-SMX mixing experiment, it would 
appear that the antibiotics tested here have an additive or synergistic effect on 
selective endpoints in combination which was particularly evident for the TRMP-
SMX combination. 
4.5.2 Comparison of individual and mixture selective endpoints with 
measured environmental concentrations 
Macrolides 
Limitations in experimental design (a limited concentration range was used) 
mean that no difference in LOEC (defined by ermF) could be reliably 
determined between single antibiotics and the mixture. The ermF prevalence 
data might suggest, however, that a synergistic effect is likely as the average 
prevalence was higher at each concentration in the mixture than the average for 
each antibiotic in isolation (Figure 39). From this preliminary data, therefore, it 
was clear that the macrolides have at least an additive (possibly synergistic) 
effect. As these antibiotics are often found in combination in environmental 
compartments, therefore, their predicted no effect concentration (PNEC) values 
should be adjusted accordingly. Table 6 shows the LOEC, NOEC and PNEC 
values for when ERY was used in isolation and in a 1:1:1 mixture combined with 
AZ and CLA and an additive effect was assumed. A NOEC of 250 µg/L 
(suggested by the verification experiment where a NOEC of 250 µg/L was 
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defined for ERY) was assumed as a “best case scenario” for the mixture 
experiment but this may actually be lower.  
Table 6: Selective endpoints, NOECs and PNEC values for ERY defined by 
ermF when experiments are undertaken in isolation and with AZ and CLA 
in a 1:1:1 ratio. i = the values when the experiment was undertaken with the 
antibiotic in isolation. m = values when the experiment was undertaken when 





This PNEC value of ERY in the mixture experiment (8.33 µg/L) has been 
reduced by 3 times in comparison to the PNEC where ERY was used in 
isolation and is now in the same order of magnitude as the MECmax of ERY (see 
Chapter 3 - 2.42 and 4 µg/L for ERY and ERY-H2O, respectively). The data 
presented here would suggest that, to mitigate the risk of development of 
resistance from the greater impact from the combination of antibiotics, 
measures may need to be taken to reduce concentrations of macrolides 
entering the aquatic environment. The limitations of this experiment means, 
however, the values for ERY in the mixture are speculative and may be 
significantly lower and even more of an environmental concern. Values for ERY 




LOEC NOEC PNEC 
i m i m i m 
ERY 500 166.6 250 83.3 25 8.33 
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Trimethoprim and sulfamethoxazole 
Table 7 shows the MSCs, LOECs, NOECs and PNECs for TRMP and SMX 
when the experiment was undertaken with them in isolation (TRMP/SMX 
experiment 2) and when they were mixed. 
Table 7: Selective endpoints, NOECs and PNEC values for TRMP and SMX 
defined by intI1 when experiments are run in isolation and in combination 
with eachother in a 1:4 ratio. 1 = PNEC value derived from applying a 10-fold 
assessment factor to the MSC. 2 = PNEC value calculated when applying a 10-
fold assesment factor to the NOEC. i = the values when the experiment was 
undertaken with the antibiotic in isolation. m = values when the experiment was 
undertaken with the antibiotics mixed in a 1:4 ratio. All values are in µg/L. 
 
MSC PNEC1 LOEC NOEC PNEC2 
i m i m i m i m i m 











SMX 863 74 86.3 7.4 1000 125 500 62.5 50 6.25 
 
 
The MECmax on the UBA database for TRMP is 27,680 µg/L found in untreated 
pharmaceutical wastewater (Umweltbundesamt 2016). This is significantly 
higher than all of the values shown in Table 7, but is also an unusually high 
environmental concentration. Removing the concentrations of residues found in 
pharmaceutical waste gives a more representative view of typical environmental 
concentrations so that the MECmax was 95.1 µg/L found in hospital wastewater 
(Umweltbundesamt 2016). This is still higher than all of the values in Table 7 
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and means that environmental concentrations of TRMP are likely to select for 
resistance whether found in isolation or in combination with SMX.  
For SMX, the MECmax seen on the UBA database is 200,000 µg/L, again found 
in untreated pharmaceutical waste (Umweltbundesamt 2016). This 
concentration is, incidentally, the highest concentration of any antibiotic found 
on the database. Based on all of the selective endpoints determined here, this 
concentration is high enough to select for resistance in complex communities. It 
is again, however, significantly higher than typical concentrations found in the 
environment. Removing pharmaceutical waste from the UBA database the 
MECmax is 81.1 µg/L in hospital wastewater (Umweltbundesamt 2016). This 
concentration is approximately 10 times lower than the LOEC and the MSC for 
the SMX experiment 2 and, therefore, selection for intI1 in the environment if 
SMX is found in isolation would not be expected. This concentration is, 
however, between the LOEC and NOEC and is similar to that of the MSC of 
SMX when found in combination with TRMP. It is possible, therefore, that 
combining these two antibiotics in a 1:4 ratio means that current environmental 
concentrations of SMX are now a potential risk.  
4.5.3 Previous work on selective endpoints for combinations 
The only study investigating the selective endpoints of any combination of 
antibiotics is by Bengtsson-Palme and Larsson, 2016. This study used the 
clinical breakpoints from the EUCAST database and a mathematical approach 
to determine a PNECR by an applying an assessment factor to breakpoints. The 
EUCAST database provides the clinical breakpoint of TRMP and SMX 
combination because it is a combination used in the clinic. It determined the 
breakpoint for a combination ratio of 1:19 (TRMP:SMX), deemed to be the 
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optimal serum ratio in terms of synergism between the two. The PNECRs 
determined by Bengtsson-Palme and Larsson, 2016 were also based on this 
ratio. In contrast, the work presented here used the environmental ratio of 1:4 
(TRMP:SMX).  
Bengtsson-Palme and Larsson, 2016 determined the PNECRs for TRMP and 
SMX in isolation to be 0.5 and 16 µg/L, respectively, which are 1-2 orders of 
magnitude lower than those generated in the current study. When they were 
combined in the 1:19 ratio, however, TRMP continues to have the same PNECR 
of 0.5 µg/L whereas the PNECR of SMX decreases to 9.5 µg/L. This suggests 
that TRMP was causing a synergistic effect on SMX, but no additive or 
synergistic effect was occurring to TRMP in the presence of SMX in contrast to 
the synergistic effect reported here. 
The synergistic effect, in regards to the MSCs and LOECs, when these two 
compounds were combined in a 1:4 ratio (the environmental ratio (Straub 2013; 
Straub 2015)) was greater than the difference in PNECRs in the 1:19 ratio. The 
1:19 or 1:20 ratio is used in the clinic as this is the ratio that produces the 
greatest synergistic effect. When investigating drug efficacy in humans and 
animals there are a host of additional factors to be taken into account, such as 
bioavailability, pharmacodynamics and pharmacokinetics (Queralt & Castells 
1985; Schwartz & Rieder 1970; Günther et al. 1987) whereas in this work, 
however, the only relevant issue when combining the two antibiotics is the 
development of resistance.  
4.5.4 Reproducibility of assay with different inoculum 
For TRMP and SMX, two sets of experiments were run: the preliminary dataset 
run with the assistance of visiting students (TRMP/SMX experiment 1 - Section 
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4.4.2.1 and 4.4.2.2) and the compounds run in isolation as part of the mixing 
experiment (TRMP/SMX experiment 2 - Section 4.4.2.3). The preliminary data 
for determining MSCs for TRMP and SMX used different wastewater inoculum 
from each other and from the mixing experiment. It is interesting, therefore, to 
see how reproducible the assay is using the same compounds with differing 
microbial communities. In this case, two wastewater communities were 
collected from the same wastewater treatment plant but at a 2 year interval 
(TRMP experiment 1 in 2015 and TRMP experiment 2, SMX experiment 2 and 
TRMP-SMX experiment in 2017) and a third was collected from a different 
wastewater treatment plant (SMX experiment 1). The results obtained for the 
individual compounds as part of the mixing experiment align well to the previous 
preliminary data obtained.  
For TRMP, in the mixing experiment the LOEC was 62.5 µg/L and the NOEC 
was 31.25 µg/L. In the preliminary experiment, the LOEC was 250 µg/L and the 
NOEC was 125 µg/L, although significant selection to 90% confidence was 
observed down to 62.5 µg/L. The MSCs, defined by selection coefficient graphs, 
were 23.9 µg/L and 37.9 µg/L for the preliminary data and the mixing 
experiment, respectively. These slightly different values were probably a result 
of variability in the replicates which may have skewed each dataset slightly 
differently and because the lines of best fit are different for the different 
datasets. These two MSC values were in the same order of magnitude as each 
other.  
For SMX, slightly different concentration regimes were used for each 
experiment. For the experiment undertaken as preliminary work, concentrations 
were increased by 10-fold increments. This meant there was a 10-fold 
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difference between the LOEC (2,000 µg/L) and the NOEC (200 µg/L). In the 
individual compound data from the mixture experiment, however, the 
concentration was increase by 2-fold at each increment. The LOEC and NOEC 
from this experiment (1,000 and 500 µg/L, respectively) were in between the 
LOEC and NOEC of the preliminary experiment. The MSC for these two 
experiments were, as with TRMP, in the same order of magnitude as each other 
(786.24 µg/L and 862.5 µg/L for the preliminary and the mixture experiment, 
respectively). The similarities between the data obtained from the preliminary 
work and the subsequent work on the same compounds suggests that the 
assay is reasonably robust generating similar results with different inocula.  
For the macrolide data, however, a decrease in MSC was observed with the 
inoculum used in the experiment presented in this chapter (Section 4.4.1) in 
comparison to the work undertaken in Chapter 3. The verification experiment 
was run to ensure that the LOEC of ERY did not decrease below 500 µg/L. 
Although the LOEC did not decrease below 500 µg/L, a biological effect was 
observed at lower concentrations of ERY. Significance to 90% confidence was 
seen at 100 µg/L, although there was no significant difference between the no 
antibiotic control and 250 µg/L. For intI1, previous work in Chapter 3 was not 
able to define a LOEC for AZ, although significance to 90% confidence was 
observed at 1,000, 10,000 and 100,000 µg/L. In work presented in this chapter, 
significant positive selection was observed at 500 µg/L of AZ but as no 
concentration below this was tested it is not possible to confirm that significant 
selection has reduced more than 2-fold.  




As a result of a limited concentration range being tested for the macrolide 
antibiotics, it was not possible to define how combining the macrolides affects 
the LOEC/MSC. Further investigations into how resistance genes are affected 
at a more extensive range of concentrations could be important in 
understanding how these antibiotics behave in a mixture.  
The presence of AZ might be having a stronger contributory effect than CLA 
and ERY. The LOEC for AZ was 500 µg/L (although no concentration was 
tested lower than this) and for CLA and ERY was 10,000 µg/L when the 
compounds were used in isolation. When they were used in combination, 
however, the LOEC of each was 250 µg/L (750 µg/L of total antibiotic was 
required to see a significant difference). It would, therefore, be interesting to 
determine the roles of each of the antibiotics through further investigations. 
Combining two antibiotics at a time in a 1:1 ratio may help to understand the 
effect each has on each other. Whilst it is possible to speculate that AZ causes 
a strong synergistic effect on CLA and ERY it, as it has been shown to be more 
potent than ERY (Jelić & Antolović 2016), this cannot be verified without 
investigating two compounds at a time.   
Trimethoprim and sulfamethoxazole 
Three replicates from each concentration in the TRMP, SMX and TRMP-SMX 
mixing experiment have been sent for metagenome analysis. This includes 
samples from where TRMP and SMX were run in isolation as well as samples 
from when they were combined. Unfortunately, at the time of writing, the return 
of sequencing from Exeter Sequencing Service is still awaited and cannot, 
therefore, be presented here. The samples have been sent for sequencing as 
the only gene targeted in this experiment was intI1. No antibiotic resistance 
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genes specific to either class of TRMP or SMX were targeted using qPCR. The 
sequencing would be able to show what is occurring to individual class specific 
resistance genes and, in addition, compare the effect of mixing on these genes. 
As antibiotic resistance genes to these two compounds are regularly associated 
with intI1 (Moura et al. 2009), the 3 replicates (of 5 run in the mixing selection 
experiment) with the highest intI1 prevalence were sent for sequencing. It will 
also be interesting to determine how co-selection for other antibiotic classes is 
affected by the combination of the two antibiotics, as intI1 is known to be 
associated with many different resistance genes of many classes (Gillings et al. 
2015).  
4.6 Conclusion 
The mixtures tested demonstrated additive or synergistic effects on selective 
endpoints with reduced PNECs for individual antibiotics in mixtures. In general, 
an additive or synergistic effect on prevalence was also observed, although this 
became antagonistic with increasing concentrations of TRMP and SMX. The 
combination of antibiotics tested here was relatively simple in comparison to 
mixtures of pharmaceuticals found in the environment. This is important 
preliminary work that shows combinations of antibiotics in hotspots, such as 
WWTPs, need to be considered when determining risk of the development of 
resistance. It is a complex task to determine the effect that different 
combinations within the environment could have on selection for antibiotic 
resistance: there is an almost infinite number of possible combinations of 
different antibiotics interacting; of the ratios of those antibiotics involved in that 
interaction and of the concentrations of antibiotics that may be involved. In 
addition, antibiotic degradation products, other APIs and chemical compounds 
such as biocides and heavy metals may also interact with antibiotics and 
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change the effect they have on selection for resistance in the environment. 
Nevertheless, the work that has been undertaken is an important preliminary 
step to understanding the role interactions between compounds have in driving 



















Chapter 5: The effect of temperature on selective 
endpoints of antibiotics 
Author contributions 
The author, under the supervision of named supervisors, undertook the growth 
rate experiments, the 24 hour sampling experiment to obtain samples for 
chemical degradation analysis and the selection experiment and subsequent 
analysis. Felicity Elder, University of Bath, analysed the degradation of AZ from 
the 24 hour experiment using mass spectrometry.  
5.1 Abstract 
A recent study investigated whether the difference in minimum temperatures 
across the United States correlated with an increase in the clinical rates of 
antimicrobial resistance seen. That study determined that a difference of 10 °C 
in those minimum temperatures resulted in significant increases in resistance in 
three common clinical pathogens. Whilst this study showed a correlation 
between the temperature increase and resistance, no causal link was 
determined. The aim of the work reported in this chapter was, therefore, to 
determine how an increase in temperature affected the selective endpoints of 
azithromycin (AZ).   
Selection experiments were undertaken at 37, 28 and 20 °C. Isosensitest broth 
was inoculated with raw wastewater influent and passaged over a 7 (37 and 28 
°C experiments) or 14 (20 °C experiment) day period with appropriate 
concentrations of AZ. QPCR targeted ermF, mphA and intI1 to investigate the 
selective effect of AZ at different temperatures.  
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For all three genes targeted, the selectivity of AZ decreased with decreasing 
temperature and, therefore, an increase in AZ concentration needed for 
selection of the three genes was observed. 
The data reported in this chapter represents a preliminary study into the effect 
of temperature on selective endpoints. More work needs to be undertaken to 
determine whether the selective potential of AZ is affected at different 
temperatures or whether there are other macrolide resistance genes, 
associated with different taxa, that were not targeted as part of this work. 
Metagenome analysis should be undertaken to determine candidate genes 
which would best evaluate whether the overall selective effect of AZ changes at 
20 and 28 °C as the qPCR targets tested in this study were chosen based on 
selection by AZ at 37 °C. 
5.2 Introduction 
Climate change is defined as “change in global or regional climate patterns” 
(Lineman et al. 2015) and recent trends show that anthropogenic activities are 
implicated in current warming (IPCC 2018). 
The Intergovernmental Panel on Climate Change (IPCC) stated in their 2018 
report that since the industrial revolution, anthropogenic activities have already 
been responsible for an increase of 1 °C of global temperature. If this trend 
continues at its current rate (approximately 0.2 °C a decade), the critical value 
of an increase of 1.5 °C will be reached between 2030 and 2052 (IPCC 2018). 
In the 2011 Annual report of the Chief Medical Officer, Dame Sally Davies 
stated that the threat of antimicrobial resistance is “arguably as important as 
climate change for the world” (Davies 2013). There is very limited data on the 
link between rates of AMR and anthropogenic climate change and, until 2018, 
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no direct link had been identified. A 2010 paper suggested that increasing 
natural disasters caused by climate change might lead to an increase in 
unsanitary conditions and hence, an increase in infection rate. Treating 
infections would then increase antibiotic use and subsequently exert an 
increase in selective pressure for antibiotic resistant bacteria to emerge. This 
study, therefore, showed that climate change would indirectly increase antibiotic 
resistance levels (Gould 2010). 
A study published in 2018, however, linked an increase in local temperature and 
increasing antibiotic resistance rates (MacFadden et al. 2018). This study 
investigated whether differences in local temperature across the United States 
affected rates of antibiotic resistance in the bacterial pathogens E. coli, K. 
pneumoniae and S. aureus. By using patient information from 2013 to 2015, the 
authors determined that an increase of 10 °C of minimum local temperature was 
associated with an increase in resistance rates of 4.2%, 2.2% and 2.7%, 
respectively, for the pathogens mentioned above. The relationship of resistance 


















The authors of the 2018 study put forward a number of hypotheses for why this 
correlation was observed. First, it was suggested that increasing temperature 
may increase the rate of horizontal gene transfer (HGT), and, therefore, 
facilitate the spread of resistance genes through bacterial populations. 
Secondly, the authors suggested that the correlation could be a result of the fact 
that bacterial growth rate is highly dependent on temperature: an increase in 
temperature, and hence growth rate, may result in increased carriage of 
pathogens in and increased transfer events between human and animal hosts. 
Finally, it was suggested that temperature may enhance the growth rates of 
resistant bacteria residing in the environment which may, subsequently, lead to 
an increase in transmission of these strains from environmental sources. The 
authors did note, however, that their study only shows a correlation between 
antibiotic resistant bacteria and local temperature and did not prove any causal 
link between the two. They suggested that further experimental work would 
This image has been removed by the author of this thesis for copyright 
reasons. 
Figure 57: Graph reproduced from MacFadden et al., 2018. A: Normalised 
prevalence of resistant E. coli in the United States. B: Minimum 
temperatures in the United States. A correlation is observed between 
temperature and prevalence of resistant E. coli across the United States. 
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need to be undertaken to determine whether a causal link can be shown 
(MacFadden et al. 2018). 
To date, no work has investigated the effect of temperature on selective 
endpoints of antibiotics. Limited work has, however, been undertaken on the 
effect of temperature on minimum inhibitory concentration (MIC). One study, 
published in 1985, investigated the effect of incubation temperature on the MIC 
of a number of antibiotics in three clinical bacterial pathogens. No effect on MIC 
was observed for any antibiotic tested with Enterobacteriaceae or P. 
aeruginosa. A difference was seen, however, with Pseudomonas maltophilia 
(later reclassified as Strenotrophomonas maltophilia (Conly 1996)) where 
antibiotics either had lower MICs at a higher temperature (37 °C) in comparison 
to the lower temperature (30 °C) or no difference between the two was 
observed (Wheat et al. 1985). This is, however, only one clinical strain and it 
cannot, therefore, be assumed that the selective endpoints of any particular 
antibiotic will behave in the same way (decreasing with increasing temperature) 
when investigating this in a diverse bacterial population. 
The aim of the work presented here was, therefore, to determine whether 
increasing temperatures have an effect on the minimal selective concentrations 
(MSCs)/lowest observed effect concentrations (LOECs) of an antibiotic. For this 
experiment, azithromycin (AZ) was used as the study compound and three 
different temperatures were used. This would show whether a correlation exists 
between temperature and selective endpoints. In addition, investigating whether 
a relationship could be seen between different temperatures could show how 
selective endpoints are affected in different environmental and non-





AZ (Sigma-aldrich) was the chosen antibiotic for this experiment and was 
dissolved in ethanol (Acros Organics). 
5.3.2 Temperatures 
Three temperatures were chosen to undertake this series of experiments. 
These were 37, 28 and 20 °C. The temperature 37 °C was chosen as a 
comparison for the experiments undertaken in Chapter 3 and 4. 20 °C is the 
current guideline temperature used in the OEDC guidelines for the activated 
sludge respiration inhibition test (ASRIT) for ecotoxicology guidelines (OECD 
2010). Finally, 28 °C was chosen as an intermediate in order to see whether a 
trend would be able to be observed with change in temperature.  
5.3.3 Growth rate experiment 
Growth rate experiments were undertaken to determine the doubling time of the 
mixed community bacteria. This enabled a passage period to be determined.  
Growth rate plates were set up with 6 replicates of 200 µl of iso-sensitest broth 
(Oxoid) and inoculated with washed wastewater at 10% v/v and 6 replicates of a 
broth control.  
For 37 °C and 28 °C treatments, plates were placed in the BioTek Synergy 2 
plate reader. These were set to the appropriate temperature, set to read optical 
density (OD) at 600 nm and to shake at a medium speed. The 37 °C plate was 
read every hour for 24 hours and the 28 °C plate was read every hour for a total 
of 48 hours.  
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As the plate reader was unable to hold a stable temperature until it reached 5 
°C above room temperature, and as the room temperature of the laboratory 
used fluctuated from 18 °C to 23 °C, the 20 °C plate was placed in an incubator 
at 140 rpm and regular readings were taken. In order to capture the exponential 
phase, readings were taken, using the BioTek Synergy 2 plate reader, at 600 
nm every hour from hour 14 to 23 in addition to obtaining an initial and final OD. 
Growth rate was calculated using the equation: R = (LN[OD2/OD1])/(T2-T1). 
Two timepoints were chosen in the exponential phase (T1 and T2) and the 
corresponding OD values (OD1 and OD2, respectively) were used in this 
calculation. 
5.3.4 Chemical degradation of AZ 
As antibiotics degrade over time, it was important to determine whether 
temperature affects the speed at which this occurs. Further, to ensure that 
results determined from selection experiments are comparable, it is important 
that the bacterial community is exposed to the same concentration of antibiotic.  
A 24 hour experiment was conducted to investigate the extent of degradation at 
the different experimental temperatures. Iso-sensitest broth was inoculated with 
10% v/v washed raw wastewater and with 10,000 µg/L of AZ. Five replicates of 
broth, wastewater and antibiotics were left shaking at 180 rpm at each 
temperature (20, 28 and 37 °C). In addition, 5 replicates of just iso-sensitest 
broth and AZ were run at 37 °C to test if bacterial resistance elements, such as 
enzymes, were degrading the AZ over time or if the degradation of AZ was 
happening irrespective of the presence of bacteria.  
AZ was chosen as the antibiotic for this experiment as it was studied 
extensively in the work presented in Chapter 3. It is also known to be more 
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stable than the original macrolide antibiotic, erythromycin (although this is 
based on pH stability) (Lode et al. 1996) and for its low removal rates during the 
wastewater treatment plant (WWTP) process (Čizmić et al. 2019). It was hoped, 
therefore, that minimal degradation would occur and no additional measures 
would need to be undertaken in the selection experiment set-up to account for 
degradation. 
Sampling occurred at the beginning of the experiment and then at every hour up 
until 6 hours. After 6 hours, samples were taken every 3 hours until 24 hours. 
50 µl of sample was added to 400 µl of methanol (Fisher) and 50 µl of an 
internal standard (LGC Standards). Methanol was used to kill bacteria and 
dilute the broth so that this did not block the chemical analysis machinery. An 
internal standard was used at a set concentration to ensure that, if degradation 
occurred during storage or transportation, a calculation could be undertaken to 
ensure an accurate measurement of AZ.  
Samples were stored at -80 °C for 24 hours and were then centrifuged at 
16,200 xg for 10 minutes to pellet the bacteria. The supernatant was removed 
and placed in polypropylene LCMS vials (Waters). This was then stored at -80 
°C (or on ice packs when travelling) until the analysis was undertaken. 
The chemical analysis was undertaken by Felicity Elder, a PhD student based 
at the University of Bath on three of the five replicates at hour 0 and 24. Mass 
spectrometry was used, as per the methods in Lopardo, Rydevik and Kasprzyk-
Hordern, 2019, to determine the degradation rate of AZ over the 24 hour period. 
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5.3.5 Selection experiment 
The concentration range of AZ was the same as that used in the final selection 
experiments in Chapter 3. These were 0, 100, 250, 500, 750, 1,000, 10,000 and 
100,000 µg/L. 
5.3.6 qPCR targets 
The qPCR targets used here were the ermF, mphA, intI1 and 16S rRNA genes. 
These targets were chosen based on the results presented in Chapter 3, as 
these genes were positively selected for at 37 °C. 
5.4 Results 
5.4.1 Growth rate of a mixed community at three temperatures 
To ensure that the experiments were comparable, it was necessary to 
determine that the same number of generations of bacteria was exposed to the 
antibiotic before passage. Growth rate experiments were, therefore, undertaken 
at three temperatures to determine the rate of growth during the exponential 
phase.  
The rate of growth is shown in Table 8, along with the passage period chosen 
for the selection experiment.  
Table 8: Results from growth rate experiments. Shown here is the rate at 
which the bacterial community grew at a specific temperature as well as the 
passage period determined for subsequent selection experiments. 
Temperature Rate Passage period 
37 °C 0.145302 24 hours 
28 °C 0.12359 24 hours 
20 °C 0.063118 48 hours 
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Growth at 28 °C was shown to be 1.18 times slower than that at 37 °C. 
Stationary phase, however, was reached before 24 hours (as with 37 °C) and 
passage would occur, therefore, at the same time as the 37 °C experiment.  
Growth rate at 20 °C was shown to be approximately 2.3 times slower than at 
37 °C. Stationary phase was reached by 48 hours and reached a similar OD as 
the other two temperatures. There will have been, therefore, a similar number of 
bacterial generations by 48 hours at 20 °C as with the other two temperatures at 
24 hours. Passaging of this experiment was, therefore, undertaken every other 
day for 7 passages (14 days). 
Growth rate curves can be seen for each temperature in Figures 97, 98 and 99 
(Page 331 - Appendix). 
5.4.2 Chemical degradation of AZ at three temperatures 
No degradation of AZ was observed in the presence of bacteria at any of the 
three temperatures over a 24 hour period. In addition, no difference was 
observed in the absence of the bacterial community at 37 °C. As there was no 
change, intermediate timepoints were not analysed. Data showing the 
concentration at the beginning and end of the 24 hour degradation experiment 

























5.4.3 The effect of temperature on the selective endpoints of AZ 
ermF 
Figure 59A, B and C shows ermF as a function of AZ at 37, 28 and 20 °C, 
respectively. No LOEC was determined for ermF selection by AZ at 37 °C 
although significant selection to 90% confidence was observed at 10,000 µg/L 
(p = 0.0720, Dunn’s test). A significant increase in prevalence was observed in 
Figure 58: Degradation of AZ over a 24 hour period at 3 temperatures. No 
degradation of AZ was observed at any of the temperatures tested (20, 28 
and 37 °C). Presence or absence of bacteria did not affect the degradation. 
Three of five replicates were analysed and are presented here. Standard error 
is represented by the error bars. 
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comparison to the no antibiotic control at 100, 250, 500, 750 and 1,000 µg/L (p 
= 0.035, 0.0142, 0.0107, 0.0027, 0.0442, respectively, Dunn’s test) although 
none of these concentrations elevated the prevalence of ermF above the initial 
starting prevalence. At 20 and 28 °C, no significant positive selection was seen 
to occur at any concentration of AZ used. For 20 °C, however, a significant 
increase in prevalence, in comparison to the no antibiotic control, was observed 
to 95% confidence at 750 and 10,000 µg/L (p = 0.0371 and 0.0152, 
respectively, Dunn’s test) and to 90% confidence at 1,000 µg/L (p = 0.0971, 




Figure 59A: ermF as a function of AZ at 
37 °C. B: ermF as a function of AZ at 28 
°C. C: ermF as a function of AZ at 20 
°C. x = significant increase in comparison 
to the control to 90% confidence.  xx = 
significant increase in comparison to the 
control to 95% confidence.  * = significant 
positive selection to 90% confidence. 






Figure 60A, B and C shows the selection of mphA by AZ at 37, 28 and 20 °C, 
respectively. At 37 °C a LOEC of 750 µg/L of AZ was determined (p = 0.0212, 
Dunn’s test). Significant selection was also observed at every subsequent 
concentration tested. Running the experiment at 28 °C increased the LOEC to 
1,000 µg/L (p = 0.0174, Dunn’s test). A significant increase in prevalence to 
90% confidence in comparison to the no antibiotic control was, however, 
observed at 750 µg/L (p = 0.0758, Dunn’s test) although this did not increase 
over the initial prevalence of mphA at day 0. A LOEC of 10,000 µg/L was 
observed when the experiment was undertaken at 20 °C (p = 0.0003, Dunn’s 
test). Prevalence of mphA at day 14 at concentrations of 500, 750 and 1,000 
µg/L was significantly higher than the prevalence of mphA in the no antibiotic 
control (p = 0.0371, 0.0291 and 0.008, respectively, Dunn’s test), as with the 28 
°C experiment. This was not, however, significantly higher than the starting 











When only data from day 7 (28 and 37 °C experiments) or day 14 (20 °C 
experiment) from a limited range of concentrations are plotted, the correlation 
between the significant increase over the no antibiotic control at 20 and 28 °C 
and the positive selection observed for mphA observed at 37 °C is more 
evident. This can be seen in Figure 100 (Page 333 - Appendix). 
intI1 
Figure 61A, B and C shows intI1 selection by AZ at 37, 28 and 20 °C, 
respectively. At 37 °C, a LOEC of 750 µg/L was determined (p = 0.0274, Dunn’s 
test). Significant selection was also observed at the higher concentrations of 
1,000, 10,000 and 100,000 µg/L (p = 0.0186, 0.0008 and 0.0417, respectively, 
Dunn’s test). At 28 °C, no significant selection was observed until 100,000 µg/L 
Figure 60A: mphA as a function of AZ at 
37 °C. B: mphA as a function of AZ at 28 
°C. C: mphA as a function of AZ at 20 
°C. x = significant increase in comparison 
to the control to 90% confidence.  xx = 
significant increase in comparison to the 
control to 95% confidence.  ** = significant 
positive selection to 95% confidence. 





(p = 0.0394, Dunn’s test) and this, therefore, was defined as the LOEC. A LOEC 
of 100,000 µg/L of AZ was also determined for the experiment run at 20 °C (p = 
0.0350, Dunn’s test). 
 
5.5 Discussion 
5.5.1 Stability of AZ at three different temperatures 
The concentration of AZ did not decrease in any of the treatments undertaken. 
Temperature did not affect the degradation rate of AZ in this system as no 
degradation was observed at all over the 24 hour period. Furthermore, the 
presence or absence of a microbial community did not affect degradation rate.  
Figure 61A: Selection for intI1 in 
the presence of AZ at 37 °C. B: 
Selection for intI1 in the presence 
of AZ at 28 °C. C: Selection for intI1 
in the presence of AZ at 20 °C. ** = 
significant positive selection to 95% 
confidence. Standard error is 




AZ is synthesised as a semi-synthetic derivative of erythromycin with greater 
stability than the parent compound, although this is in regards to stability in 
acidic conditions and not temperature effect (Lode et al. 1996). Furthermore, AZ 
is known for its low removal rates in WWTPs (Čizmić et al. 2019). It could, 
therefore, be expected that AZ would be extremely stable with minimal 
degradation over a 24 hour period regardless of the temperature it was exposed 
to.  
There are many genes that confer macrolide resistance. A number of these 
resistance mechanisms work by enzymatically modifying the compound (Golkar 
et al. 2018) and it would be expected, therefore, that more degradation would 
be observed in the samples with bacteria present in comparison to the abiotic 
control. This, however, proved not to be the case. It could be assumed, 
therefore, that other macrolide resistance mechanisms, such as efflux pumps 
(Roberts 2008) or base substitution in the 23S rRNA subunit of the ribosome 
(Vester & Douthwaite 2001), play a larger role in phenotypic resistance in this 
system than resistance genes that enzymatically degrade AZ. 
5.5.2 Effect of temperature on selective endpoints 
When investigating the selection of ermF, mphA and intI1 by AZ there appeared 
to be a trend with all three of these genes: that the selective ability of AZ 
decreased with decreasing temperature. The selective endpoint for 20 and 28 
°C, therefore, was higher than that at 37 °C in regards to all genes tested. This, 
therefore, appears to be consistent with the data presented in MacFadden et 
al., 2018 which determined that an increase in clinical resistance was observed 
with higher local temperatures within the United States (MacFadden et al. 
2018). It also is consistent with another study that observed a decrease in MIC 
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of various antibiotics to Pseudomonas maltophilia with increasing temperature 
to 37 °C from 30 °C (Wheat et al. 1985). 
These results suggest, therefore, that the assay used in the experiments 
presented here and in Chapters 3 and 4 may be most protective in terms of 
selective endpoints for bacteria that are likely to be human associated being 
favoured by growth at 37 °C. However, only 2 macrolide resistance genes and 
intI1 were targeted by qPCR in the experiment reported here. There are many 
other genes that confer macrolide resistance that were not targeted (Roberts 
2008). Previous data has shown that bacterial community structure is 
significantly affected by temperature. For example, one study determined that 
temperature had a significant effect on bacterial diversity from biomat, soil and 
sediment samples obtained from geothermal sites in New Zealand and Canada. 
The highest bacterial diversity was observed at 24 °C with decreasing diversity 
observed with both an increase and decrease in temperature (Sharp et al. 
2014). A difference in the bacterial species dominating in the experiments run at 
different temperatures may mean that different resistance genes are harboured 
in these communities at 20 and 28 °C in comparison to those in the 37 °C 
experiment. Whilst mphA, ermF and intI1 were not selected for at similar 
concentrations in the lower temperature experiments, other resistance genes 
may be.  
5.5.3 An inoculum effect on selective endpoints 
As with the macrolide work undertaken in Chapter 4, an inoculum effect was 
observed when using the Falmouth/Penryn 2017 wastewater here in 
comparison to the Falmouth/Penryn 2015 wastewater used in Chapter 3. For 
the mphA and intI1 data presented in this chapter, LOECs were determined to 
241 
 
be 750 µg/L of AZ at 37 °C, whereas a LOEC of 1,000 µg/L was observed for 
mphA in Chapter 3 and although no LOEC was determined for intI1, significant 
selection to 90% confidence was observed at 1,000 µg/L. The LOECs run as 
part of the experiments presented here, therefore, have reduced by a quarter, 
but were still significantly higher than environmental concentrations.  
For ermF, a lower initial prevalence was observed in the 37 °C experiment in 
comparison to the 20 and 28 °C experiments, although steps were undertaken 
when setting up the selection experiment to ensure that the starting inoculum 
for all three experiments was homogenised. No LOEC was able to be 
determined and significant positive selection was only observed to 90% 
confidence at 10,000 µg/L. This was 10-fold higher than the LOEC determined 
in Chapter 3 for the selection of ermF by AZ. The lower starting prevalence of 
ermF in the 37 °C experiment might explain the higher concentration needed to 
see positive selection. A low starting prevalence of the bacterial species 
harbouring these genes may mean that they were outcompeted by other 
species carrying different resistance genes during the experimental period.  
5.5.4. Sub-MSC trends 
When changes in mphA prevalence at the end of the selection experiment, 
relative to the no antibiotic control, were examined in more detail (Figure 100, 
Page 333 - Appendix), significant changes in prevalence were observed at 20 
and 28 °C at some of the same concentrations at which positive selection was 
observed at 37 °C. For example, significant positive selection was observed at 
750, 1,000, 10,000 and 100,000 µg/L of AZ at 37 °C. At 28 °C, significant 
positive selection was first observed at 1,000 µg/L, but a significant increase in 
prevalence, in comparison to the no antibiotic control, was seen at 750 µg/L. 
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This was not higher than the starting prevalence. Similarly, at 20 °C, significant 
positive selection was observed at 10,000 and 100,000 µg/L of AZ, but a 
significant increase in prevalence, in comparison to the no antibiotic control, 
was observed at 500, 750 and 1,000 µg/L. Again, this was not higher than the 
starting prevalence. 
This suggests that some form of selection for mphA at 20 and 28 °C was 
occurring at concentrations similar to where positive selection was observed at 
37 °C but at a reduced level and not above the starting prevalence of mphA. 
This may be as a result of competition with other resistant species which may 
carry different resistance mechanisms that survive better at the different 
temperatures at which the experiments were undertaken. 
5.5.5 Future work 
In order to further understand the effect of temperature on selective endpoints 
the next steps undertaken should be to use metagenome analysis on the DNA 
from the selection experiment presented above. From this, it will be possible to 
identify additional candidate gene targets for qPCR that are enriched at different 
temperatures in the presence of AZ. The qPCR targets chosen so far and 
presented here were based on results from the experiments run at 37 °C that 
are presented in Chapter 3. As different bacterial species are able to survive 
under different conditions (such as different temperatures) it follows that 
different resistance genes may be harboured in these different species of 
bacteria. By undertaking metagenome analysis it will be possible to determine 
overall MLS resistance as a function of the AZ concentrations and to determine 
changes in species diversity with temperature (as was undertaken in Chapter 3, 
Section 3.4.4.4). It will then be possible to identify the specific gene or genes 
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responsible for this response at 20 and 28 °C. Only then will it be possible to 
determine how temperature effects the selection for total resistance elements of 
a bacterial community. 
5.6 Conclusion 
Although preliminary data appears to determine that AZ becomes less selective 
with decreasing temperature, more work needs to be undertaken to investigate 
the effect AZ has on other macrolide resistance genes at the three 
temperatures tested. Examination of differential rates of negative selection 
illustrated an increase in several gene targets at 20 and 28 °C, relative to the no 
antibiotic control, at the same AZ concentration as observed LOECs for positive 
selection at 37 °C. This also raises questions relating to LOEC/MSCs being the 
most appropriate endpoint for environmental protection. This is discussed 











Chapter 6: A comparison of methods for determining 
selective endpoints for antibiotic resistance 
Author contribution 
The author undertook all experiments in this chapter, under the supervision of 
named supervisors. Samples for metagenome sequencing were sent to Exeter 
Sequencing Service where library preparation and sequencing was undertaken. 
Raw sequence reads had adaptor sequences removed by Exeter Sequencing 
Service. All subsequence analysis was undertaken by the author. 
6.1 Abstract 
A number of studies have investigated the selective effects of low 
concentrations of antibiotics. Two of these studies investigated the selective 
effect of tetracycline (Lundström et al. 2016) and of ciprofloxacin (Kraupner et 
al. 2018) in a complex microbial community and used experimental methods 
attempting to replicate environmental conditions, such as low temperature and 
low nutrient content. The aim of the research reported in this chapter was, 
therefore, to investigate whether the high temperature / nutrient method used 
here was comparable to the more environmentally relevant, but less controlled, 
methods of previously published studies.  
A selection experiment using a range of tetracycline concentrations was 
undertaken to compare selection experiments presented in this thesis to the 
biofilm system used in Lundström et al. 2016. When analysing the data using 
just tetG prevalence at day 7, a significant difference, compared to the no 
antibiotic control, was seen at 1, 10 and 100 µg/L of tetracycline. This correlates 
with the Lundström et al. 2016 data. When investigating the data using both day 
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0 and day 7, however, as undertaken in investigations reported in this thesis, a 
decrease in prevalence of tetG was observed at every concentration tested. 
Instead of positive selection occurring, a decrease in negative selection or an 
increase in persistence of tetG was observed to be occurring at 1, 10 and 100 
µg/L of tetracycline.  
As a result of this lack of positive selection, a larger selection experiment was 
carried out to determine a minimal selective concentration (MSC) and lowest 
observable effect concentration (LOEC) of tetracycline. The LOEC determined 
by intI1 was 2,000 µg/L and the MSC was approximately 651 µg/L. 
Metagenome analysis showed an increase in total TET resistance genes at 125 
µg/L and at every higher concentration tested. No samples from lower 
concentrations were sent for sequencing, so it is conceivable, therefore, that a 
significant increase over the control is also occurred at lower concentrations. 
Metagenome data was also used to identify significant increases for individual 
TET resistance genes not targeted by qPCR. Further analysis of these genes 
will need to be undertaken to establish an accurate LOEC and MSC for TET. 
Although the phenomenon of increased persistence is less of an environmental 
concern than if positive selection occurs, it does increase the total number of 
resistant bacteria found in the environment relative to no antibiotics being 
present. The potential for horizontal gene transfer and the risk of human 
exposure to these genes are, therefore, also increased. A new selective term is 
proposed – minimal increased persistence concentration (MIPC). 
6.2 Introduction 
A minimal selective concentration (MSC) is defined as the lowest concentration 
of an antibiotic or co-selective agent “where the resistant mutant is enriched 
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over the susceptible strain” (Andersson & Hughes 2011). In other words, the 
concentration at which positive selection for the resistant strain or resistance 
gene is observed.  
There are a small number of studies, described briefly in Chapter 1, which used 
a variety of methods to investigate antibiotic MSCs. This introduction sets out a 
detailed description of currently published methods and a discussion of the 
limitations surrounding each assay used to determine selective endpoints. The 
rationale behind these studies was to investigate whether positive selection 
occurs in the environment, at environmental concentrations of antibiotics, and 
whether protective measures need to be implemented to reduce current 
measured environmental concentrations (MECs) and, in turn, reduce selection 
for antibiotic resistance.  
The first two studies to investigate the potential selective effects of sub-
minimum inhibitory concentrations (MICs) of antibiotics were Gullberg et al. 
2011 and Gullberg et al. 2014. In the 2011 study, Escherichia coli and 
Salmonella enterica were used in competition assays where susceptible and 
resistant strains of the same bacteria were competed at various concentrations 
of antibiotics in rich media. The antibiotics tested were aminoglycosides, 
fluoroquinolones and tetracyclines with corresponding resistant mutants which 
carried an appropriate chromosomal mutation. Both susceptible and resistant 
strains were tagged with different fluorescent markers and were quantified by 
flow cytometry. The authors were able to determine a MSC for each resistant 
strain at various concentrations of antibiotics by calculating selection 
coefficients, plotting these against antibiotic concentration, finding the line of 
best fit and calculating where this line crossed the x axis. The MSCs ranged 
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from 1/4 to 1/230 of the MIC of the susceptible bacterium. The absolute MSC 
values ranged from 1,000 µg/L of streptomycin to 0.1 µg/L of ciprofloxacin.  
The 2014 study used the same approach, competing a susceptible E. coli 
against a resistant E. coli harbouring plasmid borne resistance genes, instead 
of chromosomal resistance. This study tested 4 antibiotic compounds: 
erythromycin, kanamycin, tetracycline and trimethoprim. Both susceptible and 
resistant strains were fluorescently tagged and change in prevalence of 
resistance in the population was observed over time using flow cytometry. As 
with the 2011 study, selection was observed at sub-MIC concentrations for all 
antibiotics test. These concentrations ranged from 1/17 to 2/3 of the MIC for 
trimethoprim and kanamycin, respectively. This equated to concentrations of 33 
µg/L and 470 µg/L of antibiotic, respectively.  
Limitations of this work are centred on the environmental relevance of both 
studies which comprised experiments that used a single species and competed 
a susceptible bacterial strain against a resistant mutant. Single species are 
never found in isolation, with mixed communities of varied species found 
throughout environmental settings. The broth used (Muller Hinton) was nutrient 
rich and not representative of the nutrient content of many environmental 
settings. Although these studies were a valuable first step in understanding 
selection at low, environmentally relevant concentrations of antibiotics, this data 
may not be representative of what happens in the natural environment. It may, 
therefore, not provide the most appropriate endpoints when determining safe 
release levels of antibiotics from wastewater treatment plants (WWTPs) 




A study by Bengtsson-Palme & Larsson in 2016 used a mathematical approach 
to calculate concentrations that could potentially select for resistance and 
suggested these could be used as safe release concentrations of antibiotics into 
the environment. This mathematical methodology obtained MIC values for all 
antibiotics found in the EUCAST database and identified the lowest 1%. Values 
were adjusted where a limited number of species were tested and, by applying 
a 10-fold assessment factor to all values, predicted no effect concentrations for 
the selection of resistance (PNECRs) were calculated. The application of an 
assessment factor was to allow for the difference between MICs and MSCs. 
This study calculated PNECR values for 111 antibiotics found on the EUCAST 
database and 11 combinations of antibiotics. The PNECRs ranged from 0.008 
µg/L to 64 µg/L for itraconazole and nitrofurantoin, respectively. This 
concentration range was lower than the range of MSCs established by both 
Gullberg et al., 2011 and Gullberg et al., 2014 (0.1 to 1,000 µg/L), although 
there was crossover between the two approaches. 
This method defined endpoints for all antibiotics and combinations of antibiotics 
on the EUCAST database and is intended, according to the study, to inform and 
aid regulators in implementing mitigation strategies to reduce the risk of the 
development of environmental antibiotic resistance. The EUCAST MIC values, 
and hence the PNECR values calculated, are, however, based on inhibitory 
thresholds for clinical bacterial strains, rather than selective thresholds in 
environmental bacteria. This, therefore, brings into question the relevance of 
these values with reference to environmental discharge limits. Further, the 
method used is a purely mathematical approach and, as the authors did note, 
experimental work determining MSCs for individual compounds, using complex 
microbial communities, should also be undertaken to better refine safe antibiotic 
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discharge limits and validate the values calculated in the Bengtsson-Palme & 
Larsson 2016 study. The same group has continued this work by undertaking 
such experiments using complex microbial communities (Lundström et al. 2016; 
Kraupner et al. 2018). 
Lundström et al. 2016 used a variety of methods (metagenome analysis, colony 
forming unit counts, MIC of isolates, pollution induced community tolerance 
assay, functional diversity and qPCR) to investigate the effect of low tetracycline 
(TET) concentrations on a complex microbial community. QPCR was reported 
as the most sensitive assay to calculate the MSC of TET. The authors used a 
complex community from sewage effluent to establish a biofilm in a flow through 
system. The experiment was conducted at 20 °C with a constant inflow of 
nutrient, antibiotic and inoculum and the resulting nutrient concentration in the 
aquaria was approximately 1/60 R2A broth. Biofilms were harvested after 9 
days and tetA and tetG prevalence was quantified using qPCR (normalised to 
the 16S rRNA gene). An increase in both tetA and tetG prevalence was 
observed at 1 and 10 µg/L compared to the no antibiotic controls. These 
concentrations are in the same range as current MECs of tetracycline 
(Lundström et al. 2016). 
Kraupner et al. 2018 investigated the selective potential of ciprofloxacin. They 
investigated both a test tube system (run at 25°C in 10X diluted R2A broth) and 
the same biofilm flow through system described above, to compare the results 
of each system. Both in the biofilm and test tube system, plating was used to 
isolate E. coli from the community and to calculate the percentage of resistant 
E. coli to find which concentration of TET was selecting for resistance in 
comparison to the no antibiotic control. Using the biofilm system, a significant 
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difference in the percentage of resistant E. coli was observed at 10 µg/L of 
ciprofloxacin, but not at 1 µg/L. Although the test tube system saw a significant 
reduction in community diversity, similar MSCs were determined for 
ciprofloxacin in comparison to the biofilm system. In the test tube system, a 
significant difference was observed at 5 µg/L but not at 1µg/L but it should be 
noted that 5 µg/L was not tested in the biofilm experiment. 
The main limitation of both studies was that the prevalence of the resistance 
genes at the beginning of their experiment in the original inoculum were not 
quantified (Murray et al. 2018). As a result, they were unable to determine 
whether positive selection was occurring. A comparison to the no antibiotic 
control is important; as key information about the change of prevalence of the 
genes tested over time is missing from these studies. Another flaw in their 
methodology is that in order to maintain the biofilm it was necessary to 
constantly input bacteria from the raw, unevolved inoculum into their 
experimental system. It is not, therefore, possible to determine whether the 
increase in resistance observed, relative to the no antibiotic control, is due to 
selection in the biofilm or introduction of resistant bacteria into the biofilm 
population during the experiment. 
Two studies, Murray et al. 2018 and Stanton et al., 2019, both used the same 
methods. These methods were selection experiments using a complex 
microbial community as described in Chapter 2. Both studies analysed class 
specific resistance genes and, in the case of Stanton et al., 2019, intI1 gene 
prevalence using qPCR. The change in prevalence of these genes at the 
beginning and the end of the selection experiment was determined.  
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The study by Murray et al. 2018 investigated the selective potential of 
cefotaxime in a complex microbial community. Following metagenome analysis 
to identify a suitable gene target, the authors quantified blaCTX-M prevalence 
using qPCR (normalised to 16S rRNA copy number) and determined a MSC for 
cefotaxime of 0.4 µg/L. 
Stanton et al., 2019 investigated the selective potential of 2 classes of 
compounds that have been placed on the European Commission’s Water 
Framework Directive’s Priority Watch List (European Commission 2015a; 
European Commission 2018) due to their toxicity to aquatic organisms. These 
were three macrolide antibiotics (azithromycin (AZ), clarithromycin (CLA) and 
erythromycin (ERY)) and ciprofloxacin. LOECs, using the macrolide specific 
ermF resistance gene, were determined for AZ, CLA and ERY as 1,000, 750 
and 1,000 µg/L, respectively, and a MSC of 514 µg/L was determined for ERY 
(Chapter 3). This study also investigated the selective potential of ciprofloxacin. 
The intI1 gene was used to determine a MSC of 10.5 µg/L and a LOEC of 
15.625 µg/L of ciprofloxacin.  
The methods used in Murray et al. 2018 and Stanton et al., 2019 and 
throughout this thesis, although more environmentally relevant than Gullberg et 
al. 2011, Gullberg et al. 2014 and Bengtsson-Palme & Larsson 2016 could be 
argued to be less environmentally relevant than the biofilm flow through system 
used in Lundström et al. 2016 and Kraupner et al. 2018 which used a low 
growth medium and lower temperatures, more representative of environmental 
conditions, as opposed to the experiments reported in this thesis, all of which 
used a rich nutrient broth at 37 °C. However, as described previously there are 
major limitations to the biofilm flow through system. 
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The aim of research reported in this chapter was to determine whether the 
experimental set up used here gave comparable results to the more 
“environmentally realistic” method used by Lundström et al. 2016 and Kraupner 
et al. 2018. The initial part of the work presented in this chapter was conducted 
in 2016, before the study from Kraupner et al. 2018 was published, and, 
therefore, replicated the experiment in Lundström et al. 2016 using TET as the 
study compound. This work aimed to determine a MSC for TET using the 
resistance gene tetG as an endpoint using the selection experiment 
methodology described in Chapter 2.  
A subsequent aim of this chapter was to determine a MSC for TET.  
6.3 Methods 
6.3.1 Antibiotics and antibiotic concentrations tested 
6.3.1.1 Comparison of in vitro tests for determining MSCs 
Tetracycline hydrochloride (Fisher), dissolved in water and sterilised using a 
0.22 µm filter, was used at concentrations of 0.1, 1, 10 and 100 µg/L. This was 
to test a more extended range of TET concentrations than that used in the study 
by Lundström et al. 2016. 
6.3.1.2 Determining a MSC for tetracycline 
Tetracycline hydrochloride was prepared and sterilised by the same method 
described in Section 6.3.1.1. In this experiment, a wide concentration range was 
targeted. The literature was searched in order to find an MIC or breakpoint for 
Enterobacteriacae as a highest concentration. The article “Determination of 
minimum inhibitory concentrations” suggested a concentration range of TET at 
which MICs of TET for Enterobacteriacae might be expected to be seen 
(Andrews 2001). 128,000 µg/L was the top concentration suggested and was, 
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therefore, used as the top concentration of TET in this experiment and a 2-fold 
serial dilution was undertaken down to the concentration 0.9765625 µg/L 
(comparable to the concentration range undertaken in Lundström et al., 2016). 
6.3.2 Selection experiment 
As the concentration range (presented in Section 6.3.1.2) was large, it was 
necessary to split this experiment into two halves. The high TET concentrations 
were set up in the morning and the low concentrations in the afternoon of the 
same day. This enabled the period of time between the bacteria being exposed 
to the concentration of antibiotic and the day 0 samples being frozen to be 
minimised, which therefore minimised the variation in prevalence of genes 
tested in the day 0 samples. Sufficient bacterial culture for both halves of the 
experiment was defrosted. These were mixed together to ensure a 
homogenised inoculum. Whilst the first half of the experiment was being set up, 
the rest of the inoculum was stored at 4 °C to minimise growth and change in 
community structure. 
Each half of this experiment had its own no antibiotic control to account for any 
community structure change whilst the inoculum was stored. 
6.3.3 QPCR targets 
6.3.3.1 Comparison of in vivo tests for determining MSCs 
The only qPCR targets used here were the tetracycline resistant tetG gene, 
alongside the 16S rRNA gene to determine prevalence. This was one of two of 
the genes targeted by qPCR in the Lundström et al. 2016 study. 
6.3.3.2 Determining a MSC for tetracycline 
TetG was, once again, tested alongside tetM (which encodes a ribosomal 
protection protein) and intI1. TetG was chosen as it was used in Lundström et 
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al., 2016. Lundström et al. 2016 chose tetG as a qPCR target as this gene 
showed one of the strongest correlations to TET concentration from 
metagenome data produced and presented in the same study. TetM was 
chosen as it has been previously described as a genetic indicator for 
tetracycline resistance in the environment (Berendonk et al. 2015). IntI1 was 
chosen as it has been described as a good proxy for the presence of antibiotic 
resistance genes in the environment (Gaze et al. 2011; Gillings et al. 2015). 
Two sets of primers for tetA were also tested, the first from Lundström et al. 
2016 (tetA (1) – Table 2, Section 2.4.1) and the second from Zhu et al., 2017 
(tetA (2) - Table 2, Section 2.4.1). Neither of these primer sets are presented 
here as it was not possible to determine specific melt curves for either despite 
trying different primer concentrations and annealing temperatures. 
6.3.4 Data analysis 
The post-hoc tests (Dunnett’s/Dunn’s) were undertaken in relation to each half 
of the experiment described in Sections 6.3.1.2 and 6.3.2, comparing each half 
to its own no antibiotic control.  
6.4 Results 
6.4.1 Comparison of in vitro tests for determining MSCs 
An experiment targeting a small range of concentrations was undertaken to 
determine if the selection experiment, used for all experiments presented in 
thesis, was comparable to the biofilm system presented in Lundström et al. 
2016.  
The results from this experiment can be seen in Figure 62. When the data was 
interrogated in the same way as Lundström et al. 2016 (without plotting the 
initial tetG prevalence) a dose response between tetG prevalence and 
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tetracycline was seen. This is presented in Figure 62A. Statistical analysis 
showed a significant difference in prevalence, compared to the no antibiotic 
control, to 90% confidence at 1 µg/L (p = 0.0784, Dunn’s test), 10 µg/L (p = 
0.0658, Dunn’s test) and 100 µg/L (p = 0.0784, Dunn’s test). If, however, the 
starting prevalence of tetG is plotted alongside the day 7 prevalence (Figure 
62B) no significant positive selection was observed over the 7 day period for 
tetG at any TET concentration tested (0.1, 1, 10 & 100 µg/L). The average 
prevalence at day 0, in all of the replicates of every concentration, was 0.0096 
and the highest prevalence of all of the replicates at any concentration at the 
end of the 7 day experimental period was 0.0000043 (>1,000 times decrease). 
As the prevalence at day 7 is vastly lower than that at day 0, it cannot be 
visualised on Figure 62B, although it has been plotted. The significant 
difference between those samples treated with 1, 10 and 100 µg/L of TET and 
the no antibiotic control showed a decreased rate of negative selection; in other 
















Plotting only the day 7 prevalence of tetG (Figure 62A) gave comparable results 
to the effect observed and presented in Lundström et al., 2016 (Figure 63) 
although as the prevalence of tetG in the starting inoculum was not quantified in 
their biofilm experiment, it is not possible to say with certainty that what they 





Figure 62: TetG as a function of TET concentrations. A: Graph shows 
only the day 7 prevalence data. B: Graph shows the prevalence data from 
both days, although prevalence of tetG at the end of the experiment is so 
low that this cannot be observed on the graph. Please note that these 
graphs are on different axes as the day 7 data (A) cannot be visualised 
otherwise. Standard error is represented by the error bars. x = a significant 















If the selection experiment data is plotted as a selection coefficient, the line of 
best fit (polynomial order 2, y = -1.7 + 0.038x – 0.0038x2, R2 = 0.007067, 
standard error = 0.4041) never crosses the x axis as no positive selection was 





This image has been removed by the author 
of this thesis for copyright reasons. 
Figure 63: TetG as a function of TET concentrations 
in a biofilm flow through system. Reproduced from 
Lundström et al. 2016. * = p <0.05, *** = p < 0.001. A one 
– tailed Student’s t-test was used on log2 transformed 
















It was impossible, therefore, to determine a MSC or LOEC for positive selection 
from this data set. 
6.4.2 Determining a MSC for tetracycline 
As the definition of a MSC is the concentration at which “the resistant mutant is 
enriched over the susceptible strain” (Andersson & Hughes 2011), the results 
presented above and in Lundström et al. 2016 may not be true MSCs. No 
positive selection was demonstrated; rather differential rates of negative 
selection or increased persistence are likely to account for the TET result. A 
Figure 64: Selection coefficient of tetG by TET.  The square 
root of tetracycline concentration was plotted. Absolute 
concentrations represented by this graph are 0, 0.1, 1, 10 and 
100 µg/L of TET. The blue line is the polynomial line of best fit 
(order 2), the grey shading represents the confidence intervals 




wider range of TET concentrations were, therefore, tested in order to determine 
the MSC. 
6.4.2.1 qPCR analysis 
A number of targets were used for qPCR analysis. These were intI1, tetM and 
tetG. The qPCR data sets presented here are split into the two halves in which 
they were undertaken and statistical comparison is to the relevant no antibiotic 
control. For determining selection coefficients, the datasets from the two halves 
of the experiment were grouped together where appropriate. This allowed a line 
















TetG was also tested for this dataset with the aim of determining a LOEC and a 
MSC for this gene at higher concentrations than those tested in Section 6.4.1. 
For both halves of this experiment, however, no positive selection was observed 
for tetG. This can be seen in Figure 65. It was impossible, therefore, to 









Figure 65: TetG as a function of a large range of TET concentrations. The 
low range of concentrations are represented in 65A and the high in 65B. Two 
high outlier replicates have been removed from the 3.90625 µg/L sample and 




If only the day 7 data are displayed, as in Section 6.4.1, increase in persistence, 
or decreased negative selection, was once again observed. This time, however, 
there was no distinct dose response pattern to this increase. At the low 
concentrations of TET, a significant increase in persistence was observed 
compared to the no antibiotic control at 3.90625, 7.8125, 15.625, 31.25 and 250 
µg/L (p = 0.0254, 0.0003, 0.0009, 0.0230 and 0.0310, respectively, Dunn’s 
test). No increase in comparison to the no antibiotic control was observed at 





Figure 66: TetG as a function of low TET concentrations – 
day 7 only. Standard error is represented by the error bars. xx 
= significant persistence to 95% confidence. 
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At higher concentrations of TET, a significant increase compared to the no 
antibiotic control was only observed at 8,000 µg/L (p = 0.0413, Dunn’s test). 




If a selection coefficient graph is plotted, the line of best fit never crossed the x 
axis and, therefore, as in Section 6.4.1, positive selection was never occurring. 
This can be seen in Figure 101 (Page 334 - Appendix). 
 
 
Figure 67: TetG as a function of high TET concentrations – day 7 only. 
Standard error is represented by the error bars. xx = significant persistence 




As with tetG, no positive selection was observed for tetM as a result of 
exposure to lower TET concentrations. An increase in prevalence was seen, 








Figure 68: TetM as a function of low TET concentrations. 
Standard error is represented by the error bars.  
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With the higher TET concentrations, no significant selection was seen at any of 
the TET concentrations, compared to the no antibiotic control, except at 
128,000 µg/L (p = 0.0376, Dunn’s test). The LOEC (lowest observable effect 
concentration) was 128,000 µg/L and a NOEC (no observable effect 
concentration) was 64,000 µg/L. Again, an increase in tetM over time was seen 












No MSC was able to be determined because an increase was observed at each 
concentration, including the no antibiotic control. The line of best fit, therefore, 
never crossed the x axis. The selection coefficient graph can be seen in Figure 
102 (Page 335 - Appendix).  
 
Figure 69: TetM as a function of high TET concentrations. 
Standard error is represented by the error bars. ** = significant 




No significant increase in intI1 was seen in comparison to the no antibiotic 
control at any concentration of TET tested in the low concentration experiment, 
although a biological effect appears to occur at 250 µg/L. As a result of 
variability of prevalence between the replicates, this is not statistically significant 











Figure 71 shows the response of intI1 to the higher concentrations of TET 
tested. No significant increase in intI1 was seen at concentrations of 500 and 
1,000 µg/L. A significant increase was seen to 95% confidence at the 
concentrations of TET of 2,000, 4,000, 8,000, 16,000, 32,000 and 128,000 (p = 
0.0127, 0.0207, 0.0008, 0.0015, 0.0342 and 0.0001, respectively, Dunn’s test) 
Figure 70: IntI1 as a function of low TET 
concentrations. Standard error is represented by the 
error bars.  
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and to 90% confidence at 64,000 (p = 0.0859, Dunn’s test). The LOEC was, 





A MSC was determined as approximately 651 µg/L (Figure 72). To get the most 
accurate and protective MSC, only a subset of concentrations were used and 
the line of best fit (polynomial order 2, y = -0.15 + 0.00027x – 6.1e-08x2, R2 = 
0.3024, standard error = 0.156, x intercept = 651.43) was plotted. The 
concentrations of TET plotted here are 62.5, 125, 250, 500, 1,000 and 2,000 
µg/L. As a result of the natural variation in the biological replicates, it is only 
possible to determine an approximation for the MSC value. 
Figure 71: IntI1 as a function of high TET concentrations. Standard error 
is represented by the error bars. * = significant positive selection to 90% 
















6.4.2.2 Metagenome analysis 
As the lowest MSC and LOEC were both determined by intI1, and not by a 
class specific resistance gene, a subset of samples from the selection 
experiment were sent for metagenome sequencing to identify possible new 
class specific targets that were being selected for but which had not been 
targeted by qPCR. Three replicates were chosen with the highest intI1 
prevalence from the concentrations 125, 250, 500, 1,000, 2,000, 4,000, 8,000 
and 16,000 µg/L as well as three replicates from the no antibiotic controls from 
each half of the experiment. As intI1 showed the lowest effect, it was presumed 
Figure 72: Selection coefficient of intI1 by TET. A reduced range of 
concentrations ranging from 62.5 to 2,000 µg/L of TET is plotted here to 
make the line of best fit more accurate and the most protective. The blue line 
is the polynomial line of best fit (order 2), the grey shading represents the 
confidence intervals and the purple points represent the selection coefficients 
for each replicate. 
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that selection for other class specific genes was occurring around this 
concentration range and that these had not previously been targeted by qPCR. 
By undertaking metagenome analysis, it was hoped that other TET specific 
resistance genes could be identified. 
Overall tetracycline resistance 
ARGs-OAP identifies antibiotic class and subtype. First, the sum of all detected 
tetracycline genes was analysed. A significant increase in TET resistance 
genes occurred at every concentration of TET tested, relative to the appropriate 
no antibiotic control. Significant increase was seen to 90% confidence at 2,000 
µg/L (p = 0.06782, Dunnett’s test) and to 95% confidence at 125, 250, 500, 
1,000, 4,000, 8,000 and 16,000 µg/L (p = 0.0107, 0.050, 0.01283, 0.02658, 
0.01006, 0.00609, 0.00884, respectively, Dunnett’s test). This can be seen in 










Figure 73: Tetracycline resistance gene prevalence from 
metagenome analysis as a function of TET concentration. 
Standard error is represented by the error bars. ** = 
significance to 95% confidence. 
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Tetracycline resistance genes by subtype 
A number of specific TET resistance genes increased in prevalence, compared 
to the no antibiotic control, at concentrations lower than the current qPCR 
LOEC determined by intI1 (2,000 µg/L). The results showing the effect on all 
genes on the ARG-OAP database can be seen in the heatmap in Figure 103 
(Page 336 - Appendix).  
The genes that significantly increased at the lowest concentration of TET were 
tetW (which encodes a ribosomal protection protein) (Figure 74), tetA (Figure 
75) and tet32 (which encodes a ribosomal protection protein) (Figure 76). TetW 
saw a significant increase at the lowest concentration sequenced at 125 µg/L (p 
= 0.0032, Dunn’s test) and at every concentration tested except 2,000 µg/L, 
although a biological effect was observed here. Without testing the lower 
concentrations, it is unclear if this was the lowest concentration at which tetW 














TetA (p = 0.00245, Dunnett’s test) and tet32 (p = 0.0169, Dunn’s test) both 
significantly increased in prevalence at 250 µg/L of TET, compared to the no 
antibiotic control. Biological effects were also seen for both of these genes at 
125 µg/L, but statistical significance was not observed. The response that tetA 
had to TET best mimics the response observed to overall TET resistance 
(Figure 73). A significant increase was seen at every subsequent concentration 
of TET except 4,000 and 8,000 µg/L, although biological effects were observed 
at these concentrations in comparison to the no antibiotic control. 
 
Figure 74: TetW as a function of TET concentration. Standard error is 
represented by the error bars. * = significance to 90% confidence. ** = 








For tet32, a significant increase in prevalence was observed in comparison to 
the no antibiotic control at 250 µg/L and every higher concentration except 
1,000 µg/L. A biological effect was observed at 1,000 µg/L in comparison to the 
no antibiotic control but, as variation between replicates was high, it was not 
found to be statistically significant. 
 
 
Figure 75: TetA as a function of TET concentration. Standard 
error is represented by the error bars. * = significance to 90% 







Other TET specific genes significantly increased at concentrations lower than 
the current LOEC (based on the intI1 qPCR data). These were tetJ and tetL, 
both of which encode efflux pumps, and tetO and tetQ, both of which encode a 
ribosomal protection protein. TetJ significantly increased at 1,000 µg/L only (to 
90% confidence) (p = 0.0941, Dunn’s test). TetL and tetO significantly 
increased, in comparison to the control, at 500 µg/L (p = 0.0242 and 0.0436, 
respectively, Dunn’s test) and, for tetO at most, and for tetL at all, TET 
concentrations higher than this. The prevalence of tetQ significantly increased 
Figure 76: Tet32 as a function of TET concentration. Standard error is 
represented by the error bars. * = significance to 90% confidence. ** = 
significance to 95% confidence. 
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(to 90% confidence), compared to the no antibiotic control, at 1,000 µg/L (p = 
0.05, Dunn’s test) and at all higher concentrations except 2,000 µg/L. 
Co-selection for antibiotic resistance gene classes by TET 
Other data that can be determined from the metagenome datasets was the co-
selective potential of TET, see Figure 104 (Page 337 - Appendix). Co-selection 
for aminoglycosides, bleomycin and trimethoprim is determined at the lowest 
concentration of TET sequenced (125 µg/L). 
6.5 Discussion 
6.5.1 A comparison of in vitro experiments 
The biofilm flow through system used by Lundström et al. 2016 and Kraupner et 
al. 2018 is a complicated method to determine selective endpoints. As 
demonstrated in the paper by Bengtsson-Palme & Larsson 2016, there are a 
high number of antimicrobial compounds and a significant number of clinical 
combinations of antimicrobials that require testing for their selective potential. 
To perform biofilm experiments with enough replication would be a labour 
intensive task. In addition, the flow cells are “open” with inoculum continually 
entering the biofilm. The selection experiment methodology presented in this 
thesis, and in Murray et al. 2018 and Stanton et al., 2019, are simpler and less 
labour intensive making it more appropriate for routine risk assessment. It was 
important, however, to compare this method to the biofilm methodology used 
previously.  
When only the prevalence at day 7 was considered, the TET selection 
experiment reported here produced comparable data to that reported in 
Lundström et al. 2016. The TET resistance gene tetG illustrated a significant 
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increase in prevalence at 1, 10 and 100 µg/L compared to the no antibiotic 
control. In Lundström et al. 2016, a significant increase was also seen at 1 and 
10 µg/L compared to the control. When interpreting the tetG data, by including 
the starting prevalence of the gene, however, a significant reduction in 
prevalence was observed at every TET concentration tested over the 7 day 
experimental period. To fully understand the data and the selective effect of the 
test antibiotic, it is clearly important to determine the prevalence of the 
resistance gene in the original inoculum. What was being observed here can be 
described in two ways: either, a reduction in the rate of negative selection of 
tetG at the concentrations of 1, 10 and 100 µg/L of TET relative to the no 
antibiotic control; or the increased persistence of tetG. The results from both the 
preliminary experiment that was undertaken for comparative purposes to 
Lundström et al., 2016 reported in Section 6.4.1 and that in the full TET 
experiment presented in Section 6.4.2 aligned reasonably well with each other 
at low TET concentrations. A significant increase in prevalence was first 
observed at 1 µg/L of TET in the preliminary experiment, whereas in the full 
TET experiment reported in Section 6.4.2 it was observed at 3.90625 µg/L. A 
slight difference in where significance is first observed may be expected as 
these two experiments were run using different inocula and so would have had 
different community compositions. Significant increase, compared to the no 
antibiotic control, did not occur at many of the higher concentrations in the 
experiments presented in this section. It is unclear whether this lack of increase 
in tetG prevalence would have been observed at higher concentrations in the 
initial experiment (Section 6.4.1) and in Lundström et al., 2016 as these 
concentrations were not tested in either. 
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The first part of the work reported in this chapter was undertaken in 2016, 
before the study by Kraupner et al. 2018 was published. By the time that study 
was published, Aimee Murray had already undertaken a selection experiment to 
determine the MSC and LOEC of ciprofloxacin using the selection experiment 
method. This data, which can be seen in supplementary data Figures 87 and 88 
(Appendix), is due to be published in Stanton et al., 2019 alongside the 
macrolide data, as all of these compounds have been included on the 2018 
European Commission’s Water Framework Directive’s priority watch list 
(European Commission 2018). The Kraupner et al. 2018 study determined a 
selective endpoint for ciprofloxacin of 5 µg/L for the test tube system and 10 
µg/L for the biofilm system (although 5 µg/L of ciprofloxacin was not tested in 
the biofilm system). The test tube system used in Kraupner et al. 2018 used a 
lower temperature and lower nutrient content and was, therefore, more 
environmentally relevant than the methods used in this thesis. The ciprofloxacin 
data from Stanton et al., 2019 determined a MSC of approximately 11 µg/L and 
a LOEC of 15.625 µg/L using the intI1 gene. This, again, aligns well with the 
biofilm approach used by Kraupner et al., 2018 and validates the selection 
experiments used here against more environmentally relevant conditions. It may 
be coincidental, however, that on this occasion their results align well with the 
ciprofloxacin data determined by Aimee Murray using our experimental 
approach. Without determining the starting prevalence of the resistance genes 
tested, there is no clear evidence that what Kraupner et al., 2018 observed was, 
in fact, positive selection, or whether it is actually reduced negative 
selection/increased persistence, as we hypothesise was observed with tetG. 
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6.5.2 Increased persistence and the MIPC 
The MSC is defined as the concentration at which “the resistant mutant is 
enriched over the susceptible strain” (Andersson & Hughes 2011). The MSC 
was not, therefore, determined for tetracycline by Lundström et al. 2016 in all 
likelihood as no positive selection was seen to occur when repeating the 
experiment even though their observations could be approximately replicated 
(Figure 62A). This cannot be confirmed, however, without repeating their study 
and quantifying the prevalence in the starting inoculum. This raises an issue 
surrounding observations of significant effects within a sub-MSC selective 
window and a new selective endpoint is, therefore, proposed. The concentration 
at which a significant increase in persistence (or a reduced rate of negative 
selection) is observed could be defined as the minimal increased persistence 
concentration (or the MIPC). This is the lowest concentration at which there is 
an increase in resistance gene prevalence in comparison to when no antibiotic 
is present. However, the prevalence of the resistance gene is lower than the 
starting prevalence of the gene in the original inoculum and decreases over 
time. 
Although the MIPC is less concerning than the MSC when quantifying 
environmental risk, it will still increase the numbers of resistance genes and 
resistant bacteria found in the environment, in comparison to where no antibiotic 
is present. This will, in turn, increase the probability of horizontal gene transfer 
events and will also increase human exposure risk in the environment. As 
mentioned in Chapter 1, there can be human exposure to antibiotic resistance 
genes / bacteria in environmental settings, such as coastal waters, and this 
may, in turn, lead to gut colonisation by resistant bacteria (Leonard et al. 2018). 
Moreover, the increased prevalence of resistance genes and resistant bacteria 
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at concentrations above the MIPC (compared to when no antibiotic is present) 
may prime the community in the environment so that if the concentration of 
antibiotic were to increase to above the MSC, at a later date, a significant surge 
in resistance may be seen. If no antibiotic had been present, or had only been 
present at concentrations lower than the MIPC, there would be fewer, or no 
antibiotic resistant bacteria and resistance genes in the environment for 
selection to act upon. It could be reasoned, therefore, that the MIPC, rather than 
the MSC or the LOEC, should be used when determining discharge limits that 
protect against the development of resistance in the environment, as this will 
also minimise human exposure to resistant bacteria in the environment and 
reduce probability of further resistance evolution.  
The graph from the Gullberg et al. 2011 study, shown in Figure 3 in Chapter 1, 
has been revised to include the MIPC and is shown in Figure 77. As can be 
seen from this revised graph, both at sub-MIPC concentrations and throughout 
the sub-MSC persistence window, susceptible bacteria out-compete resistant 
bacteria. When a threshold concentration of antibiotic is reached (the MIPC) the 
growth rate of the susceptible bacteria starts to decrease. This reduces the 
susceptible to resistant bacterial ratio in the community, and hence increases 
the prevalence of the resistant bacteria, in comparison to when no antibiotic is 
present. Only when the MSC is reached, and the growth rate of the susceptible 
bacteria decreases below the growth rate of the resistant, is the resistant strain 
enriched over the susceptible and positive selection is observed. 
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Figure 77: Bacterial growth rate as a function of antibiotic 
concentration. Graph adapted from Gullberg et al. 2011 to include the sub-
MSC persistence window (blue area) and the MIPC. The blue line indicates 
the change of growth rate of susceptible bacteria with increasing 
concentrations of antibiotic. The red line shows the change in growth rate of 




6.5.3 Comparison to environmental concentrations of TET 
The LOEC and MSC reported here were based on intI1 prevalence and not on 
a TET specific resistance gene. These were 2,000 µg/L (LOEC) and 651 µg/L 
(MSC) of TET. PNECs (predicted no effect concentrations) of 100 and 65.143 
µg/L were calculated by applying a 10-fold assessment factor to the NOEC and 
MSC, respectively. The metagenome analysis found that a significant increase 
in prevalence of total TET resistance genes was observed at 125 µg/L, although 
no lower concentration was sequenced. This was lower than the LOEC and the 
MSC defined by qPCR, but as sequencing was not undertaken on the day 0 
samples it cannot be said with certainty that this was positive selection as 
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opposed to increased persistence. All of the values calculated here were, 
however, significantly higher than typical MECs of TET. 
Environmental concentrations taken from the UBA’s 2016 database determined 
a MECmax of 2,260 µg/L of TET in surface water in China. This is only slightly 
higher than the LOEC but significantly higher than the MSC determined for intI1. 
This MEC is, however, highly unusual. The MECmean and MECmedian are much 
more indicative of the typical range of environmental concentrations of TET. 
These were 17.035 µg/L and 0.108 µg/L, respectively, and do not take into 
account the many studies where TET was below the limit of detection. The 
range of typical MECs (i.e. MECmean and MECmax) are lower than the LOEC, 
MSC and PNECs determined here (Umweltbundesamt 2016).  
6.5.4 Comparison to previously defined selective endpoints 
TET MSCs determined by single species competition assays were 15 µg/L 
(from Gullberg et al. 2011) and 45 µg/L for plasmid based resistance, but 
decreased to 30 µg/L when this resistance element was transferred to a 
chromosome (Gullberg et al. 2014). The PNECR calculated by Bengtsson-
Palme & Larsson 2016 was 1 µg/L. It is expected that there would be 
differences between results from single species experiments and mathematical 
models on the one hand and the complex community experiments on the other 
hand. However, these results are significantly different to the selective 
endpoints determined in this chapter. The results from the work presented here 
would suggest that LOEC and MSC (defined here by intI1) may be 
underestimating selection of TET, although recent data suggests that a complex 
community context increases the MSC for gentamicin by over 40 times in 
comparison to single species assays (Klümper et al. 2019). TET resistance 
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genes from the metagenome data, illustrate a significant increase in prevalence 
over the control at every concentration tested. It is important, therefore, to use 
the information obtained by the metagenome analysis to inform further work 
using qPCR analysis to quantify other TET specific resistance genes. Results 
from that might then better align with previously defined selective endpoints. 
6.5.5 tetG and tetM 
No positive selection was observed for tetG at any concentration of TET in 
either of the selection experiments undertaken and reported in this chapter.  
One explanation is that tetG is not maintained well in environmental bacteria. In 
a study by Wang et al. 2014, however, tetG was strongly correlated with intI1 in 
reclaimed wastewater. It is possible to conclude, therefore, that tetG might 
follow a similar selective pattern to intI1 and that these environmental bacteria 
are able to maintain this gene. This, however, was not observed in the 
experiments reported here. Another explanation is that the bacterial species 
carrying these resistance genes were not favoured by the experimental 
conditions. This does not, however, negate the MIPC and importance of 
quantifying the prevalence at day 0. If day 0 had not been tested at these 
concentrations, positive selection may have been determined as the outcome at 
1 µg/L of TET. To fully understand what is occurring in experimental systems in 
relation to selection, quantifying the prevalence at day 0 is of great importance.  
Increased persistence is not only observed for tetG selection by TET. In 
Chapter 3, Section 3.4.3, a significant increase in prevalence of ermB was 
observed in comparison to the no antibiotic control for the all three macrolide 
antibiotics tested. This increase in prevalence was never higher than the 
original prevalence in the inoculum indicating increased persistence. There was 
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not, however, a dramatic drop in ermB prevalence from the beginning to the end 
of the experimental period, as was observed with change of tetG prevalence. 
The bacteria that are harbouring the ermB genes do not, therefore, appear to be 
impacted by the experimental conditions. It is concluded, therefore, that an 
increase in persistence is a true phenomenon that can occur and that positive 
selection was not observed for tetG because of an inability to adapt the 
laboratory conditions. 
For tetM, positive selection was observed at every concentration tested and in 
the no antibiotic control. This may be because the bacteria harbouring these 
genes are highly adapted to the experimental conditions. The increase 
observed at the no antibiotic control was, therefore, as a result of tetM 
harbouring bacteria outcompeting other bacteria less well adapted to these 
growth conditions. Only when a concentration of 128,000 µg/L of TET was 
reached was a significant increase in tetM genes seen in comparison to the no 
antibiotic control. This was determined, therefore, that this concentration of TET 
that is having a selective effect on this gene. 
To fully understand whether growth and shift in the community structure is 
behind the results for tetG and tetM, a method such as epicPCR (Spencer et al. 
2016) could be used in the future to link the resistance genes to their bacterial 
hosts. This could be used, in conjunction with 16S sequencing to determine 
diversity of the community, to fully understand the underlying mechanisms 




6.5.6 Future work 
Metagenome analysis identified alternative TET resistance genes that could be 
used to determine a more accurate LOEC and MSC than the intI1 endpoint and 
that may align better with selective endpoints from previous studies. However, a 
point to note is that when the community context is considered the intI1 MSC of 
approximately 651 µg/L is 14.5 times greater than the 45 µg/L reported by 
Gullberg et al., 2014, which aligns closely to the 13-fold difference observed for 
a focal species in the absence/presence of a community under kanamycin 
selection (Klümper et al. 2019). 
Three TET specific gene targets were promising candidates for future work on 
determining the MSC and LOEC of TET. Tet32, tetA and tetW all saw a 
biological effect at the lowest concentration of TET sequenced, with tetW 
determined to have a statistically significant increase at this concentration (125 
µg/L). Tet32 and tetA first saw a significant increase at 250 µg/L, the next 
concentration tested. QPCR should be undertaken on these genes to determine 
if this was positive selection, or significant increased persistence. TetA was 
tested in Lundström et al., 2016. Whilst attempts were made to use the qPCR 
primers from this study, it was found that they were unable to determine specific 
melt curves and new primers would, therefore, need to be designed for further 
work. 
6.6 Conclusion  
The methods used in experiments for this thesis; in Stanton et al., 2019 and 
Murray et al., 2018 are comparable to the more environmentally relevant 
methods used in Lundström et al., 2016 and Kraupner et al., 2018. This has 
been demonstrated by the TET work presented in this chapter and by the work 
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undertaken by Aimee Murray on ciprofloxacin. The ciprofloxacin work 
determined a comparable MSC and LOEC to the LOECs determined in 
Kraupner et al., 2018. The TET work, when analysing the data looking at day 7 
only, also aligned well to the MSC value given in Lundström et al., 2016.  
The TET work has also provided a valuable insight into a sub-MSC persistence 
window phenomenon. It has demonstrated the value of quantifying the 
prevalence of genes at the beginning of the experimental period in order to fully 
understand the changes of antibiotic resistance gene prevalence at varying 
concentrations of antibiotics over time. This was also the first time that a 
concentration at which increased persistence (i.e. reduced rates of negative 
selection) has been shown. The concentration at which this phenomenon first 
occurs can be defined as the minimal increased persistence concentration (or 
MIPC).  
An increase in persistence would lead to an increase in the absolute number of 
resistance genes found in the environment (compared to the situation where no 
antibiotic was present) and could potentially increase human exposure events 
to antibiotic resistance genes. It could be argued that the MIPC should be used 
(instead of the MSC) as the endpoint for defining safe release concentrations 
from wastewater treatment plants.  
Metagenome analysis revealed a significant increase, in comparison to the 
control, at the lowest concentration of TET sent for sequencing. Work to 
calculate a true MSC/LOEC for TET is still being undertaken with potential 
targets for qPCR being identified from the metagenome analysis. If the 
significant increases in these resistance genes, observed in the metagenome 
analysis, are from an increase in persistence, rather than positive selection, the 
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MSC of TET, currently defined by intI1, would be significantly higher than typical 


















Chapter 7: Discussion 
7.1 Real world implications and applications 
The work presented in this thesis provides novel insights into selection for 
antibiotic resistance at environmentally relevant antibiotic concentrations. Work 
presented in Chapter 3 is the first study to determine experimentally derived 
selective endpoints in complex microbial communities for the three macrolide 
antibiotics on the European Commission’s Water Framework Directive’s priority 
watchlist (European Commission 2015b; European Commission 2018). This 
work showed that current measured environmental concentrations (MECs) of 
macrolide antibiotics are not likely to select for resistance whether genotypic or 
phenotypic. In addition, Chapter 4 presents the first work showing the effects 
that mixtures of antibiotic compounds have on selective endpoints, suggesting 
that these tend to have additive or synergistic effects on selective endpoints. 
Furthermore, there has been no previous work investigating temperature effects 
on selective endpoints. Preliminary data presented in Chapter 5 illustrates that 
certain macrolide resistance genes are under weaker selection at lower 
temperatures and that minimal selective concentration (MSC) increases with 
decreasing temperature. Finally, Chapter 6 defined the term minimal increased 
persistence concentration (MIPC) and described the phenomenon of increased 
persistence for the first time in a comparison to previous work by Lundström et 
al., 2016.  
The findings presented in this thesis can be used to inform policy makers about 
the risk antibiotic residues pose to human health via selection for resistance in 
bacteria found in the environment. With this information, informed decisions can 
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be made to decide whether implementation of mitigation strategies is needed to 
reduce or eliminate antibiotic residues from entering the environment. 
7.1.1 Selective endpoints vary for different antibiotics 
From data produced and presented in this thesis and from other work which 
investigated selection for resistance in complex microbial communities, such as 
that by Murray et al., 2018 and Kraupner et al., 2018, it is clear that a “one size 
fits all” approach is not appropriate for determining the selective endpoints of 
antibiotics. Antibiotics such as cefotaxime (Murray et al. 2018), ciprofloxacin 
(Kraupner et al., 2018 and Figure 87 and 88 (Page 325 - Appendix)) and 
trimethoprim (TRMP) (Chapter 4) were selective at concentrations similar to 
those found in the environment when in isolation, whereas the macrolides 
(Chapter 3) and sulfamethoxazole (SMX) (Chapter 4) have selective endpoints 
that were significantly higher than current typical environmental concentrations.  
It appears that the variation in antibiotic potency leads to different selective 
ability. If the potency of the antibiotic is high and a lower concentration is 
required to see an effect, it follows that there will also be a strong selective 
pressure for resistance to develop at these lower concentrations. For example, 
AZ is known to be more potent and to have lower minimum inhibitory 
concentration (MIC) values than erythromycin (ERY) (Retsema et al. 1987) and 
it was typically more selective than ERY as can be seen from intI1 and mphA 
data from the qPCR analysis and total MLS (macrolide-lincosamide-
streptogramin) resistance from metagenome analysis (Chapter 3). It is unclear 
whether mode of action influences the potency of an antibiotic and whether a 
correlation is observed between mode of action and selective ability. Based on 
the results from antibiotics that select at low concentrations, such as TRMP 
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which disrupts synthesis of folic acid (Eliopoulos & Huovinen 2001); 
ciprofloxacin which prevents DNA replication (Redgrave et al. 2014) and 
cefotaxime which inhibits cell wall synthesis (LeFrock et al. 1982), and those 
that select at higher concentrations, such as SMX which disrupts folic acid 
synthesis (Eliopoulos & Huovinen 2001) and the macrolides which inhibit 
protein synthesis (Mazzei et al. 1993; Kannan & Mankin 2011), there is no clear 
correlation between mode of action and selective ability. A correlation may, 
however, become evident if the selective ability of more antibiotics is tested as 
the selective endpoints of only a limited range of antibiotics have been tested to 
date. 
Another explanation could be that there are differing fitness costs associated 
with the resistance genes tested. It is clear from the investigation in Chapter 3 
that different macrolide resistance genes behave differently at the same 
concentrations of antibiotic. The lower the fitness cost of the resistance gene 
and the genetic material associated with it, the lower the concentration needed 
for selection. For example, integrons have relatively low fitness cost (Lacotte et 
al. 2017) whereas plasmids are known for their high fitness cost (San Millan & 
MacLean 2017). The intI1 gene was quantified for all antibiotics tested. 
Concentrations of antibiotic needed to select for intI1 varied greatly, ranging 
from a lowest observable effect concentration (LOEC) of 62.5 µg/L of TRMP 
(Chapter 4) to LOECs of 100,000 µg/L for clarithromycin (CLA) and ERY 
(Chapter 3). The intI1 gene, encoding the class 1 integron, is often found in 
association with antibiotic resistance genes, and depending on the identity of 
the cassette genes associated with intI1, and where the integron is located (for 
example embedded in a plasmid (Gillings et al. 2008)), a different fitness cost 
may occur.  
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It is clear from the data presented in this thesis, and by other studies 
investigating selective endpoints, that environmental risk assessments must be 
undertaken on a compound by compound basis.  
7.1.2 Designing a risk assessment for selective endpoints 
Data presented in this thesis can be used to help inform the design of effective 
risk assessment protocols to help minimise selection for resistance in the 
environment. A number of factors should be taken into account: 
1. It is important to use a mixed microbial community when undertaking these 
risk assessments. Mixed community experiments provide more realistic insights 
into how an antibiotic affects a range of bacterial species, as well as the 
resistance genes and mobile genetic elements (MGEs) associated with those 
species, and how competition within a community impacts selection (Klümper et 
al. 2019). Although using mixed communities is important, this method does 
come with limitations. Natural variation between replicates can often be high, 
presumably related to small founder effects and stochastic processes, which 
may mean that a biological effect is seen but statistical significance is not 
determined at the lower concentrations where effect size is small. This variation 
is also evident when determining the line of best fit for selection coefficient 
graphs, as the highest R2 values are often relatively low. Increasing the number 
of replicates in these types of assays may be a way to minimise variation when 
undertaking risk assessments.  
2. It is clear that compounds cannot be assessed on an individual basis to 
provide information about selection in the environment as, based on data 
provided in Chapter 4, mixing of antibiotics always produces a stronger 
selective effect than when compounds are found in isolation. An effective risk 
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assessment must include complex mixtures if it is to mitigate selection in the 
environment. Current work has only investigated the effect of mixtures on 
selection for class specific antibiotic resistance genes or the intI1 gene. It is 
conceivable that a mixing effect of antibiotics could also increase co-selection 
for resistance genes effective against other antibiotic classes. 
3. Using qPCR has been reported as the most sensitive method for assessing 
selection for resistance (Lundström et al. 2016; Murray et al. 2018), although 
choice of candidate gene can greatly influence the results observed (as can be 
seen from the different results observed between ermF, mphA and intI1 for the 
macrolide antibiotics – Chapter 3). This would need to be taken into account 
when selecting gene targets for risk assessment. Metagenome sequencing can 
provide a useful tool to identify candidate genes. However, as has been seen 
with ermF (Chapter 3), the gene that responds at the lowest concentration does 
not always give the greatest response in terms of increase in prevalence. This 
could mean that, although a response is observed for a gene at a “lowest” 
concentration, other genes (such as mphA and intI1) may influence phenotypic 
resistance of the whole community on a greater scale. Quantifying intI1 using 
qPCR may be a useful tool to compare different antibiotics when investigating 
selective endpoints, as it is independent of specific gene identity. It may be a 
useful starting point to understand the concentration range at which selection 
may occur when there are a number of genes that are able to confer resistance 
to a particular antibiotic.  
4. It is critical to quantify the prevalence of the candidate gene in the inoculum 
or in the day 0 samples in order to fully understand the change in the 
prevalence of gene over time. Knowing the starting prevalence will mean it will 
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be possible to determine if positive selection is occurring or if it is, in fact, a 
significant increase in persistence. Without this, it is possible to misinterpret the 
data as a significant increase in positive selection when this may not, in fact, be 
the case. 
5. Once there is sufficient data on how temperature affects selective endpoints, 
temperature may need to be taken into consideration when undertaking risk 
assessments. If there is found to be a temperature effect, the temperature at 
which the experiment is undertaken may need to be adjusted to best mimic the 
environmental conditions for which the risk assessment is being undertaken, 
although arguably 37 °C is more likely to reflect selection in human adapted 
strains which are of greatest concern. However, it is possible that further work 
will reveal that selective endpoints are independent of temperature: 
ciprofloxacin selection experiments at 25 °C (test tube system) and 20 °C 
(biofilm system) in Kraupner et al., 2018 and at 37 °C (see Figure 87 and 88 
(Page 325 - Appendix)) reveal similar  selective endpoints. Although, as 
Kraupner et al., 2018 did not quantify the starting prevalence of resistance in 
their inoculum, this similarity may be coincidental.  
6. Finally, it will also be important for regulators to determine which selective 
endpoint to use for risk assessment. For positive selection, LOECs and MSCs 
are used throughout the work presented here. MSCs often provide a more 
protective selective estimate than LOECs. With natural communities, however, 
variation between biological replicates can often mean that a line of best fit 
(determined by statistical means) does not correlate well to the selection 
coefficient data. In addition, it is not always possible to determine a MSC value 
from a selection coefficient graph. If an increase in prevalence is observed over 
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time in the no antibiotic control (presumably as the bacteria harbouring these 
genes have a competitive advantage over other species in the starting 
inoculum), the line of best fit never crosses the x axis, which is the point that is 
defined as the MSC. Whereas the MSC might provide a more protective 
estimate, a LOEC value might provide a more realistic endpoint. Another 
consideration would be whether to use the MIPC as the selective endpoint as, 
although positive selection of resistance genes is not occurring, increased 
persistence (reduced rate of negative selection) could lead to increased 
numbers of resistant bacteria / resistance genes in the environment and, 
therefore, increased exposure risk and probability of horizontal gene transfer 
(HGT) and emergence of novel resistance mechanisms. 
7.1.3 Holistic approach for environmental risk assessment 
Work produced for this thesis, and by Murray et al., 2018, shows that 
implementing mitigation strategies to minimise selection for resistance would be 
more protective than existing ecotoxicology test endpoints. For example, a MSC 
of 0.4 µg/L was determined for cefotaxime by Murray et al., 2018. By applying a 
10-fold assessment factor to this value, a predicted no effect concentration 
(PNEC) of 0.04 µg/L was calculated. This is lower than the PNEC for the 
environment provided by the “AMR Industry Alliance Antibiotic Discharge 
Targets” document which lists 0.1 µg/L as the PNEC calculated from traditional 
ecotoxicology data (AMR Industry Alliance 2018). This is, however, not always 
the case. For example, LOECs of 1,000 µg/L were determined for AZ and ERY 
and 750 µg/L of CLA in Chapter 3. By applying a 10-fold assessment factor to 
the no observable effect concentrations (NOECs), PNECs of 75, 50 and 75 µg/L 
are calculated for AZ, CLA and ERY, respectively. These values are 
significantly higher than the PNEC values for surface water presented in the 
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meta-analysis study by Le Page et al., 2017 which were 0.019, 0.084 and 0.2 
µg/L for AZ, CLA and ERY, respectively. 
When undertaking risk assessment for antibiotics, and other co-selecting 
compounds, it is, therefore, important to determine the potential concentration 
thresholds for effects on non-target aquatic organisms in order to understand 
where, and at what concentration, mitigation needs to be implemented to 
protect the environment and human health. 
7.2 The importance of sub-MSC selection and the MIPC 
In Chapter 6, the persistence of antibiotic resistance genes was discussed and 
the MIPC defined. Increased persistence was identified for the first time when 
comparing the assay used in experiments presented in this thesis to the biofilm 
experiment reported in Lundström et al., 2016. It was suggested in Chapter 6 
that the MIPC might be a more appropriate and conservative estimate to use for 
environmental risk assessment, as opposed to using the MSC or LOEC, as it 
would be the most protective value to use when attempting to prevent the 
maintenance or enrichment of resistant bacteria and resistance genes in 
environmental microbial communities. 
The work presented in Chapters 3, 4 and 5 used thresholds for positive 
selection (LOECs/MSCs) to define selective endpoints and compared these 
endpoints to current MECs. If the MIPC is used as the selective endpoint, there 
is a question of whether mitigation strategies would need to be implemented to 
reduce the risk of increased persistence where they were not previously 
required. Further, for antibiotics where mitigation strategies are already needed, 
because current MECs are similar to LOEC/MSCs, there is a question of 
whether more stringent mitigation measures would be needed to prevent 
293 
 
persistence of resistance genes. It was considered appropriate, therefore, to 
reanalyse the data presented in Chapters 3, 4 and 5 using the MIPC as the 
selective endpoint to determine whether there is potential for those genes 
tested in the previous chapters to persist at current MECs.  
7.2.1 Selective endpoints of macrolides – work from Chapter 3 
Table 9 shows a comparison of LOECs, MIPCs and MECmax from data 
presented in Chapter 3. 
Table 9: Comparison of LOECs, MIPCs and MECmaxs (data presented in 
Chapter 3). 1 = PNECs derived by applying 10-fold assessment factor to the 
NOEC. 2 = Gene used to define LOEC. 3 = PNEC calculated by applying a 10-
fold assessment factor to MIPC. 4 = Gene used to define MIPC. 5 = MECmax 
values presented in Table 5 (Chapter 3). Concentrations are in µg/L. 
 LOEC NOEC PNEC1 Gene2 MIPC PNEC3 Gene4 MECmax5 
AZ 1,000 750 75 ermF 10,000 1,000 ermB 1.5 
CLA 750 500 50 ermF 100 10 mef  1 
ERY 1,000 750 75 ermF 0.1 0.01 ermB 2.42 
 
The MIPCs of CLA and ERY were lower than the LOECs. The MECmax of CLA 
was 6.6 times lower than the PNEC derived from the MIPC, as opposed to 33.3 
times when using the PNEC calculated from the LOEC. This may mean that 
strict monitoring of concentrations released from wastewater treatment plants 
(WWTPs) may need to occur and mitigation strategies implemented in the 
future. The MIPC of 0.1 µg/L of ERY, even without deriving a PNEC, was, 
however, lower than the MECmax. Mitigation strategies would, therefore, need to 
be implemented, which is not the case for the PNEC calculated from the LOEC.  
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7.2.2 Effect of mixtures on selective endpoints – work from Chapter 4 
Significant persistence of intI1 was observed to 90% confidence at 200 µg/L of 
SMX in SMX experiment 1 (p = 0.0806, Dunn’s test). If the MIPC is defined by 
using statistical significance to only 95% confidence, then no MIPC was found. 
It does, however, suggest an effect is occurring at 10-fold lower than the LOEC 
determined by the same experiment (2,000 µg/L). This value is now only 2.09 
times higher (as opposed to 20.9 times higher when using the LOEC) than the 
MECmax of SMX on the UBA database (when pharmaceutical effluent data has 
been removed) (Umweltbundesamt 2016).  
7.2.3 Effect of temperature on selective endpoints – work from Chapter 5 
The patterns of persistence observed for ermF and mphA are presented in 
Table 10. IntI1 is not shown as no persistence was observed. For mphA 
increased persistence was observed at a similar concentration when the 
experiment was undertaken at 20 and 28 °C as where positive selection was 
observed in the 37 °C experiment. 
Table 10: Comparison of LOECs and MIPCs of ermF and mphA at different 
temperatures. 1 = PNECs derived by applying 10-fold assessment factor to the 
NOEC. 2 = PNECs calculated by applying 10-fold assessment factory to MIPC. 
3 = Significant increase to 90% confidence is observed at 10,000 µg/L. 
Concentrations are in µg/L. 
Gene Temperature LOEC NOEC PNEC1 MIPC PNEC2 
ermF 
37 °C N/A3 N/A N/A 100 10 
28 °C N/A N/A N/A N/A N/A 
20 °C N/A N/A N/A 750 75 
mphA 
37 °C 750 500 50 N/A N/A 
28 °C 1,000 750 75 750 50 
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20 °C 10,000 1,000 100 500 50 
 
The qPCR targets were chosen for this temperature experiment based on the 
genes that were positively selected for in Chapter 3. For gene targets where no 
positive selection, but increased persistence, was observed (Chapter 3), these 
genes were not targeted in the temperature experiment (Chapter 5). It would be 
interesting to see, therefore, whether firstly, these genes still persist at 
temperatures below 37 °C and secondly, whether significant positive selection 
occurs at similar concentrations at which persistence was observed at 37 °C. 
The different bacterial hosts in which specific resistance genes reside may be 
more competitive at lower temperatures and, therefore, positive selection may 
occur at lower temperatures at concentrations where only significant 
persistence was previously observed at higher temperatures. Using qPCR to 
quantify genes such as ermB and mef family in this experiment may be an 
important next step to understanding the link between persistence, 
environmental conditions and lab assays. 
7.2.4 Summary of the persistence phenomenon 
Having analysed the data presented in this thesis from a persistence 
perspective, it is clear that this phenomenon occurs for a range of antibiotics 
from a number of different classes and not just for TET. An increase in 
persistence was observed for a number of antibiotic resistance genes at a 
range of antibiotic concentrations, including those indicative of environmental 
concentrations. As when determining MSCs/LOECs, a case by case basis 
approach would need to be taken to determine the MIPC for each antibiotic for 
each gene.  
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Data produced from the temperature experiment indicates that persistence 
occurring at a low temperature (20 or 28 °C) could be indicative of positive 
selection occurring at a higher temperature (37 °C). It would be interesting to 
test other genes that do not see positive selection at 37 °C to see if the opposite 
is true.  
In some cases (such as ermB in the presence of ERY) a linear relationship was 
not observed for increased persistence. At relatively low antibiotic 
concentrations, a significant increase in persistence occurs, which then 
disappears at concentrations immediately above, but a significant increase was, 
once again, observed at even higher concentrations. It might be expected that 
the relationship between antibiotic concentration and resistance gene 
prevalence should be linear, however, in a complex bacterial community it is 
entirely possible that a certain species or group of species that are unable to 
compete at low concentrations without harbouring resistance genes will see an 
increase in resistance prevalence. As concentrations of the antibiotic become 
toxic to this species, the resistance prevalence of this gene may drop back 
down. Species that are more tolerant to the low levels of antibiotics may only 
significantly increase their resistant mutants at significantly higher 
concentrations of antibiotic. “Environmental filtering” (where it is proposed that 
the environment (here the antibiotic concentration) that species reside in, 
selects for certain species and affect community structure (Cadotte & Tucker 
2017)) could explain why a non-linear dose response in prevalence was 
observed across an antibiotic concentration gradient. There are a multitude of 
factors that need to be considered such as host/gene interaction and 
gene/mobile genetic element interaction and the associated fitness cost of such 
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interactions at various antibiotic concentrations to explain the non-linear 
response observed.  
7.3 Future work 
In light of the novel data presented here, it is evident that there is still a 
significant amount of work needed to fully elucidate aspects of selection and 
maintenance of resistance genes in the environment. In addition to future 
research suggested in individual chapters (investigating the effect of more 
complex mixtures and continuing work to fully determine the effect of 
temperature on selective endpoints), there are two other key areas where 
further work is essential to help improve environmental risk assessment: 
1. Investigating the effect of inoculum on selective endpoints. 
It is clear in the case of TRMP and SMX (Chapter 4), TET (Chapter 6 in 
comparison to Lundström et al., 2016) and ciprofloxacin (experiment 
undertaken by Aimee Murray, presented in Stanton et al., 2019 and in the 
Figure 87 and 88 (Page 325 - Appendix) in comparison to Kraupner et al., 2018) 
that different inocula does not significantly affect selective endpoints. This does 
not appear to be the case, however, for the macrolides for which the 
concentration at which positive selection was observed varies with inoculum 
used. This variation was particularly evident for ermF. In Chapter 3, a LOEC of 
10,000 µg/L was established whereas in Chapter 5, a LOEC could not be 
determined when repeating the experiment under the same experimental 
conditions but with new inoculum. Significance to 90% confidence was 
observed at 10,000 µg/L, which was 10-fold higher than the LOEC determined 
in Chapter 3. For ERY, in Chapter 3 the LOEC was 1,000 µg/L. In the 
verification experiment reported in Chapter 4 (Figure 38), the LOEC was 500 
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µg/L and was, therefore, reduced by a half. It is unclear whether this change in 
response is a result of the gene, the bacterial species where it is found, the 
antibiotic or a combination. It is also unclear if overall macrolide resistance 
would also be affected, as data from the metagenome analysis showing MLS 
resistance, correlate better with other macrolide resistance genes and intI1. 
Understanding more about the inoculum effect and whether selective endpoints 
are significantly affected will be important in understanding the robustness of 
the assay used in data presented in this thesis and whether it can be used for 
determining selective endpoints as part of risk assessment. 
2. Investigating whether persistence at one temperature is an indicator of 
positive selection at another 
Increased persistence and the MIPC have been observed for a number of 
resistance genes for three of the four antibiotic classes tested. Results from the 
temperature experiment presented in Chapter 5 showed that significant positive 
selection at 37 °C could potentially be an indicator of significant persistence at 
lower temperatures. Next steps would be to investigate whether this is the case 
for other antibiotics and other resistance genes or whether it just a phenomenon 
observed for mphA. If increased persistence is occurring regularly for the 
majority of antibiotics, it may justify use of the MIPC as the selective endpoint 
for environmental risk assessment. 
7.4 Concluding remarks 
Data produced and presented in this thesis shows that there are many variables 
to consider when assessing thresholds of antibiotic concentrations that will limit 
selection for resistance in the environment. Selection for resistance can occur 
by the introduction of antibiotic residues from anthropogenic sources, such as 
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WWTPs. By limiting the release of antibiotic residues, the maintenance and 
persistence of resistance genes in environmental microbial communities may be 
reduced. Developing a risk assessment that is able to encompass all of these 
considerations is vital for reducing selection and for minimising human exposure 
events. Limiting mobilisation of environmental resistance genes to clinical 
pathogens, which may occur in polluted environments, could prove to be one 
critical approach to reducing resistance load when treating clinical infections 




















Figure 78: Map showing the two wastewater treatment plant sampling sites in 
Cornwall. Red indicates the Camborne and Redruth plant which serves a 
population of approximately 34,000 people. Blue indicates the Falmouth and 
Penryn plant that serves a population of approximately 43,000 people. Map was 










Table 11: Measured environmental concentrations of macrolide antibiotics. 
Table shows the measured environmental concentrations of azithromycin (AZ), 
clarithromycin (CLA), erythromycin (ERY) and erythromycin – H2O (ERY-H2O). 
The matrix, location and reference for each study can also be seen. All 
concentrations are in µg/L.  
Location AZ CLA ERY ERY-H2O Reference 




0.068 - - - 
(Gros et al. 
2007) 
Ebro River 
Basin – Ebro 
0.016 - 0.034 - 





0.009 - 0.029 - 
(Gros et al. 
2007) 
Ebro River 
Basin – Arga 
0.022 - 0.037 - 
(Gros et al. 
2007) 
Ebro River 
Basin – Ebro 
0.023 - 0.071 - 





0.017 - 0.021 - 
(Gros et al. 
2007) 
Ebro River 
Basin – Ebro 
0.014 - 0.044 - 










0.6695 - - - 
(Bartelt-




0.0635 - - - 
(Bartelt-






1.5467 - - - 
(Bartelt-




0.2835 - - - 
(Bartelt-




0.6904 - - - 
(Bartelt-




0.150 - - - 
(Grujić et 
al. 2009) 
Milan, Italy - 0.104 0.034 - 
(Zuccato et 
al. 2010) 
Varese, Italy - 0.052 0.027 - 
(Zuccato et 
al. 2010) 
Lugano, Italy - 0.437 0.059 - 
(Zuccato et 
al. 2010) 





- 0.702 - - 
(Spongber




- 0.6106 - - 
(Spongber




0.960 1 - - 
(Morasch 
et al. 2010) 





- 0.0181 0.0474 - 
(Zuccato et 
al. 2010) 
Colorado (1) - 0.01 - - 
(Ferrer et 
al. 2010) 




Colorado (3) - 0.172 1.2 - 
(Ferrer et 
al. 2010) 













Iowa (1) - - - 0.22 
(Kolpin et 
al. 2004) 






- - 0.43 - 
(Weihai Xu 




- - 2.054 - 
(Weihai Xu 




- - 0.216 - 
(Weihai Xu 




- - 0.259 - 
(Weihai Xu 
et al. 2007) 
Surface 
Water 
















































- 0.0083 0.0045 - 
(Zuccato et 
al. 2010) 
Colorado (1) - - 0.052 - 
(Ferrer et 
al. 2010) 






- 0.0089 - - 
(Heberer et 
al. 2008) 



















































































- - 0.0056 - 
(Lissemore 




- - - 0.00335 
(Wei-hai 





- - - 0.03 
(Wei-hai 







- - - 0.46 
(Wei-hai 















- - 0.00757 - 





- - 0.510 - 





- - 2.42 - 






- - 0.24 - 
(Matongo 
et al. 2015) 
Jianhan 
Plain, China 
- - - 4 




- - - 0.0678 





- - - 0.0896 









  0.107  
(Osorio et 
al. 2012) 
Ebro, Spain - - 0.071 - 
(Osorio et 
al. 2012) 































































     
Belgrade, 
Serbia 












- - - 2.3 





     
Chivasso, N. 
Italy 
- 0.0203 0.0159 - 
(Calamari 
et al. 2003) 
Mezzano, N. 
Italy 
- 0.00124 0.00392 - 
(Calamari 
et al. 2003) 
Boscone, N. 
Italy 
- 0.00156 0.00324 - 
(Calamari 
et al. 2003) 
Pacenza, M. 
Italy 
- 0.00338 0.00456 - 
(Calamari 
et al. 2003) 
Cremona, N. 
Italy 
- 0.00049 0.00141 - 
(Calamari 
et al. 2003) 
Casalmaggio
re, N. Italy 
- 0.0008 0.0014 - 
(Calamari 




- 0.00167 0.00275 - 
(Calamari 




- 0.00831 0.0045 - 
(Calamari 








Figure 79: mef family as a function of low azithromycin concentrations (1 high 









Figure 80: Scatter plot showing the variation in mphA prevalence at day 7 in 











Figure 81: Graph showing the selection coefficient of ermF by AZ. The line of 
best fit (polynomial order 3, y = 0.2305 + 0.001955x – 4.514e-06x2 + 2.9e-09x3, R2 
= 0.3268, standard error = 0.165) lies above and never crosses the x axis. A 








Figure 82: Graph showing the selection coefficient of ermF by CLA. The line of 
best fit (polynomial order 3, y= 0.05846 + 0.0006282x – 2.2e-06x2 + 1.752e-09x3, 
R2 = 0.07934, standard error = 0.2595) never crosses the x axis and no MSC 









Figure 83: Bar chart showing the change in ermB with increasing concentrations 
of ERY from the metagenome dataset. A biological effect is observed at every 
concentration of ERY but this is not reflected by the statistical analyses. 

















Table 12: Table showing the macrolide resistance genes prevalence data as a 
function of AZ concentration. This corresponds to the heat map in Figure 24.  
AZ Concentration (µg/L) 
Gene 0 250 750 1,000 10,000 100,000 
ereA 3.54103E-05 0 0 0 0 0 
erm(33)  4.6E-05  2.81E-05 3.31E-05 0.000474 
erm(35) 0 0 0 1.28E-05 0 0 
erm(TR) 0.00746485 0.006062 0 7.02E-05 0 0 
ermA 0.000194058 8.49E-05 1.53E-05 7.38E-05 0.000248 0.000706 
ermB 0.023137095 0.009235 0.002392 0.002942 0.016567 0.01461 
ermC 0.031146696 0.018534 0.003893 0.003684 0.027257 0.654675 
ermF 0.000277894 0.000993 0.005862 0.001605 0.00387 0 
ermG 1.77022E-05 0.000232 0.000164 7.89E-05 0.000231 0 
ermT 1.77022E-05 0 2.7E-05 0 0 0.000184 
ermX 0 8.84E-05 0.000105 0.000273 0.001221 0 
macA 0.044334584 0.05598 0.058576 0.061876 0.056861 0.018053 
macB 0.037428599 0.047557 0.041486 0.049973 0.05255 0.017585 
mefA 0.000249631 0.001168 0.000658 0.000296 0.000241 0 
mphA 0.034428077 0.073797 0.005827 0.329763 0.773598 0.811059 
mphC 0 0 0 0 4.08E-05 0 
msrA 0 0 0 0 3.09E-05 0 
msrC 0 0.000301 0.00033 4E-05 0.000892 0.000914 
 
Table 13: Table showing the macrolide resistance genes prevalence data as a 
function of CLA concentration. This corresponds to the heat map in Figure 25.  
CLA Concentration (µg/L) 
Gene 0 250 750 1,000 10,000 100,000 
ereA 0 0 3.28E-05 0 0 0 
erm(33) 3.6E-05 2.53539E-05 0.000105412 2.71E-05 8.08E-05 0.000263 
erm(35) 1.62E-05 0 8.88741E-05 0 0 0 
erm(TR) 0.004957 0.002411652 0.003208841 0 0 0 
ermA 0.000779 0.000749452 0.001184186 0.000166 0.000965 0.002859 
ermB 0.000569 0.009769525 0.008855561 0.005629 0.002608 0.006882 
ermC 0.000942 0.015195154 0.017274193 0.011173 0.0078  0.049227 
ermF 0.000361 0.002727658 0.002717686 0.004233 0.007371 0 
ermG 5.28E-05 5.05E-05 0.000560938 0.001114 0.000998 0 
ermT 1.77E-05 0 0.000775099 0 0 5.43E-05 
ermX 0.000411 0.000283887 0.000578388 0.000643 0 0 
macA 0.051843 0.058223806 0.05135268 0.060243 0.058272 0.054447 
macB 0.038174 0.046608147 0.039035005 0.048187 0.055031 0.053273 
mefA 4.02E-05 0.0003612 0.000234183 0.000974 0.002772 9.76E-05 
mphA 0.061343 0.01591802 0.017642728 0.025576 0.177631 0.625464 
mphC 0 8.24215E-05 0 0 0 8.56E-05 
313 
 
msrA 0 5.95362E-05 0 0 0 8.16E-05 
msrC 0.000152 0.000247554 0.000597686 0.000342 0.000374 0.000309 
 
Table 14: Table showing the macrolide resistance genes prevalence data as a 
function of ERY concentration. This corresponds to the heat map in Figure 26.  
ERY Concentration (µg/L) 
Gene 0 250 750 1,000 10,000 100,000 
ereA 0 3.598E-05 0 0 0 1.43E-05 
ereB 0 0 0 0 0 3.2991E-05 
erm(33) 5.92E-05 0 0 0 6.9E-05 0 
erm(TR) 0.00826 0 0 0 0 0 
ermA 0.0012979 0.00118248 0.00022 0.00013 0.00092 0.000443 
ermB 0.0001945 0.0067202 0.00297 0.00425 0.00932 0.009428 
ermC 0.0010816 0.0129639 0.00515 0.00375 0.009 0.0159287 
ermF 0.0003654 0.00062207 0.000905 0.00362 0.00754 0.00033338 
ermG 0 5.538E-05 6.14E-05 0.00025 0.00146 0.000643 
ermT 2.95E-05 0 0 0 0.00152 0 
ermX 0.000103 0.000225 0.001027 0.00066 0.0002 0 









mefA 1.815E-05 0.000455 4.98E-05 0.00093 0.00013 5.066E-05 
mphA 0.0974475 0.00816996 0.00022 0.027 0.1371 0.68416351 
msrA 0 0 1.02E-05 0 0 0 
msrC 0.000157 0.0003775 6.84E-05 0.00025 0.00035 0.0006817 
 
Table 15: Table showing the prevalence data of antibiotic resistance gene 
classes as a function of AZ concentration. This corresponds to the heat map in 
Figure 29.  
AZ Concentration (µg/L) 






















































Fosmidomycin 0.04222 0.05944 0.04929 0.05864 0.05855 0.02023
314 
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Table 16: Table showing the prevalence data of antibiotic resistance gene 
classes as a function of CLA concentration. This corresponds to the heat map in 
Figure 30.  
CLA Concentration (µg/L) 















































































































































































Table 17: Table showing the prevalence data of antibiotic resistance gene 
classes as a function of ERY concentration. This corresponds to the heat map 
in Figure 31.  
ERY Concentration (µg/L) 































































































































































Figure 84: Heatmap showing the total community structure of samples 








Table 18: Table showing the data that corresponds to the heatmap shown in Figure 34. Data is the output from MetaPhlAn2 is relative 
abundance of species found in the day 7 sample of the AZ evolution experiment. Relative abundance is calculated by normalising the 
total reads per clade to the nucleotide length of the clade’s key markers (Segata et al. 2012). E. unclassified = Escherichia unclassified. 
Azithromycin 
(µg/L) 0 250 750 1000 10000 100000 
V. ratti 8.64 0 
21.0
2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
S. infantarius 3.30 0.95 2.67 0 0 0 0.01 0.03 0 0 
0.00
5 0 0.02 0 0.01 0.33 0.19 0.03 
A. baumannii 0.54 0.72 0.00 0 0 0 0 0 0 0 0 0 0 0.22 0 0 0 0 
P. harei 1.40 
16.8
5 0.00 0 
11.4
4 0.03 0 0 0 0 0 0 0 0 0 0 0 0 
S. aureus 0.77 
16.5
7 1.13 0 0.00 0.00 0 0 0 0 0 0 0 0 0 0 0 0 
E. limosum 0.01 0.22 0.00 0.21 1.98 0.56 0 0 0 0 0 0 0 0 0 0 0 0 
B. dorei 0.22 0.28 0.09 0.03 1.32 0.33 2.36 0 0.06 0.85 0.96 0.19 0 0 0 0 0 0 
F. ulcerans 3.61 0.15 0.00 0.00 1.62 3.95 6.79 0 0 0.02 0 0.02 0 0 0 0 0 0 
M. morganii 0.68 0.44 0.54 1.83 0.99 1.39 0.43 1.30 0.39 1.05 0.49 0.53 3.17 1.08 1.54 0 0 0 
B. uniformis 1.17 0 0.53 0.90 1.48 1.12 0.47 1.47 0.56 0.58 0.87 0.45 1.08 8.30 0.54 0 0 0 
C. freundii 0.30 0.19 0.11 0.20 0.07 0.02 0.25 0.12 0.07 0 0.21 0.30 0.01 0 0 0 0 0 
B. 
thetaiotaomicro
n 0.42 0.29 0.11 0.32 0.33 0.32 0.23 0 0.60 0 0 0.61 0 0 0 0 0 0 
B. fragilis 0.17 0.88 0.30 0.25 0.18 0.10 0.94 0.41 0.10 0 0 0.22 0.26 0 0 0 0 0 
P. alcalifaciens 0.00 0 0.00 0.03 0.00 0.06 0.48 0.39 0.08 0 0.22 0.06 0 0 0 0 0 0 
E. cloacae 0.13 0 0.03 0.62 0.05 0.15 0.35 1.10 0.05 0.05 0.18 0 0 0 0 0 0 0 






E. avium 0.14 0.17 0.13 0.15 0.50 0.44 0.31 0.07 0.09 0 0.21 0 0.45 0 0.42 0.19 1.21 1.35 
E. faecalis 0.43 0.10 1.84 0.74 0.10 1.21 0.00 0.02 0 0.06 0 0 0 0.05 0 2.00 0.60 1.73 
S. lutetiensis 0.00 0 0.00 0.04 0.11 0.12 0.06 0.24 0 0 0.10 0.05 0.06 0 0.03 0.98 0.51 0.17 
P. mirabilis 6.45 13.6 
21.2







































9 4.78 8.10 
14.4
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4 8.53 4.29 
10.5


































C. phage CR5 0.00 0 0.00 0 0 0 0 1.15 2.68 0 0 
14.9
3 0 0 0 0.00 0 0 








Figure 85: Heatmap showing the total community structure of samples 







Table 19: Table showing the data that corresponds to the heatmap shown in Figure 35. Data is the output from MetaPhlAn2 is relative 
abundance of species found in the day 7 sample of the CLA evolution experiment. Relative abundance is calculated by normalising the 
total reads per clade to the nucleotide length of the clade’s key markers (Segata et al. 2012). E. unclassified = Escherichia unclassified. 
K. unclassified = Klebsiella unclassified. 
Clarithromycin 
(µg/L) 
0 250 750 1000 10,000 100,000 
S. simulans 6.45 0.23 2.21 0 0 0 4.23 0 0 0 0 0 0 0 0 0 4.50 0 
S. haemolyticus 0 0.02 0 0 0 0 0 0 0.27 0 0 0 0.13 0 0 2.28 3.50 1.40 
E. faecalis 0 0.31 0.09 2.80 0 0 12.22 0 0 1.96 0 0 1.28 1.10 0 2.93 1.18 0.14 
P. harei 0.05 0 10.93 0 0 0.07 0.04 2.04 0 0 0 0 0 0 0 0 0 0 
S. aureus 0 6.20 12.63 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
S. infantarius 4.33 0.14 8.20 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
E. unclassified 6.69 22.18 9.53 11.82 17.55 9.00 8.90 14.00 21.86 26.63 16.80 14.08 26.66 15.32 15.95 22.12 20.01 28.07 
E. coli 40.24 36.44 9.40 40.81 44.30 35.98 27.62 37.79 42.51 49.01 53.21 30.30 60.51 53.06 67.32 72.10 68.21 67.21 
P. mirabilis 33.33 21.09 40.61 33.68 21.51 25.18 34.55 23.60 9.49 4.08 2.01 37.73 0 23.82 0.62 0 0 0 
K. pneumoniae 4.33 2.24 3.51 6.13 5.23 22.42 7.40 12.95 7.37 11.90 12.62 8.93 3.27 3.61 8.12 0 0 0.07 
V. ratti 0 0 0 0 0 0 0 1.93 14.49 0 0 0 0 0 0 0 0 0 
E. faecium 0.09 0.20 0.04 0.25 0.25 0.33 0 1.77 0.55 0.02 0 1.29 0 0 1.67 0 0 1.01 
B. dorei 0.29 0.36 0.15 0.29 0 0 0 0.22 0 0 2.67 0.83 0 0 2.20 0 0 0 
M. morganii 0.78 0.03 0.32 0.69 0.92 0.86 0.59 0.56 0.83 0.94 2.60 0.07 0.15 0 0 0 0 0 
B. uniformis 0.83 0.53 1.00 1.87 3.96 1.03 1.56 3.41 0.82 3.54 1.74 2.01 0.20 0.00 3.30 0 0 0 
K. unclassified 0 0.22 0 0 0 0 0 0.51 0 0 1.17 0.97 0 0.68 0 0 0 0 






E. cloacae 0.12 0.14 0 0.11 0.18 0.48 0.27 0.35 0.07 0.06 0.10 0.24 0.04 0 0 0 0 0 
C. freundii 0.33 0.01 0.03 0.14 0.06 0.47 0.14 0.01 0.15 0.13 0 0.19 0.04 0 0 0 0 0 
B. 
pseudolongum 0 0 0 0.26 0 0.43 0.50 0.29 0.30 0 0 1.77 0 0 0 0.02 0 0 
E. avium 0.59 0.62 0.22 0.08 0.62 1.69 0.16 0 0.46 0.01 0.03 1.07 0.18 0 0 0.21 0.58 1.60 
B. 
thetaiotaomicron 0.37 0.58 0.17 0 0.69 0.49 0 0 0.46 0 0 0 0 0 0 0 0 0 
E. raffinosus 0 0.13 0 0.46 0 0 0 0 0 0 0 0 0 0.17 0.58 0 0 0 
E. asini 0 0 0 0.34 0 0 0.66 0 0 0.37 0 0 0 0 0 0 0 0 




Figure 86: Heatmap showing the total community structure of samples 









Table 20: Table showing the data that corresponds to the heatmap shown in Figure 36. Data is the output from MetaPhlAn2 is relative 
abundance of species found in the day 7 sample of the ERY evolution experiment. Relative abundance is calculated by normalising the 
total reads per clade to the nucleotide length of the clade’s key markers (Segata et al. 2012). E. unclassified = Escherichia unclassified. 
K. unclassified = Klebsiella unclassified. 
Erythromycin 
(µg/L) 
0 250 750 1000 10,000 100,000 
K. pneumoniae 
4.33 2.24 3.51 5.94 2.80 3.46 2.32 2.66 
17.6
4 
9.00 7.49 2.45 0.33 2.68 4.40 0.00 0 0 
S. simulans 6.45 0.23 2.21 3.87 0 0 0 0.03 0 0 0 0 0 3.89 0 0 0 0 



















































































5.54 3.80 0 
15.6
6 






4.99 0 0 0.05 
V. ratti 
0 0 0 0 2.10 0 0 0 0 0 
19.4
3 
0 0 0 0 0 5.56 0 
B. 
thetaiotaomicron 
0.37 0.58 0.17 0 0.61 0 0 0 0 0 0.98 0 0 0 0 0 0 0 
B. ovatus 0.44 0.09 0.15 0 0 0.07 0 0 0.09 0 0 0.69 0 0 0 0 0 0 
E. cloacae 0.12 0.14 0 0 0 0.13 0 0 0.34 0.05 0.26 0 0 0.20 0 0 0 0 
B. longum 0 0.06 0 0.21 0.33 0.14 0 0.07 0.79 0.16 0.07 0.13 0 0 0 0 0.00 0 
E. faecium 0.09 0.20 0.04 0 0.04 1.08 0 0.03 0.76 0.67 0.61 0.04 0 0.54 0.89 0 2.09 0.70 






M. morganii 0.78 0.03 0.32 0 0 0.08 0 0 0.75 0.03 0.66 0.02 0 0.07 2.49 0 0 1.75 
B. uniformis 0.83 0.53 1.00 1.23 3.57 0.24 0.28 0.15 0.72 0.28 0.77 0.52 0.10 0.79 5.86 0 0.52 0 
B. dorei 0.29 0.36 0.15 0.04 3.85 0 0 0.01 3.21 0 0 1.94 0 5.12 3.77 0 0 0 
E. faecalis 0 0.31 0.09 6.67 2.31 0 0.76 0.58 0 0 0 1.75 5.22 0 0 0.74 0 0 
B. fragilis 0.21 0.63 0.42 0.16 0 0.07 1.70 0.93 0 0.49 0.13 6.36 0.32 0 0 0 2.44 0 
K. unclassified 0 0.22 0 0 0 0 0.00 0.16 0 1.13 0 0 0 0 0 0 0 0 
E. raffinosus 0 0.13 0 0 0 0 0 0.06 0 0.52 0 0 0 0.01 0 0 0.09 0 
B. 
pseudolongum 
0 0 0 0.02 0 0 0.28 0.24 0 0.56 0.16 0 0.65 0 0 0 0 0 
S. gallolyticus 0 2.26 0 0 0 2.26 0 0 0 0 0 0 0.00 0 0 0 0 0 
E. hirae 0 2.56 0 0 0 0 0 0 0 0 0 0 0 0 0.04 0 0 0 





Figure 87: Selection of intI1 by ciprofloxacin. Significant positive selection was 
observed to 90% confidence at 15.625 (p = 0.0634, GLM Gamma (identity)) and 
31.25 (p = 0.0553, GLM Gamma(identity)) and to 95% confidence at 62.5 µg/L 
(p = 0.0491, GML, Gamma (identity)) and at every subsequent higher 
concentration. Standard error is represented by the error bars. * = significant 









Figure 88: Selection coefficient of intI1 in the presence of ciprofloxacin. The line 
of best fit (polynomial, order 4 – y = 0.1093 + 0.293x – 0.5274x2 + 0.1921x3 – 
0.0188x4, R2 = 0.4397, standard error = 0.2645, x intercept = 10.77) determines 
a MSC of approximately 11 µg/L of ciprofloxacin. The square root of 



















Figure 89: Graph showing full 24 hour growth rate for SMX experiment 1 






Figure 91: Graph showing full 24 hour growth rate for SMX experiment 2 
 
 





Figure 93: Selection coefficient graph for intI1 in the presence of TRMP in 









Figure 94: Selection coefficient graph for intI1 in the presence of TRMP in when 











Figure 95: Selection coefficient graph for intI1 in the presence of SMX in 
isolation. The MSC is determined to be approximately 841 µg/L. The square 
root of SMX concentration has been plotted. The data values plotted equate to 




















Figure 96: Selection coefficient graph for intI1 in the presence of SMX in when 
mixed with TRMP. The MSC is determined to be approximately 69 µg/L. The 
square root of SMX concentration has been plotted. The data values plotted 
equate to the absolute concentration values of 0, 62.5, 125 and 250 µg/L of 








Figure 97: Graph showing the growth rate of a mixed community at 37 °C during 










Figure 98: Graph showing the growth rate of a mixed community at 28 °C during 








Figure 99: Graph showing the growth rate of a mixed community at 20 °C. A 
starting and final OD was quantified. Hour readings were taken between hour 












Figure 100: mphA as a function of AZ at 37 °C at day 7. B: mphA as a function 
of AZ at 28 °C at day 7. C: mphA as a function of AZ at 20 °C at day 14. x = 
significant increase in comparison to the control to 90% confidence.  xx = 
significant increase in comparison to the control to 95% confidence.  ** = 
significant positive selection to 95% confidence. Standard error is represented 








Figure 101: Selection coefficient of tetG by TET. A MSC is not determined as 
the line of best fit (polynomial order 4, y = -1.357 – 0.01895x + 0.0003157x2 – 
1.439e-06x3 + 1.994e-09x4, R2 = 0.239, standard error = 0.4172) never crosses 
the x axis. The square root of all tetracycline concentrations from both the low 




















Figure 102: Selection coefficient of tetM by TET. A MSC is not determined here 
as the line of best fit (polynomial order 2, y = 0.41 – 0.0024x + 7.5e-6x2, R2 = 
0.119, standard error = 0.119) never crosses the x axis. The square root of 
tetracycline concentration was plotted. All of the concentrations from both the 



















Figure 103: Heatmap showing all detectable tetracycline resistance genes as a 
function of TET concentration. If the prevalence is displayed the genes with high 
prevalences skew the data and it appears that genes at lower prevalences are 
undetectable. The log(prevalence) is, therefore, represented in this graph. 
Genes that were undetected in all samples were excluded; these were tcr3, 
tet31, tet36, tet39, tet41, tet43, tetG, tetT, tetV, tetY and tetZ. White areas 
represent where the gene was below the limit of detection. * = significance to 

















Figure 104: Co-selection of antibiotic resistance gene classes by tetracycline. 
Co-selection is observed at the lowest concentration of TET sequenced for the 
classes aminoglycoside, bleomycin and trimethoprim. Other classes displayed 
here see an increase in their resistance genes at higher concentrations. White 
represents where the prevalence of a class is below the limit of detection. 
Classes that were below the limit of detection in every sample sequenced are 
not represented here. These were carbomycin, fusidic-acid, puromycin, 
spectinomycin and tetracenomycin-C. * = significance to 90% confidence, ** = 
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